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Many patients have suffered gnevously and needlessly because a series of clinicians 
unacquainted with myofascial tngger points erroneously applied the psychogenic label to 
them covertly if not overtly 
Dr Janet Traveil (1901 - 1997) and dr David Simons (1922 - 2010) 
INTRODUCTION 
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INTRODUCTION 
Incidence and prevalence of shoulder pain 
Shoulder pain is a very common musculoskeletal disorder In primary care, the yearly 
incidence is estimated to be 14 2 per 1000 people The one-year prevalence in the general 
population is estimated to be 20 to 50% The estimates are strongly influenced, for example, 
by the definition of shoulder disorders, including or excluding limited motion, age, gender, 
and anatomic area Thus, shoulder pain is widespread and imposes a considerable burden 
on the affected person and on society Women are slightly more affected than men and the 
frequency of shoulder pain peaks between 46 and 64 years of age ' People at high nsk of 
shoulder pain include those working as cashiers, garment workers, welders and bricklayers 
as well as those who work with pneumatic tools or in the meat industry Hairdressers, 
plasterers, assembly workers, packers and people who work for long hours at computers, 
such as secretanes and programmers, are also at high nsk 2 Shoulder pain tends to be per-
sistent or recurrent ' Between 22 and 46% of patients who visu a medical practitioner 
because of shoulder pain report a history of a previous pain episode ' 4 Six months after 
initial medical consultation and despite medical treatment, persistent shoulder symptoms 
have been reported in up to 79% of patients Of those with persistent symptoms, more 
than half typically do not seek any additional treatment't , 
Definition of shoulder pain, shoulder complaints and shoulder disorder(s) 
Shoulder pain, shoulder complaints and shoulder disorders are frequently used terms and 
appear synonymous According to the online version of the Oxford dictionary, a disorder 
is defined as a disruption of normal physical or mental function, a complaint as an illness 
or medical condition (especially a relatively minor one) and pain as physical suffenng or 
discomfort caused by illness or injury (http //oxforddictwnanes com accessed October 2010) 
It is clear from these definitions that there is certain overlap between the terms In this 
thesis, we will use the term shoulder pain 
Most shoulder pains are caused by a small number of relatively common conditions 
One of the most common causes of shoulder pain is thought to be the subacromial impinge-
ment syndrome (SIS) This syndrome includes tendonitis or tendinopathy of the rotator 
cuff and the long head of the biceps brachu muscle, or subacromial or subdeltoid bursitis 
Other less common causes of shoulder pain are tumors, infections and nerve related 
injunes 6 ' ' 
The clinical picture 
The main clinical feature of SIS is pain, which is mostly localized at the front and lateral 
side of the shoulder and halfway up the upper arm, sometimes radiating past the elbow to 
the radial side of the hand Pain may already be present at rest but will definitely occur or 
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increase in seventy dunng or shortly after movement It is especially painful when reaching 
forward, sideways or above the head or when putting the hand behind the back The 
patient may wake up frequently dunng the night because of the pain caused by lying on 
the affected shoulder but also while sleeping on the unaffected side The patient may 
display a so-called painful arc Dunng abduction 12, the first part (0 to 60°) often progresses 
without pam, the middle part (60 tol20o) is painful and the last part (120 to 180°) is again 
without pain or at least much less painful Due to these impairments, patients are often 
limited in their daily activities, including work, leisure and sports 
Inflammation 
Steinfeld et al proposed that up to 90% of all shoulder pain is related to local inflammation 
of the subacromial soft tissue 13 However, Khan et al found that there is a lack of evidence 
that pain is related to the inflammation of tendons '4 Light microscopy in patients operated 
on for tendon pain revealed collagen separation with thin, frayed and fragile tendon fibnls 
separated from each other lengthwise and disrupted in cross section Although there was 
an apparent increase in tenocytes with myofibroblastic differentiation (tendon repair cells), 
the classic inflammatory cells were usually absent Therefore, they proposed to abandon 
the term tendinitis and replace it by tendinopathy l* 15 
Rotator cuff degeneration and other structural abnormalities 
Partial or full thickness ruptures of the rotator cuff tendons are very common and their 
prevalence increases with age 1 6 1 7 Rotator cuff tears are seen as often in symptomatic as in 
asymptomatic subjects 1β The size of the tear does not correlate with pain intensity or level 
of disability 19 Therefore, it is uncertain to what extent rotator cuff ruptures cause shoulder 
pain Other abnormalities seen in magnetic resonance imaging (MR1) and ultrasonography 
(US), including osteophytes, subacromial and joint fluid, are often seen in asymptomatic 
high level athletes and does not predict shoulder pain or disability 2 " 2 1 
Etiology 
In 1972, Neer ^ described SIS as a distinct clinical entity although Jarjavay first recognized 
subacromial disorders in 1867 when he described a few cases of subacromial bursitis ^ 
Neer hypothesized that the antenor third of the acromion, the coracoacromial ligament 
and the acromioclavicular joint impinges upon the insertion of the supraspinatus tendon 
into the greater tubercle He also postulated that osteophytes within the coracoacromial 
ligament lead to tearing of the rotator cuff tendons This is referred to as outlet stenosis or 
external impingement (see below for internal impingement) 
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Table 1 : Neer's classification of SIS 
Stage age (years) Findings 
1 < 25 Shoulder pain is experienced that corresponds to the explanation originally 
provided by Neer but no abnormalities can be found by modern imaging 
techniques. These complaints are often explained as acute Inflammation of 
the subacromial structures. 
2 25 to 40 It is assumed that the pain is caused by a chronic inflammation of the 
subacromial structures. This Is associated with edema formation and minor 
hemorrhage. 
3 and 4 > 40 It Is possible to detect abnormalities through medical imaging techniques, 
namely partial (stage 3) or full thickness (stage 4) ruptures and the formation 
of osteophytes, especially on the undersurface of the anterior portion of the 
acromion. 
It is apparent from Table 1 that there is a chronological order between the four stages. 
Several studies have shown that there is a strong association between age and rotator cuff 
rupture, indicating that ruptures of the rotator cuff tendons become more prevalent with 
increasing age, while the association between rotator cuff ruptures and pain intensity and 
dysfunction seems to be absent16·17·ig·26-28. 
A further distinction is made between primary SIS and secondary SIS. Imaging reveals 
abnormalities comparable to stage 3 according to Neer only in primary SIS, whilst secondary 
SIS is defined by the same symptoms but without demonstrable abnormalities, which is 
comparable to Neer's stages 1 and 2. 
Secondary SIS can be defined as a relative decrease in subacromial space as a result of 
instability of the shoulder 2g. This instability is described as being subtle, mild, minor, 
occult or functional i0 ". It is believed that this level of instability cannot be identified by 
clinical tests or medical imaging techniques 29. This kind of SIS is mostly seen in younger 
patients (< 40 years), who are often active in sports. The theory behind this concept comes 
from Jobe et al. 30· M who hypothesized that a combination of shortening of the posterior 
capsule and instability of the anterior capsuloligamentous complex could lead to compres-
sion of subacromial tendons and bursae. This hypothesis has never been confirmed. 
Recently, Poitras et al. found that experimental shortening of the posterior capsule in 
cadavers did not lead to an increase of subacromial pressure 35. 
A third distinction is made with external and internal impingement. Walch et al. first 
identified internal impingement during shoulder arthroscopy ^ Individuals presenting 
with posterior shoulder pain brought on by positioning of the arm at 90° of abduction and 
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90° or more of external rotation, typically from overhead positions in sport or industrial 
situations, may be considered as potential candidates Mcfarland et al have argued against 
this and consider the contact between the undersurface of the rotator cuff tendons and the 
glenoid nm as purely physiological and not pathological37 It is worth mentioning that in 
the position of the arm at 90° of abduction and 90° or more of external rotation, the sub-
scapulans muscle is under stretch and may contribute to pain in the shoulder during this 
maneuver Referred pain from the subscapulans muscle is located at the back of the 
shoulder according to Simons et al 3Θ 
Physical examination and clinical tests 
A few orthopedic tests have been described with regard to SIS The Neer test, Hawkins-
Kennedy test, empty can or Jobe test, and the painful arc test are specifically designed to 
assess subacromial impingement, while external rotation lag sign, drop arm test, supine 
impingement test, and belly press test are designed to detect rotator cuff tears M In general, 
the results of these tests should be interpreted with caution With these tests, it is not 
sufficiently possible to make a reliable statement about whether subacromial impingement 
is present in patient groups that have not been selected in advance The most reliable tests 
are the painful arc test, the empty can test (Jobe), and the external rotation-against-
resistance test for detecting rotator cuff tears, while tests for impingement without rotator 
cuff tears are worthless for diagnostic purposes Specifically, the sensitivity of the test 
increases with the seventy of SIS The highly sensitive tests seem to have low specificity 
values and the highly specific ones seem to have low sensitivity values 4 0 35 
Imaging 
The options for viewing various tissues in the body have increased significantly in recent 
decades Thanks to x-ray photography, diagnostic US and MRI, it is possible to detect the 
presence of structural abnormalities in the shoulder However, detecting abnormalities in 
patients with shoulder pain does not provide a guarantee that the abnormalities are actually 
responsible for the pain Research in which groups of volunteers without shoulder pain are 
examined in a similar fashion can provide insight into the importance of the demonstrated 
abnormalities in patients with shoulder pain Using MRI, partial (Stage 3) or full thickness 
(Stage 4) ruptures were found in 34% of the people in a group of 96 volunteers with no 
shoulder pain 19 In another MRI study, 42 patients with shoulder pain and 31 patients 
without were compared Rotator cuff ruptures were found in the shoulder of patients with 
pain as well as in the shoulder of patients without pain in over 50% of cases26 The authors 
came to the conclusion that there was a significant relationship between age and the 
occurrence of ruptures but no relationship was found between pain and the presence of 
rotator cuff ruptures In an MRI study of the shoulder of professional baseball players, 
specifically pitchers (n=14), without symptoms of shoulder pain, no or hardly any diffe­
rence was found between the pitching arm and the non-pitching arm 20 In approximately 
80% of the cases, rotator cuff ruptures and labral injuries were found in both shoulders, 
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and acromional osteophytes were observed in half of the players One throwing athlete had 
a so-called SLAP (superior labrum from anterior to posterior) tear in both shoulders A 
comparable study with asymptomatic high-level athletes (baseball and tennis) (n=20) also 
revealed a high incidence of ruptures 21 In this study, fluid in the subacromial space (19 of 
the 40 shoulders) and in the glenohumeral joint (36 of the 40 shoulders) was also reported 
Based on these data, it seems reasonable to be cautious and not necessanly conclude that 
abnormalities found during imaging can fully explain the pain in individual patients 
Interventions 
While many interventions have been employed for shoulder disorders, including steroid 
injections, non-steroidal anti-inflammatory drugs (NSA1D) and other painkillers, surgery, 
physical therapy, manual mobilization and manipulation, acupuncture, and low level laser 
therapy, scientific evidence of their efficacy is limited ,6 70 Physical therapy is often the first 
choice in the management of shoulder pain in patients and may consist of vanous treatment 
modalities, such as exercise therapy, massage therapy, muscle stretching exercises, or 
ultrasound 7I u Although frequently administered, the efficacy of these interventions has 
not been established 
Myofascial trigger points and shoulder pain 
Simons et al ™ claim that "neither impingement syndrome nor rotator cuff disease, as each 
term is commonly used, is a specific or satisfactory diagnosis (page 545)" As mentioned 
before, inflammation of subacromial structures is not very common in shoulder pain, 
which may explain the limited effect of steroid injections and NSAIDs Narrowing of the 
subacromial space may result in degenerative changes of the rotator cuff but not in inflam-
mation Since these degenerative changes occur as often m asymptomatic as in symptomatic 
subjects, this might again not explain the pain and disability in patients Physical exami-
nation, including specific tests for subacromial impingement, do not take into account that 
muscles surrounding the shoulder may be tested as well as other structures, and that these 
muscles may produce the shoulder pain instead of the tendons or bursae Although the 
pain is felt deep in the shoulder and clinicians locate the pain in the subdeltoid or sub-
acromial region, the pain might come from painful muscle tissue that is remote from the 
place where it is felt75 7g Finally, until recently, MR1 and US did not reveal abnormalities 
within muscle tissue, other than intramuscular ruptures However, MRI combined with 
elastography and high resolution US have shown tissue charactenstics that are characteristic 
features of myofascial trigger points (MTrPs) This makes the concept of myofascial pain 
caused by MTrPs more acceptable for physicians and therapists 
Problems studied in this thesis 
This thesis aims to contribute to the knowledge of the role of MTrPs in shoulder pain In 
our physical therapy practice, we treat patients with shoulder pain using a comprehensive 
therapy approach specifically aimed at treating MTrPs Although patients and therapists 
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have been satisfied with our treatment for many years, we felt a need to study the effectiveness 
in a methodologically well-designed study, which was the main motivation for the research 
presented in this thesis If effectiveness can be proven, continuation and possibly wider 
implementation of the comprehensive therapy targeted at MTrPs would be recommendable 
Objectives of the thesis 
The aim of this thesis was to determine the importance of MTrPs in patients with chronic 
unilateral shoulder pain We wanted to explore three major questions 
• Can we reliably identify MTrPs in shoulder muscles under controlled conditions7 
• How common are MTrPs in patients with chronic shoulder pain7 
• What is the effectiveness of treatment of MTrPs in patients with chronic unilateral 
shoulder pain7 
Outline of the thesis 
This thesis consists of three studies an interrater reliability study, an observational study, 
and a randomized controlled tnal conducted in a primary care physical therapy practice 
specializing in musculoskeletal disorders of the arm, shoulder and neck 
Chapter 2 provides an evidence-informed review of the current scientific understanding 
of MTrPs with regard to their etiology, pathophysiology and clinical implications 
Chapter 3 presents the results of an interrater reliability study of a sample of three 
shoulder muscles, which were of importance in patients with shoulder pain according to 
our daily clinical experience 
Chapter 4 presents the design of the randomized controlled tnal, evaluating the effect-
iveness of a physical therapy treatment in patients with unilateral non-traumatic chronic 
shoulder pain All subjects had unilateral shoulder pain for at least six months and were 
referred to a physical therapy practice specializing in musculoskeletal disorders of the 
neck, shoulder and arm After the initial assessment, patients were randomly assigned to 
either an intervention group or a control group (wait and see) 
Chapter 5 presents the results of an observational study that aimed to assess the preva-
lence of muscles with MTrPs and their potential impact on patients with chronic non-
traumatic unilateral shoulder pain Subjects were recruited from patients included in a 
clinical tnal studying the effectiveness of physical therapy treatment in patients with 
unilateral non-traumatic shoulder pain 
Chapter 6 presents the results of a single blinded randomized controlled tnal We ass-
essed the outcome in a group of patients with shoulder pain who received comprehensive 
treatment given by a physical therapist for 12 weeks and compared this with the outcome 
in a comparable group with patients who remained on a waiting list for 12 weeks 
Finally, Chapter 7 provides the general discussion and summary of the results 
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MYOFASCIAL TRIGGER POINTS: 
AN EVIDENCE-INFORMED REVIEW 
Abstract: This article provides a best evidence-informed review of the current scientific un-
derstanding of myofascial trigger points with regard to their etiology, pathophysiology, and 
clinical implications Evidence-informed manual therapy integrates the best available scien-
tific evidence with individual clinicians'judgments, expertise, and clinical decision-making 
After a brief historical review, the clinical aspects of myofascial trigger points, the interrater 
reliability for identifying myofascial trigger points, and several characteristic features are 
discussed, including the taut band, local twitch response, and referred pain patterns The 
etiology of myofascial trigger points is discussed with a detailed and comprehensive review 
of the most common mechanisms, including low-level muscle contractions, uneven 
intramuscular pressure distribution, direct trauma, unaccustomed eccentric contractions, 
eccentric contractions in unconditioned muscle, and maximal or sub-maximal concentric 
contractions Many current scientific studies are included and provide support for 
considering myofascial trigger points in the clinical decision-making process The article 
concludes with a summary of frequently encountered precipitating and perpetuating 
mechanical, nutritional, metabolic, and psychological factors relevant for physical therapy 
practice Current scientific evidence strongly supports that awareness and working 
knowledge of muscle dysfunction and in particular myofascial trigger points should be 
incorporated into manual physical therapy practice consistent with the guidelines for 
clinical practice developed by the International Federation of Orthopaedic Manipulative 
Therapists While there are still many unanswered questions in explaining the etiology of 
myofascial trigger points, this article provides manual therapists with an up-to-date 
evidence-informed review of the current scientific knowledge 
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During the past few decades, myofascial trigger points (MTrPs) and myofascial pain syndrome 
(MPS) have received much attention in the scientific and clinical literature Researchers 
worldwide are investigating various aspects of MTrPs, including their specific etiology, 
pathophysiology, histology, referred pain patterns, and clinical applications Guidelines 
developed by the International Federation of Orthopaedic Manipulative Therapists (IFOMT) 
confirm the importance of muscle dysfunction for orthopedic manual therapy clinical prac-
tice The IFOMT has defined orthopedic manual therapy as "a specialized area of physio-
therapy/physical therapy for the management of neuromusculoskeletal conditions, based on 
clinical reasoning, using highly specific treatment approaches including manual techniques 
and therapeutic exercises " The educational standards of IFOMT require that skills will be 
demonstrated in—among others—"analysis and specific tests for functional status of the 
muscular system," "a high level of skill in other manual and physical therapy techniques 
required to mobilize the articular, muscular or neural systems," and "knowledge of various 
manipulative therapy approaches as practiced within physical therapy, medicine, osteopathy 
and chiropractic"1 
However, articles about muscle dysfunction in the manual therapy literature are sparse and 
they generally focus on muscle injury and muscle repair mechanisms2 or on muscle 
recruitment3 Until very recently, the current scientific knowledge and clinical implications 
of MTrPs were rarely included4 7 It appears that orthopedic manual therapists have not 
paid much attention to the pathophysiology and clinical manifestations of MTrPs Manual 
therapy educational programs in the US seem to reflect this orientation and tend to place a 
strong emphasis on joint dysfunction, mobilizations, and manipulations with only about 
10-15% of classroom education devoted to muscle pain and muscle dysfunction 
This review of the MTrP literature is based on current best scientific evidence The field 
of manual therapy has joined other medical disciplines by embracing evidence-based 
medicine, which proposes that the results of scientific research need to be integrated into 
clinical practice8 Evidence-based medicine has been defined as "the conscientious, explicit, 
and judicious use of current best-evidence in making decisions about the care of individual 
patients"910 Within the evidencebased medicine paradigm, evidence is not restricted to 
randomized controlled trials, systematic reviews, and meta-analyses, although this 
restricted view seems to be prevalent in the medical and physical therapy literature Sackett 
et al910 emphasized that external clinical evidence can inform but not replace individual 
clinical expertise Clinical expertise determines whether external clinical evidence applies 
to an individual patient, and if so, how it should be integrated into clinical decision making 
Pencheon11 shared this perspective and suggested that high-quality healthcare is about 
combining "wisdom produced by years of experience" with "evidence produced by 
generahzable research" in "ways with which patients are happy" He suggested shifting from 
evidence-based to evidence-informed medicine, where clinical decision making is informed 
by research evidence but not driven by it, and always includes knowledge from experience 
Evidence-informed manual therapy involves integrating the best available external scientific 
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evidence with individual clinicians' judgments, expertise, and clinical decision-making12 
The purpose of this article is to provide a best evidence-informed review of the current 
scientific understanding of MTrPs, including the etiology, pathophysiology, and clinical 
implications, against the background of extensive clinical expenence 
Brief Historical Review 
While Dr Janet Traveil (1901-1997) is generally credited for bringing MTrPs to the 
attention of healthcare providers, MTrPs have been described and rediscovered for several 
centuries by vanous clinicians and researchers1314 As far back as the 16lh century, de Baillou 
(1538-1616), as cited by Ruhmann, desenbed what is now known as myofascial pain 
syndrome (MPS)15 MPS is defined as the "sensory, motor, and autonomic symptoms caused 
by MTrPs" and has become a recognized medical diagnosis among pain specialists1617 In 
1816, British physician Balfour, as cited by Stockman, described "nodular tumors and 
thickenings which were painful to the touch, and from which pains shot to neighboring 
parts"ls In 1898, the German physician Strauss discussed "small, tender and apple-sized 
nodules and painful, pencil-sized to little-finger-sized palpable bands"19 The first tngger 
point manual was published in 1931 in Germany nearly a decade before Traveil became 
interested in MTrPs20 While these early descriptions may appear a bit archaic and 
unusual—for example, in clinical practice one does not encounter "apple-sized nodules" 
—these and other historic papers did illustrate the basic features of MTrPs quite accurately14 
In the late 1930s, Traveil, who at that time was a cardiologist and medical researcher, 
became particularly interested in muscle pain following the publication of several articles on 
referred pain21 Kellgren's descriptions of referred pain patterns of many muscles and spinal 
ligaments after injecting these tissues with hypertonic saline2221 eventually moved Traveil to 
shift her medical career from cardiology to musculoskeletal pain Dunng the 1940s, she 
published several articles on injection techniques of MTrPs2628 In 1952, she described the 
myofascial genesis of pain with detailed referred pain patterns for 32 muscles2'' Other 
clinicians also became interested in MTrPs European physicians Lief and Chaitow developed 
a treatment method, which they referred to as "neuromuscular technique"10 German physician 
Gutstein described the characteristics of MTrPs and effective manual therapy treatments in 
several papers under the names of Gutstein, Gutstein-Good, and Good1114 In Australia, Kelly 
produced a senes of articles about fibrosms, which paralleled Travel's writings1'18 
In the US, chiropractors Nimmo and Vannerson39described muscular "noxious generative 
points," which were thought to produce nerve impulses and eventually result in 
"vasoconstnction, ischaemia, hypoxia, pain, and cellular degeneration " Later in his career, 
Nimmo adopted the term "trigger point" after having been introduced to Travell's wntings 
Nimmo maintained that hypertonic muscles are always painful to pressure, a statement that 
later became known as "Nimmo's law" Like Traveil, Nimmo described distinctive referred 
pain patterns and recommended releasing these dysfunctional points by applying the proper 
degree of manual pressure Nimmo's "receptor-tonus control method" continues to be popular 
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among chiropractic physicians1940. According to a 1993 report by the National Board of 
Chiropractic Economics, over 40% of chiropractors in the US frequently apply Nimmo's 
techniques41. Two spin-offs of Nimmo's work are St. John Neuromuscular Therapy (NMT) 
method and NMT American version, which have become particularly popular among massage 
therapists30 
In 1966, Traveil founded the North American Academy of Manipulative Medicine, together 
with Dr. John Mennell, who also published several articles about MTrPs4243. Throughout 
her career Traveil promoted integrating myofascial treatments with articular treatments16 
One of her earlier papers described a technique for reducing sacroiliac displacement44. 
However, Traveil, as cited by Pans4', maintained the opinion that manipulations were the 
exclusive domain of physicians and she rejected membership in the North American 
Academy of Manipulative Medicine by physical therapists. 
In the early 1960s, Dr. David Simons was introduced to Traveil and her work, which 
became the start of a fruitful collaboration eventually resulting in several publications, 
including the Trigger Point Manuals, consisting of a 1983 first volume (upper half of the 
body) and a 1992 second volume (lower half of the body)4647. The first volume has since 
been revised and updated and a second edition was released in 199916. The Trigger Point 
Manuals are the most comprehensive review of nearly 150 muscle referred-pain patterns 
based on Travell's clinical observations, and they include an extensive review of the 
scientific basis of MTrPs. Both volumes have been translated into several foreign languages, 
including Russian, German, French, Italian, Japanese, and Spanish. Several other clinicians 
worldwide have also published their own trigger point manuals48 54 
Clinical aspects of Myofascial Trigger Points 
An MTrP is described as "a hypenrritable spot in skeletal muscle that is associated with a 
hypersensitive palpable nodule in a taut band"16. Myofascial trigger points are classified 
into active and latent trigger points16 An active MTrP is a symptom-producing MTrP and 
can trigger local or referred pain or other paraesthesiae. A latent MTrP does not trigger pain 
without being stimulated. Myofascial trigger points are the hallmark characteristics of MPS 
and feature motor, sensory, and autonomic components. Motor aspects of active and latent 
MTrPs may include disturbed motor function, muscle weakness as a result of motor 
inhibition, muscle stiffness, and restricted range of motion"56. Sensory aspects may include 
local tenderness, referral of pain to a distant site, and peripheral and central sensitization. 
Peripheral sensitization can be described as a reduction in threshold and an increase in 
responsiveness of the peripheral ends of nociceptors, while central sensitization is an 
increase in the excitability of neurons within the central nervous system. Signs of peripheral 
and central sensitization are allodyma (pain due to a stimulus that does not normally 
provoke pain) and hyperalgesia (an increased response to a stimulus that is normally 
painful). Both active and latent MTrPs are painful on compression. Vecchiet et al"39 
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described specific sensory changes over MTrPs. They observed significant lowering of the 
pain threshold over active MTrPs when measured by electrical stimulation, not only in the 
muscular tissue but also in the overlying cutaneous and subcutaneous tissues. In contrast, 
with latent MTrPs, the sensory changes did not involve the cutaneous and subcutaneous 
tissues5739. Autonomic aspects of MTrPs may include, among others, vasoconstriction, 
vasodilatation, lacrimation, and piloerection16·60 63. 
A detailed clinical history, examination of movement patterns, and consideration of 
muscle referred pain patterns assist clinicians in determining which muscles may harbor 
clinically relevant MTrPs64. Muscle pain is perceived as aching and poorly localized. There 
are no laboratory or imaging tests available that can confirm the presence of MTrPs. 
Myofascial trigger points are identified through either a flat palpation technique (Figure 1) 
in which a clinician applies finger or thumb pressure to muscle against underlying bone 
tissue, or a pincer palpation technique (Figure 2) in which a particular muscle is palpated 
between the clinician's fingers. 
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By definition, MTrPs are located within a taut band of contractured muscle fibers 
(Figure 3), and palpating for MTrPs starts with identifying this taut band by palpating 
perpendicular to the fiber direction. Once the taut band is located, the clinician moves 
along the taut band to find a discrete area of intense pain and hardness. 
Fig. 3: Palpation of a 
trigger point within a 
taut band 
(reproduced with 
permission from 
Weisskircher H-W. 
Head Pains Due to 
Myofascial Trigger 
Points. CD-ROM, 
www. trigger-point, 
com, 1997) 
Two studies have reported good overall interrater reliability for identifying taut bands, 
MTrPs, referred pain, and local twitch responses65-66. The minimum criteria that must be 
satisfied in order to distinguish an MTrP from any other tender area in muscle are a taut band 
and a tender point in that taut band65. Although Janda maintained that systematic palpation 
can differentiate between myofascial taut bands and general muscle spasms, electromyography 
is the gold standard to differentiate taut bands from contracted muscle fibers6768. Spasms can 
be defined as electromyographic (EMG) activity as the result of increased neuromuscular 
tone of the entire muscle, and they are the result of nerve-initiated contractions. A taut band 
is an endogenous localized contracture within the muscle without activation of the motor 
endplate69. From a physiological perspective, the term "contracture" is more appropriate 
then "contraction" when describing chronic involuntary shortening of a muscle without 
EMG activity. In clinical practice, surface EMG is used in the diagnosis and management of 
MTrPs in addition to manual examinations67-70·71. Diagnostically, surface EMG can assist in 
assessing muscle behavior during rest and during functional tasks. Clinicians use the MTrP 
referred pain patterns in determining which muscles to examine with surface EMG. Muscles 
that harbor MTrPs responsible for the patients pain complaint are examined first. EMG 
assessments guide the clinician with postural training, ergonomie interventions, and muscle 
awareness training67. 
The patient's recognition of the elicited pain further guides the clinician. The presence 
of a so-called local twitch response (LTR), referred pain, or reproduction of the person's 
symptomatic pain increases the certainty and specificity of the diagnosis of MPS. Local 
twitch responses are spinal reflexes that appear to be unique to MTrPs. They are characterized 
by a sudden contraction of muscle fibers within a taut band, when the taut band is 
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Fig. 4: Local twitch response in a rabbit trigger spot. Local twitch responses are elicited only when 
the needle is placed accurately within the trigger spot. Moving as little as 0.5 cm awayjrom the 
trigger spot virfuaiiy eliminates the local twitch response, 
(reproduced with permission from Hong C-Z, 1994) 
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strummed manually or needled. The sudden contractions can be observed visually, can be 
recorded electromyographically or can be visualized with diagnostic ultrasound72. When 
an MTrP is needled with a monopolar teflon-coated EMG needle, LTRs appear as high-
amplitude poly-phasic EMG discharges7378. 
In clinical practice, there is no benefit in using needle EMG or sonography, and its 
utility is limited to research studies. For example, Audette et al79 established that in 61.5% 
of active MTrPs in the trapezius and levator scapulae muscles, dry needling an active MTrP 
elicited an LTR in the same muscle on the opposite side of the body. Needling of latent 
MTrPs resulted in unilateral LTRs only. In this study, LTRs were used to research the nature 
of active versus latent MTrPs. Studies have shown that clinical outcomes are significantly 
improved when LTRs are elicited in the treatment of patients with dry needling or injection 
therapy7 4 8 0 8 1. The taut band, MTrP, and LTR (Figure 4) are objective criteria, identified 
solely by palpation, that do not require a verbal response from the patient82. 
Active MTrPs refer pain usually to a distant site. The referred pain patterns (Figure 5) 
are not necessarily restricted to single segmental pathways or to peripheral nerve 
distributions. Although typical referred pain patterns have been established, there is 
considerable variation between patients16-48. 
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Fig. 5; MTrP referred pain patterns (reproduced with permission from MED1CUP, Manual 
Medicine 1 & 2, Version 1.0a, 1997, Williams & Wilhns) 
Usually, the pain in reference zones is described as "deep tissue pain" of a dull and aching 
nature. Occasionally, patients may report burning or tingling sensations, especially in 
superficial muscles such as the platysma muscle83·84. By mechanically stimulating active 
MTrPs, patients may report the reproduction of their pain, either immediately or after a 
10-15 second delay. Normally, skeletal muscle nociceptors require high intensities of 
stimulation and they do not respond to moderate local pressure, contractions, or muscle 
stretches85. However, MTrPs cause persistent noxious stimulation, which results in 
increasing the number and size of the receptive fields to which a single dorsal horn 
nociceptive neuron responds, and the experience of spontaneous and referred pain86. 
Several recent studies have determined previously unrecorded referred pain patterns of 
different muscles and MTrPs87 90. Referred pain is not specific to MPS but it is relatively easy 
to elicit over MTrPs91. Normal muscle tissue and other body tissues, including the skin, 
zygapophyseal joints, or internal organs, may also refer pain to distant regions with 
mechanical pressure, making referred pain elicited by stimulation of a tender location a 
nonspecific finding8492 "l Gibson et al96found that referred pain is actually easier to elicit 
in tendon-bone junctions and tendon than in the muscle belly. However, after exposing the 
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muscle to eccentric exercise, significantly higher referred pain frequency and enlarged pain 
areas were found at the muscle belly and the tendon-bone junction sues following injection 
with hypotonic saline. The authors suggested that central sensitization may explain the 
referred pain frequency and enlarged pain areas97. 
While a survey of members of the Amencan Pain Society showed general agreement 
that MTrPs and MPS exist as distinct clinical entities, MPS continues to be one of the most 
commonly missed diagnoses17"8. In a recent study of 110 adults with low back pain, 
myofascial pain was the most common finding affecting 95.5% of patients, even though 
myofascial pain was poorly defined as muscle pain in the paraspinal muscles, piriformis, or 
tensor fasciae latae". A study of adults with frequent migraine headaches diagnosed 
according to the International Headache Society criteria showed that 94% of the patients 
reported migrainous pain with manual stimulation of cervical and temporal MTrPs, 
compared with only 29% of controls100"". In 30% of the migraine group, palpation of 
MTrPs elicited a "full-blown migraine attack that required abortive treatment." The 
researchers found a positive relationship between the number of MTrPs and the frequency 
of migraine attacks and duration of the illness100 Several studies have confirmed that MTrPs 
are common not only in persons attending pain management clinics but also in those 
seeking help through internal medicine and dentistry'02107 In fact, MTrPs have been 
identified with nearly every musculoskeletal pain problem, including radiculopathies104, 
joint dysfunction108, disk pathology109, tendonitis110, cramomandibular dysfunction111 m , 
migraines100114, tension-type headaches787, carpal tunnel syndrome113, computer-related 
disorders"6, whiplash-associated disorders60117, spinal dysfunction118, and pelvic pain and 
other urologie syndromes"g 122. Myofascial trigger points are associated with many other 
pain syndromes12', including, for example, post-herpetic neuralgia124125, complex regional 
pain syndrome126127, nocturnal cramps128, phantom pain129110, and other relatively 
uncommon diagnoses such as Barré-Liéou syndrome1" and neurogenic pruritus132 A recent 
study suggested that there might be a relationship between MTrPs in the upper trapezius 
muscle and cervical spine dysfunction at the C3 and C4 vertebrae, although a cause-and-
effect relationship was not established in this correlational study111. Another study described 
that persons with mechanical neck pain had significantly more clinically relevant MTrPs in 
the upper trapezius, sternocleidomastoid, levator scapulae, and suboccipital muscles as 
compared to healthy controls5. 
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Etiology of MTrPs 
Several possible mechanisms can lead to the development of MTrPs, including low-level 
muscle contractions, uneven intramuscular pressure distribution, direct trauma, 
unaccustomed eccentric contractions, eccentric contractions in unconditioned muscle, 
and maximal or submaximal concentric contractions. 
Low-level muscle contractions 
Of particular interest in the etiology of MTrPs are low-level muscle exertions and the so-called 
Cinderella Hypothesis developed by Hagg in 1988n4. The Cinderella Hypothesis postulates 
that occupational myalgia is caused by selective overloading of the earliest recruited and last 
de-recruited motor units according to the ordered recruitment principle or Hennemans "size 
principle"134135. Smaller motor units are recruited before and de-recruited after larger ones, as 
a result, the smaller type 1 fibers are continuously activated during prolonged motor tasks135. 
According to the Cinderella Hypothesis, muscular force generated at sub-maximal levels 
dunng sustained muscle contractions engages only a fraction of the motor units available 
without the normally occumng substitution of motor units dunng higher force contractions, 
which in tum can result in metabolically overloaded motor units, prone to loss of cellular 
Ca2*-homeostasis, subsequent activation of autogenic destructive processes, and muscle 
pain136137 The other pillar of the Cinderella Hypothesis is the finding of an excess of ragged 
red fibers in myalgic patients"6 Indeed, several researchers have demonstrated the presence 
of ragged red fibers and moth-eaten fibers in subjects with myalgia, which are indications of 
structural damage to the cell membrane and mitochondna and a change in the distribution 
of mitochondna or the sarcotubular system respectively138142. 
There is growing evidence that low-level static muscle contractions or exertions can 
result in degeneration of muscle fibers143. Gissell144143has shown that low-level exertions 
can result in an increase of Ca2*-release in skeletal muscle cells, muscle membrane damage 
due to leakage of the intracellular enzyme lactate dehydrogenase, structural damage, energy 
depletion, and myalgia. Low-level muscle stimulation can also lead to the release of 
interleukin 6 (IL-6) and other cytokines146147. 
Several studies have confirmed the Cinderella Hypothesis and support the idea that in 
low-level static exertions, muscle fiber recruitment patterns tend to be stereotypical with 
continuous activation of smaller type 1 fibers during prolonged motor tasks148152 As Hâgg 
indicated, the continuous activity and metabolic overload of certain motor units does not 
occur in all subjects136. The Cinderella Hypothesis was recently applied to the development 
of MTrPs116 In a well-designed study, Treasters et al116 established that sustained low-level 
muscle contractions during continuous typing for as little as 30 minutes commonly resulted 
in the formation of MTrPs They suggested that MTrPs might provide a useful explanation for 
muscle pain and injury that can occur from low-level static exertions116. Myofascial trigger 
points are common in office workers, musicians, dentists, and other occupational groups 
exposed to low-level muscle exertions153. Chen et al154 also suggested that low-level muscle 
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exertions can lead to sensitization and development of MTrPs. Forty piano students showed 
significantly reduced pressure thresholds over latent MTrPs after only 20 minutes of 
continuous piano playing154. 
intramuscular pressure disinbution 
Otten155 has suggested that circulatory disturbances secondary to increased 
intramuscular pressure may also lead to the development of myalgia. Based on mathematical 
modeling applied to a frog gastrocnemius muscle, Otten confirmed that during static low-
level muscle contractions, capillary pressures increase dramatically especially near the 
muscle insertions (Figure 6). In other words, during low-level exertions, the intramuscular 
pressure near the muscle insertions might increase rapidly, leading to excessive capillary 
pressure, decreased circulation, and localized hypoxia and ischaemia155. 
Fig. 6; intramuscular pressure 
distribution in the gastroc-
nemius muscle of the toad 
(reproduced with permission 
from E. Otten, 2006) 
With higher level contractions in between 10% and 20% of maximum voluntary effort, the 
intramuscular pressure increases also in the muscle belly156157. According to Otten, the 
increased pressure gradients during low-level exertions may contribute to the development 
of pain at the musculotendinous junctions and eventually to the formation of MTrPs 
(personal communication, 2005). 
In 1999, Simons introduced the concept of "attachment trigger points" to explain pain 
at the musculotendinous junctions in persons with MTrPs, based on the assumption that 
taut bands would generate sufficient sustained force to induce localized enthesopathies16,158. 
More recently, Simons concluded that there is no convincing evidence that the tension 
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generated in shortened sarcomeres in a muscle belly would indeed be able to generate 
passive or resting force throughout an entire taut band resulting in enthesopathies, even 
though there may be certain muscles or conditions where this could occur (personal 
communication, 2005) To the contrary, force generated by individual motor units is always 
transmitted laterally to the muscle's connective tissue matrix, involving at least two protein 
complexes containing vinculin and dystrophin, respectively159 There is also considerable 
evidence that the assumption that muscle fibers pass from tendon to tendon is without 
basis160 Trotter160 has demonstrated that skeletal muscle is comprised of in-senes fibers In 
other words, there is evidence that a single muscle fiber does not run from tendon to tendon 
The majority of fibers are in series with inactive fibers, which makes it even more unlikely 
that the whole muscle length-tension properties would be dictated by the shortest 
contractured fibers in the muscle161 
In addition, it is important to consider the mechanical and functional differences between 
fast and slow motor units162163 Slow motor units are always suffer than fast units, although 
fast units can produce more force If there were any transmission of force along the muscle 
fiber, as Simons initially suggested, fast fibers would be better suited to accomplish this 
Yet, fast motor units have larger senes of elastic elements, which would absorb most of the 
force displacement164165 Fast fibers show a progressive decrease in cross-sectional area and 
end in a point within the muscle fascicle, making force transmission even more unlikely163 
Fast fibers rely on transmitting a substantial proportion of their force to the endomysium, 
transverse cytoskeleton, and adjacent muscle fibers162163 In summary, the development of 
so-called "attachment tngger points" as a result of increased tension by contractured sarco-
meres in MTrPs is not clear and more research is needed to explain the clinical observation 
that MTrPs appear to be linked to pain at the musculotendinous junction The increased 
tension in the muscle belly is likely to dissipate across bnef sections of the taut band on 
both sides of the MTrP and laterally through the transverse cytoskeleton16616e Instead, 
Otten's model of increased intramuscular pressure, decreased circulation, localized hypoxia, 
and ischaemia at the muscle insertions provides an alternative model for the clinically 
observed pain near the musculotendinous junction and osseous insertions in persons with 
MTrPs, even though the model does not explain why taut bands are commonly present1" 
Direct trauma 
There is general agreement that acute muscle overload can activate MTrPs, although 
systematic studies are lacking169 For example, people involved in whiplash injuries 
commonly experience prolonged muscle pain and dysfunction170173 In a retrospective 
review, Schuller et al174 found that 80% of 1096 subjects involved in low-velocity collisions 
demonstrated evidence of muscle pain with myogeloses among the most common findings 
Although Schuller et al174 did not define these myogeloses, Simons has suggested that a 
myogelosis describes the same clinical entity as an MTrP175 Baker"7 reported that the 
splemus capitis, semispinahs capitis, and sternocleidomastoid muscles developed 
symptomatic MTrPs in 77%, 62%, and 52% of 52 whiplash patients, respectively In a 
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retrospective review of 54 consecutive chronic whiplash patients, Gerwin and Dommerholt176 
reported that clinically relevant MTrPs were found in every patient, with the trapezius 
muscle involved most often Following treatment emphasizing the inactivation of MTrPs 
and restoration of normal muscle length, approximately 80% of patients experienced little 
or no pain, even though the average time following the initiating injury was 2 5 years at the 
beginning of the treatment regimen All patients had been seen previously by other 
physicians and physical therapists who apparently had not considered MTrPs in their 
thought process and clinical management176 Fernândez-de-las-Penas et al177178 confirmed 
that inactivation of MTrPs should be included in the management of persons suffering from 
whiplashassociated disorders In their research-based treatment protocol, the combination 
of cervical and thoracic spine manipulations with MTrP treatments proved superior to more 
conventional physical therapy consisting of massage, ultrasound, home exercises, and low-
energy high-frequency pulsed electromagnetic therapy177 
Direct trauma may create a vicious cycle of events wherein damage to the sarcoplasmic 
reticulum or the muscle cell membrane may lead to an increase of the calcium concentration, 
a subsequent activation of actin and myosin, a relative shortage of adenosine triphosphate 
(ATP), and an impaired calcium pump, which in turn will increase the intracellular calcium 
concentration even more, completing the cycle The calcium pump is responsible for 
returning intracellular Ca2* to the sarcoplasmic reticulum against a concentration gradient, 
which requires a functional energy supply Simons and Τ^νεΐΐ17'1 considered this sequence 
in the development of the so-called "energy crisis hypothesis" introduced in 1981 Sensory 
and motor system dysfunction have been shown to develop rapidly after injury and actually 
may persist in those who develop chronic muscle pain and in individuals who have 
recovered or continue to have persistent mild symptoms1721B0 Scott et al181 determined that 
individuals with chronic whiplash pain develop more widespread hypersensitivity to 
mechanical pressure and thermal stimuli than those with chronic idiopathic neck pain 
Myofascial trigger points are a likely source of ongoing peripheral nociceptive input, and 
they contribute to both peripheral and central sensitization, which may explain the 
observation of widespread allodyma and hypersensitivity60 62 63 In addition to being caused 
by whiplash injury, acute muscle overload can occur with direct impact, lifting injuries, 
sports performance, etc 182 
Eccentric and (suWmaxima! concentric contractions 
Many patients report the onset of pain and activation of MTrPs following either acute, 
repetitive, or chronic muscle overload183 Gerwin et al184 suggested that likely mechanisms 
relevant for the development of MTrPs included either unaccustomed eccentric exercise, 
eccentric exercise in unconditioned muscle, or maximal or sub-maximal concentric 
exercise A brief review of pertinent aspects of exercise follows, preceding linking this body 
of research to current MTrP research 
Eccentric exercise is associated with myalgia, muscle weakness, and destruction of 
muscle fibers, partially because eccentric contractions cause an irregular and uneven 
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lengthening of muscle ίΛε^1 8 5 1 B 7 Muscle soreness and pam occur because of local ultra-
structural damage, the release of sensitizing algogenic substances, and the subsequent 
onset of peripheral and central sensitization8518Θ190 Muscle damage occurs at the cyto-
skeletal level and frequently involves disorganization of the Α-band, streaming of the 
Z-band, and disruption of cytoskeletal proteins, such as turn, nebulin, and desmin, even 
after very short bouts of eccentric exercise186189194 Loss of desmin can occur within 5 
minutes of eccentric loading, even in muscles that routinely contract eccentrically during 
functional activities, but does not occur after isometnc or concentric contractions191193 
Lieber and Fnden191 suggested that the rapid loss of desmin might indicate a type of 
enzymatic hydrolysis or protein phosphorylation as a likely mechanism 
One of the consequences of muscle damage is muscle weakness19619θ Furthermore, 
concentric and eccentric contractions are linked to contraction-induced capillary 
constrictions, impaired blood flow, hypoperfusion, ischaemia, and hypoxia, which in turn 
contribute to the development of more muscle damage, a local acidic milieu, and an 
excessive release of protons (H*), potassium (K+), calcitomn-gene-related-peptide (CGRP), 
bradykimn (BK), and substance Ρ (SP), and sensitization of muscle nociceptors184188 There 
are striking similarities with the chemical environment of active MTrPs established with 
microdialysis, suggesting an overlap between the research on eccentric exercise and MTrP 
research184 ' " However, at this time, it is premature to conclude that there is solid evidence 
that eccentric and sub-maximal concentric exercise are absolute precursors to the de­
velopment of MTrPs In support of this hypothesized causal relation, Itoh et al200 
demonstrated in a recent study that eccentric exercise can lead to the formation of taut and 
tender ropy bands in exercised muscle, and they hypothesized that eccentric exercise may 
indeed be a useful model for the development of MTrPs 
Eccentric and concentric exercise and MTrPs have been associated with localized 
hypoxia, which appears to be one of the most important precursors for the development of 
MTrPs201 As mentioned, hypoxia leads to the release of multiple algogenic substances In 
this context, recent research by Shah et al199 at the US National Institutes of Health is 
particularly relevant Shah et al analyzed the chemical milieu of latent and active MTrPs 
and normal muscles They found significantly increased concentrations of BK, CGRP, SP, 
tumor necrosis factor-α (TNF-a), interleukin-lß (IL-lß), serotonin, and norepinephrine in 
the immediate milieu of active MTrPs only199 These substances are well-known stimulants 
for various muscle nociceptors and bind to specific receptor molecules of the nerve endings, 
including the so-called punnergic and vamlloid receptors85 202 
Muscle nociceptors are dynamic structures whose receptors can change depending on 
the local tissue environment When a muscle is damaged, it releases ATP, which stimulates 
punnergic receptors, which are sensitive to ATP, adenosine diphosphate, and adenosine 
They bind ATP, stimulate muscle nociceptors, and cause pain Vamlloid receptors are 
sensitive to heat and respond to an increase in H+-concentration, which is especially 
relevant under conditions with a lowered pH, such as ischaemia, inflammation, or 
prolonged and exhaustive muscle contractions85 Shah et al199 determined that the pH at 
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active MTrP sites is significantly lower than at latent MTrP sites. A lowered pH can initiate 
and maintain muscle pain and mechanical hyperalgesia through activation of acid-sensing 
ion channels203 204. Neuroplastic changes in the central nervous system facilitate mechanical 
hyperalgesia even after the nociceptive input has been terminated (central sensitization)203 204. 
Any noxious stimulus sufficient to cause nociceptor activation causes bursts of SP and 
CGRP to be released into the muscle, which have a significant effect on the local biochemical 
milieu and microcirculation by stimulating "feed-forward" neurogenic inflammation. 
Neurogenic inflammation can be described as a continuous cycle of increasing production 
of inflammatory mediators and neuropeptides and an increasing barrage of nociceptive 
input into wide dynamic-range neurons in the spinal cord dorsal horn184. 
The integrated Trigger point Hypothesis 
The integrated trigger point hypothesis (Figure 7) has evolved since its first introduction as 
the "energy crisis hypothesis" in 1981. It is based on a combination of electrodiagnostic 
and histopathological evidence179183. 
Fig. 7: The integrated trigger point hypothesis. Ach-acetylcholine; AchE-acetylcholinesterase; 
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As early as 1957, Weeks and Traveil205 had published a report that outlined a characteristic 
electrical activity of an MTrP It was not until 1993 that Hubbard et al206 confirmed that this 
EMG discharge consists of low-amplitude discharges in the order of 10-50 pV and 
intermittent high-amplitude discharges (up to 500 μΥ) in painful MTrPs Initially, the 
electrical activity was termed "spontaneous electrical activity" (SEA) and thought to be 
related to dysfunctional muscle spindles206 Best available evidence now suggests that the 
SEA is in fact endplate noise (EPN), which is found much more commonly in the endplate 
zone near MTrPs than in an endplate zone outside MTrPs207 209 The electrical discharges 
occur with frequencies that are 10-1,000 times that of normal endplate potentials, and they 
have been found in humans, rabbits, and recently even in horses209210 The discharges are 
most likely the result of an abnormally excessive release of acetylcholine (ACh) and 
indicative of dysfunctional motor endplates, contrary to the commonly accepted notion 
among electromyographers that endplate noise arises from normal motor endplates181 The 
effectiveness of botulinum toxin in the treatment of MTrPs provides indirect evidence of the 
presence of excessive ACh2" Botulinum toxin (BoTox) is a neurotoxin that blocks the 
release of ACh from presynaptic cholinergic nerve endings A recent study in mice 
demonstrated that the administration of botulinum toxin resulted in a complete functional 
repair of dysfunctional endplates212 There is some early evidence that muscle stretching and 
hypertomcity may also enhance the excessive release of ACh213214 Tension on the integnns 
in the presynaptic membrane at the motor nerve terminal is hypothesized to mechanically 
trigger an ACh release that does not require Ca2* 2 Π 2 1 ' ' Integnns are receptor proteins in 
the cell membrane involved in attaching individual cells to the extracellular matrix 
Excessive ACh affects voltage-gated sodium channels of the sarcoplasmic reticulum 
and increases the intracellular calcium levels, which triggers sustained muscle contractures 
It is conceivable that in MTrPs, myosin filaments literally get stuck in the Z-band of the 
sarcomere During sarcomere contractions, titin filaments are folded into a gel-like structure 
at the Z-band In MTrPs, the gel-like turn may prevent the myosin filaments from detaching 
The myosin filaments may actually damage the regular motor assembly and prevent the 
sarcomere from restoring us resting length216 Muscle contractures are also maintained 
because of the relative shortage of ATP in an MTrP, as ATP is required to break the cross-
bridges between actin and myosin filaments The question remains whether sustained 
contractures require an increase of oxygen availability 
At the same time, the shortened sarcomeres compromise the local circulation causing 
ischaemia Studies of oxygen saturation levels have demonstrated severe hypoxia in 
MTrPs201 Hypoxia leads to the release of sensitizing substances and activates muscle 
nociceptors as reviewed above The combined decreased energy supply and possible 
increased metabolic demand would also explain the common finding of abnormal 
mitochondria in the nerve terminal and the previously mentioned ragged red fibers In 
mice, the onset of hypoxia led to an immediate increased ACh release at the motor 
endplate217 
2 Myofascial Trigger points an evidence-informed review 33 
The combined high-intensity mechanical and chemical stimuli may cause activation and 
sensitization of the penpheral nerve endings and autonomic nerves, activate second order 
neurons including so-called "sleeping" receptors, cause central sensitization, and lead to the 
formation of new receptive fields, referred pain, a long-lasting increase in the excitability of 
nociceptors, and a more generalized hyperalgesia beyond the initial nociceptive area. An 
expansion of a receptive field means that a dorsal horn neuron receives information from areas 
it has not received information from previously218. Sensitization of peripheral nerve endings 
can also cause pain through SP activating the neurokin-1 receptors and glutamate activating 
N-methyl-D-aspartate receptors, which opens post-synaptic channels through which Ca2+ions 
can enter the dorsal horn and activate many enzymes involved in the sensitization83. 
Several histological studies offer further support for the integrated trigger point hypothesis. 
In 1976, Simons and Stolov published the first biopsy study of MTrPs in a canine muscle 
and reported multiple contraction knots in various individual muscle fibers (Figure 8)li9. 
The knots featured a combination of severely shortened sarcomeres in the center and 
lengthened sarcomeres outside the immediate MTrP region219. 
Reitinger et al220 reported pathologic alterations of the mitochondria as well as increased 
width of Α-bands and decreased width of I-bands in muscle sarcomeres of MTrPs in the 
gluteus médius muscle. Windisch et al22' determined similar alterations in a post-mortem 
histological study of MTrPs completed within 24 hours of time of death. Mense et al222 studied 
the effects of electrically induced muscle contractions and a Cholinesterase blocker on muscles 
with experimentally induced contraction knots and found evidence of localized contractions, 
torn fibers, and longitudinal stripes. Pongratz and Spath223 224 demonstrated evidence of a 
contraction disk in a region of an MTrP using light microscopy. New MTrP histopathological 
studies are currently being conducted at the Friedrich Baur Institute in Munich, Germany. 
Gariphianova2" described pathological changes with biopsy studies of MTrPs, including a 
decrease in quantity of mitochondria, possibly indicating metabolic distress. Several older 
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histological studies are often quoted, but it is not clear to what extent those findings are 
specific for MTrPs. In 1951, Glogowsky and WallrafP26 reported damaged fibril structures. 
Fassbender227 observed degenerative changes of the 1-bands, in addition to capillary damage, 
a focal accumulation of glycogen, and a disintegration of the myofibrillar network. 
There is growing evidence for the integrated trigger point hypothesis with regard to the 
motor and sensory aspects of MTrPs, but many questions remain about the autonomic aspects 
Several studies have shown that MTrPs are influenced by the autonomic nervous system 
Exposing subjects with active MTrPs in the upper trapezius muscles to stressful tasks 
consistently increased the electrical activity in MTrPs in the upper trapezius muscle but not in 
control points in the same muscle, while autogenic relaxation was able to reverse the 
effects228 211. The administration of the sympathetic blocking agent phentolamine significantly 
reduced the electrical activity of an MTrP2282322". The interactions between the autonomic 
nervous system and MTrPs need further investigation. Hubbard228 maintained that the 
autonomic features of MTrPs are evidence that MTrPs may be dysfunctional muscle spindles. 
Gerwin et al184 have suggested that the presence of alpha and beta adrenergic receptors at the 
endplate provide a possible mechanism for autonomic interaction. In a rodent, stimulation of 
the alpha and beta adrenergic receptors stimulated the release of ACh in the phrenic nerve234. 
In a recent study, Gè et al61 provided for the first time experimental evidence of sympathetic 
facilitation of mechanical sensitization of MTrPs, which they attributed to a change in the 
local chemical milieu at the MTrPs due to increased vasoconstriction, an increased sympathetic 
release of noradrenaline, or an increased sensitivity to noradrenaline. Another intriguing 
possibility is that the cytokine interleukm-8 (IL-8) found in the immediate milieu of active 
MTrPs may contribute to the autonomic features of MTrP IL-8 can induce mechanical hyper-
nociception, which is inhibited by beta adrenergic receptor antagonists2". Shah et al found 
significantly increased levels of IL-8 in the immediate milieu of active MTrPs (Shah, 2006, 
personal communication). 
The findings of Shah et al199 mark a major milestone in the understanding and 
acceptance of MTrPs and support parts of the integrated trigger point hypothesis181 The 
possible consequences of several of the chemicals present in the immediate milieu of active 
MTrPs have been explored by Gerwin et al184. As stated, Shah et al found significantly 
increased concentrations of H*, BK, CGRP, SP, TNF-α, IL-Iß, serotonin, and norepinephrine 
in active MTrPs only. There are many interactions between these chemicals that all can 
contribute to the persistent nature of MTrPs through vanous vicious feedback cycles236. For 
example, BK is known to activate and sensitize muscle nociceptors, which leads to 
inflammatory hyperalgesia, an activation of high-threshold nociceptors associated with 
C-fibers, and even an increased production of BK itself. Furthermore, BK stimulates the 
release of TNF-α, which activates the production of the interleukins IL-lß, 1L-6, and IL-8 
Especially IL-8 can cause hyperalgesia that is independent from prostaglandin mechanisms 
Via a positive feedback loop, IL-lß can also induce the release of BK237. Release of BK, K*, 
H\ and cytokines from injured muscle activates the muscle nociceptors, thereby causing 
tenderness and pain184. 
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Fig. 9: The expanded MTrP hypoihesis (reproduced with permission from: Gerwin RD, Dommerholt 
], Shah]. An expansion of Simons' integrated hypothesis of tngger point formation. Curr Pain 
Headache Rep 2004;8:468-475). Ach-acetykholine; AchE-acetylcholinesterase; AchR- acetylcholine 
receptor; ATP-adenosine triphosphate; SP-substance P; CGRP-calcitonin gene-related peptide; 
MEPP-miniature endplate potential 
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Calcitonin gene-related peptide can enhance the release of ACh from the motor endplate 
and simultaneously decrease the effectiveness of acetylcholinesterase (AChE) in the 
synaptic cleft, which decreases the removal of ACh238239. Calcitonin gene-related peptide 
also upregulates the ACh-receptors (AChR) at the muscle and thereby creates more docking 
stations for ACh. Miniature endplate activity depends on the state of the AChR and on the 
local concentration of ACh, which is the result of ACh-release, reuptake, and breakdown 
by AChE. In summary, increased concentrations of CGRP lead to a release of more ACh, 
and increase the impact of ACh by reducing AChE effectiveness and increasing AChR 
efficiency. Miniature endplate potential frequency is increased as a result of greater ACh 
effect. The observed lowered pH has several implications as well. Not only does a lower pH 
enhance the release of CGRP, it also contributes to a further down-regulation of AChE. The 
multiple chemicals and lowered pH found in active MTrPs can contribute to the chronic 
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nature of MTrPs, enhance the segmental spread of nociceptive input into the dorsal horn of 
the spinal cord, activate multiple receptive fields, and trigger referred pain, allodyma, 
hypersensitivity, and peripheral and central sensitization that are characteristic of active 
myofascial MTrPs184 There is no other evidence-based hypothesis that explains the 
phenomena of MTrPs in as much detail and clanty as the expanded integrated trigger point 
hypothesis (Figure 9) 
Perpetuating Factors 
There are several precipitating or perpetuating factors that need to be identified and, if 
present, adequately managed to successfully treat persons with chrome myalgia Even 
though several common perpetuating factors are more or less outside the direct scope of 
manual physical therapy, familiarity with these factors is critical especially considering the 
development of increasingly autonomous physical therapy practice Simons, Traveil, and 
Simons16 identified mechanical, nutritional, metabolic, and psychological categories of 
perpetuating factors Mechanical factors are familiar to manual therapists and include the 
commonly observed forward head posture, structural leg length inequalities, scoliosis, 
pelvic torsion, joint hypermobihty, ergonomie stressors, poor body mechanics, etc 16102 '16 H0 
In recent review articles, GerwinHI 242 provided a comprehensive update with an emphasis 
on non-structural perpetuating factors Management of these factors usually requires an 
interdisciplinary approach, including medical and psychological intervention64 e2 Common 
nutntional deficiencies or insufficiencies involve vitamin Bl, B6, B12, folic acid, vitamin C, 
vitamin D, iron, magnesium, and zinc, among others The term "insufficiency" is used to 
indicate levels in the lower range of normal, such as those associated with biochemical or 
metabolic abnormalities or with subtle clinical signs and symptoms Nutntional or 
metabolic insufficiencies are frequently overlooked and not necessarily considered clinically 
relevant by physicians unfamiliar with MTrPs and chronic pain conditions Yet any 
inadequacy that interferes with the energy supply of muscle is likely to aggravate MTrPs242 
The most common deficiencies and insufficiencies will be reviewed briefly 
Vitamin B12 deficiencies are rather common and may affect as many as 15-20% of the 
elderly and approximately 16% of persons with chronic MTrPs103243 B12 deficiencies can 
result in cognitive dysfunction, degeneration of the spinal cord, and peripheral neuropathy, 
which is most likely linked to complaints of diffuse myalgia seen in some patients Serum 
levels of vitamin B12 as high as 350 pg/ml may be associated with a metabolic deficiency 
manifested by elevated serum or unne methylmalonic acid or homocysteine and may be 
clinically symptomatic244 However, there are patients with normal levels of methylmalonic 
acid and homocysteine, who do present with metabolic abnormalities of B12 function242 
Folic acid is closely linked to vitamin B12 and should be measured as well While folic acid 
is able to correct the pernicious anaemia associated with vitamin B12 deficiency, it does not 
influence the neuromuscular aspects 
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Iron deficiency in muscle occurs when ferritin is depleted Femtin represents the tissue-
bound non-essential iron stores in muscle, liver, and bone marrow that supply the essential 
iron for oxygen transport and iron-dependent enzymes Iron is critical for the generation 
of energy through the cytochrome oxidase enzyme system and a lack of iron may be a 
factor in the development and maintenance of MTrPs2"12. Interestingly, lowered levels of 
cytochrome oxidase are common in patients with myalgia140. Serum levels of 15-20 ng/ml 
indicate a depletion of ferritin. Common symptoms are chronic tiredness, coldness, 
extreme fatigue with exercise, and muscle pain. Anaemia is common at levels of 10 ng/ml 
or less. Although optimal levels of ferritin are unknown, Gerwin242 suggested that levels 
below 50 ng/ml may be clinically significant. 
Close to 90% of patients with chronic musculoskeletal pain may have vitamin D 
deficiency245. Vitamin D deficiencies are identified by measuring 25-OH vitamin D levels. 
Levels above 20 ng/ml are considered normal, but Gerwin242 suggested that levels below 34 
ng/ml may represent insufficiencies. Correction of insufficient levels of vitamin B12, vitamin 
D, and iron levels may take many months, during which patients may not see much 
improvement. 
Even when active MTrPs have been identified in a particular patient, clinicians must always 
consider that MTrPs may be secondary to metabolic insufficiencies or other medical diagnoses. 
It is questionable whether physical therapy and—as an integral part of physical therapy 
management—manual therapy intervention can be successful when patients have nutritional 
or metabolic insufficiencies or deficiencies. A close working relationship with physicians 
familiar with this body of literature is essential Therapists should consider the possible 
interactions between arthrogemc or neurogenic dysfunction and MTrPs4 3118133246247 
Clinically, physical therapists should address all aspects of the dysfunction There are 
many other conditions that feature muscle pain and MTrPs, including hypothyroidism, 
systemic lupus erythematosis, Lyme disease, babesiosis, ehrlichiosis, candida albicans 
infections, myoadenylate deaminase deficiency, hypoglycaemia, and parasitic diseases such 
as fasciohasis, amoebiasis, and giardia"4 242. Therapists should be familiar with the 
symptoms associated with these medical diagnoses64 
Psychological stress may activate MTrPs. Electromyographic activity in MTrPs has been 
shown to increase dramatically in response to mental and emotional stress, whereas 
adjacent non-trigger point muscle EMG activity remained normal229 230 Relaxation 
techniques, such as autogenic relaxation, can diminish the electrical activity231. In addition, 
many patients with persistent MTrPs are dealing with depression, anxiety, anger, and 
feelings of hopelessness248 Pain-related fear and avoidance can lead to the development 
and maintenance of chronic pain249. Sleep disturbance can also be a major factor in the 
perpetuation of musculoskeletal pain and must be addressed. Sleep problems may be 
related to pain, apnea, or to mood disorders like depression or anxiety. Management can be 
both pharmacologic and non-pharmacologic. Pharmacologic treatment utilizes drugs that 
promote normal sleep patterns and induce and maintain sleep through the night without 
causing daytime sedation Non-pharmacologic treatment emphasizes sleep hygiene, such 
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as using the bed only for sleep and sex, and not for reading, television viewing, and 
eating250. Therapists must be sensitive to the impact of psychological and emotional distress 
and refer patients to clinical social workers or psychologists when appropnate. 
The role of Manual Therapy 
Although the various management approaches are beyond the scope of this article, manual 
therapy is one of the basic treatment options and the role of orthopedic manual physical 
therapists cannot be overemphasized6215e. Myofascial trigger points are treated with manual 
techniques, spray and stretch, dry needling, or injection therapy Dry needling is within the 
scope of physical therapy practice in many countries including Canada, Spain, Ireland, 
South Afnca, Australia, the Netherlands, and Switzerland. In the United States, the physical 
therapy boards of eight states have ruled that physical therapists can engage in the practice 
of dry needling. New Hampshire, Maryland, Virginia, South Carolina, Georgia, Kentucky, 
New Mexico, and Colorado80. A promising new development used in the diagnosis and 
treatment of MTrPs involves shockwave therapy, but as of yet, there are no controlled 
studies substantiating us use251 ^ 
Conclusion 
Although MTrPs are a common cause of pain and dysfunction in persons with 
musculoskeletal injuries and diagnoses, the importance of MTrPs is not obvious from 
reviewing the orthopedic manual therapy literature. Current scientific evidence strongly 
supports that awareness and a working knowledge of muscle dysfunction; m particular, 
MTrPs should be incorporated into manual physical therapy practice consistent with the 
IFOMT guidelines for clinical practice While there are still many unanswered questions 
with regard to explaining the etiology of MTrPs, this article provides manual therapists 
with an up-to-date evidence-informed review of the current scientific knowledge. 
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INTERRATER RELIABILITY OF PALPATION 
OF MYOFASCIAL TRIGGER POINTS IN 
THREE SHOULDER MUSCLES 
Abstract: This observational study included both asymptomatic subjects (n=8) and 
patients with unilateral or bilateral shoulder pain (n=32) Patient diagnoses provided by 
the referring medical physicians included subacromial impingement, rotator cuff disease, 
tendonitis, tendinopathy, and chronic subdeltoid-subacromial bursitis Three raters 
bilaterally palpated the infraspinatus, the antenor deltoid, and the biceps brachu muscles 
for clinical characteristics of a total of 12 myofascial trigger points (MTrPs) as described by 
Simons et al The raters were blinded to whether the shoulder of the subject was painful 
In this study, the most reliable features of trigger points were the referred pain sensation 
and the jump sign Percentage of pair-wise agreement (PA) was > 70% (range 63-93%) in 
all but 3 instances for the referred pain sensation For the jump sign, PA was > 70% (range 
67-77%) in 21 instances Finding a nodule in a taut band (PA = 45-90%) and eliciting a 
local twitch response (PA = 33-100%) were shown to be least reliable The best agreement 
about the presence or absence of MTrPs was found for the infraspinatus muscle (PA = 69-
80%) This study provides preliminary evidence that MTrP palpation is a reliable and, 
therefore, potentially useful diagnostic tool in the diagnosis of myofascial pain in patients 
with non-traumatic shoulder pain 
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Shoulder complaints are very common in modem in-dustnal countnes. Recent reviews14 
have indicated a one-year prevalence ranging from 4.7 to 46.7%. These reviews have also 
reported a lifetime prevalence between 6 7 and 66.7% This wide variation in reported 
prevalence can be explained by the different definitions used for shoulder complaints and 
by differences in the age and other characteristics of the various study populations. Because 
making a specific structure-based diagnosis for patients with shouldercomplaints is consi-
dered difficult due to the lack of reliable tests for shoulder examination, recent guidelines 
developed by the Dutch Society of General Practitioners have recommended instead using 
the term "shoulder complaints" as a working diagnosis5. Shoulder complaints have been 
defined in a similarly non-specific manner as signs and symptoms of pain in the deltoid 
and upper arm region, and stiffness and restricted movements of the shoulder, often 
accompanied by limitations in daily activities6 
Despite the absence of reliable diagnostic tests to implicate these structures, the current-
ly prevailing assumption is that in non-traumatic shoulder complaints, mostly the anato-
mical structures in the subacromial space are involved, i.e., the subacromial bursa, the 
rotator cuff tendons, and the tendon of the long head of the biceps muscle7 g. However, this 
assumption does not take into account that muscle tissue itself can also give rise to pain in 
the shoulder region10 In our clinical expenence, myofascial trigger points (MTrPs) may 
lead to myofascial pain in the shoulder and upper arm region and contribute to the burden 
of shoulder complaints. 
The term myofascial pain was first introduced by Traveil10, who described it as "the 
complex of sensory, motor, and autonomic symptoms caused by myofascial trigger points." 
An MTrP is a hypenrntable spot in skeletal muscle that is associated with a hypersensitive 
palpable nodule in a taut band. In addition, the spot is painful on compression and may 
produce characteristic referred pain, referred tenderness, motor dysfunction, and auto-
nomic phenomena. Two different types of MTrPs have been described: active and latent. 
Active trigger points are associated with spontaneous complaints of pain. In contrast, latent 
trigger points do not cause spontaneous pain, but pain may be elicited with manual 
pressure or with needling of the trigger point Despite not being spontaneously painful, 
latent MTrPs have been hypothesized to restrict range of motion" and to alter motor 
recruitment patterns12. 
As noted above, referred pain is a key characteristic of myofascial pain Referred pain 
is felt remote from the site of origin13. The area of referred pain may be discontinuous from 
the sue of local pain or it can be segmentally related to the lesion, both of which may pose 
a serious problem for the correct diagnosis and subsequent appropnate treatment of 
muscle-related pain. The theoretical model for this phenomenon of referred pain was first 
proposed by Ruch14 and later modified by Mense1315 and Hoheisel14. Referred pain patterns 
originating in muscles have been documented using injection of hypertonic saline, electrical 
stimulation, or pressure on the most sensitive spot in the muscle17 21 In the clinical setting, 
palpation is the only method capable of diagnosing myofascial pain Therefore, reliable 
MTrP palpation is the necessary prerequisite for considering myofascial pain as a valid 
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diagnosis22 Published interrater studies have reported poor to good reliability for MTrP 
palpation23 29 However, only one study has included a muscle that could produce shoulder 
pain Gerwin et al27 reported a percent agreement (PA) of 83% for tenderness in the 
infraspinatus muscle (κ=0 48), 83% (K=0 40) for the taut band, 59% (κ=0 17) for the 
local twitch response, and 89% (K=0 84) for the referred pam 
In light of this near absence of data, of the societal impact of shoulder complaints as 
noted above, and of the potential role of myofascial pain syndrome with regard to shoulder 
pain, the aim of this study was to determine the interrater reliability of MTrP palpation in 
three human shoulder muscles deemed by us to be clinically relevant, ι e , the infraspinatus, 
the anterior deltoid, and the biceps brachu muscles 
Methods and Materials 
Subjects 
Subjects were recruited from a consecutive sample of patients with unilateral or bilateral 
shoulder pain referred by their physician to a physical therapy private practice specializing 
in the management of persons with neck, shoulder, and upper extremity musculoskeletal 
disorders To decrease limited variation within the data set and to control for rater bias, we 
also included asymptomatic subjects 
All subjects were unacquainted with and had not met the raters Additional inclusion 
cntena for participation in the study were age between 18 and 75 years and the ability to 
read and understand the Dutch language Exclusion criteria were known serious 
rheumalological, neurological, orthopaedic, or internal diseases, such as adhesive capsulitis, 
rotator cuff tears, cervical radiculopathy, diabetes mellitus, recent shoulder or neck trauma, 
or shoulder/upper extremity complaints of uncertain ongin as diagnosed by the referring 
physicians After reading a bnef synopsis of the aim of the study and the test procedure, all 
subjects signed an informed consent form The Committee on Research involving Human 
Subjects of the district Amhem-Nijmegen approved the study design, the protocols, and 
the informed consent procedure 
Raters and Observers 
The raters were three physical therapists rater A with 29, rater Β with 28, and rater C with 
16 years of clinical expenence, respectively All were employed at the pnvate practice 
where this study was conducted The raters had all specialized in the diagnosis and manage­
ment of patients with musculoskeletal disorders of the neck, shoulder, and upper extremity, 
and they had 21, 16, and 2 years of expenence, respectively, with regard to diagnosis and 
management of MTrPs 
The observers were three physical therapists who also had experience in treating patients 
with myofascial pain Prior to the study, they were informed by the lead investigator (CB) 
about the study protocol, and they participated in the training sessions with the raters 
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Fig I. The localization of trigger points in the infraspinatus, biceps brachii, and the 
anterior deltoid muscles. The numbers correspond with the sequence of palpation 
during the test. 
Illustrations courtesy of Lifeart/Mediclip, Manual Medicine 1, Version l.Oa, Williams & 
Wilkins, 1997. 
Both raters and observers participated in a total of eight hours of training. During these 
sessions, they were able to practice their skills, to compare with each other, and to discuss 
palpation technique, subject positioning, the amount of pressure used by the examiners30, 
and the location of the MTrPs (Figure 1). Before proceeding with the study, they reached 
consensus about all aspects of the examination. 
Trigger Point Fxaminaiion 
Simons et al" documented 11 muscles in total that could refer pain to the frontal or lateral 
region of the shoulder and arm (Table 1). Based on our clinical observation that these 
muscles are frequently involved in patients with shoulder pain, we chose to study the 
infraspinatus, the anterior deltoid, and the biceps brachii. Without providing specific data 
on prevalence, Simons et al31 reported that the infraspinatus is very often involved in 
shoulder pain. Hong32 noted that the deltoid and the biceps brachii could give rise to 
satellite MTrPs of the infraspinatus muscle. Hsieh33 provided evidence for the existence of 
a key-satellite relation between the infraspinatus muscle and the anterior deltoid muscle. A 
satellite trigger point may develop in the referral zone of a key MTrP located in the key 
muscle. It may also develop in an overloaded synergist that is substituting for the muscle 
that is harboring the key MTrP, in an antagonist countering the increased tension of the key 
muscle, or in a muscle that is linked apparently only neurogenically to the key MTrP. 
Sometimes this hierarchy is obvious but it is not always evident. Key and satellite trigger 
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Table 1. Muscles with a known referred pain pattern to the frontal or lateral region of the 
shoulder and/or arm31 
Muscle 
Infraspinatus 
Deltoid [anterior and middle part] 
Biceps brachii 
Supraspinatus 
Coracobrachialis 
Lattisimus dorsi 
Scalene 
Pectoralis major 
Pectoralis minor 
Subclavius 
Sternalis 
points are related to each other; our clinical observations indicate that signs and symptoms 
related to satellite trigger points diminish when key MTrPs are treated appropriately. 
Another reason for our choice of these specific muscles is that all three muscles studied 
here are part of the same functional unit with all three muscles acting as synergists active 
during shoulder flexion. Although the infraspinatus muscle is traditionally known as an 
external rotator, this is only true for the anatomical position. This muscle is one of the 
rotator cuff muscles that is active during flexion of the upper arm to provide stability of the 
glenohumeral joint during arm movements34·35. 
Although MTrPs may be found anywhere in the muscle belly we agreed to palpate for 
their presence only in close proximity to the motor endplate zones. The reason for this 
choice of location is that Simons et al31 have suggested that the primary abnormality 
responsible for MTrP formation is associated with individual dysfunctional endplates in the 
endplate zone or motor point. 
We bilaterally palpated these three muscles for MTrPs using four of the criteria proposed 
for the palpatory diagnosis of MTrPs31: 
1 Presence of a taut band with a nodule. The rater examined the subject by palpating the 
muscle perpendicular to the muscle fiber orientation with either a flat palpation (infra-
spinatus muscle and the anterior deltoid muscle) or a pincer palpation (biceps brachii 
muscle). When a taut band was identified, the rater palpated along the taut band to 
locate the nodule. The raters were asked to search for multiple MTrPs in each muscle. 
The palpatory findings were more important than the exact location of the MTrPs as 
indicated by Simons et al31. 
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Fig. 2. The localization of trigger points in the infraspinatus, biceps hrachii and the 
anterior deltoid muscles and the referred pain patterns according to Simons et al3' 
Χ = trigger point 
Solid gray shows the essential referred pain zone, nearly present in all patients, while the 
stippling represents the spiiiover zone, present in some but not all patients3'. 
Illustrations courtesy of Lifeart/Mediclip, Manual Medicine 1, Version 1.0a, Wiiliams & 
Wilkins, 1997. 
2 Reported painful sensation during compression in an area consistent with the esta­
blished referred pain pattern of the involved muscle. While compressing the palpable 
nodule in the taut band, the subject was asked if he or she felt any pain or any sensation 
(e.g., tingling or numbness) in an area remote from the compressed point. When the 
subjects reported referred sensation, they were asked to describe this area. The rater 
then decided whether this area was comparable to the established referred pain zone 
(Figure 2). 
3 Presence of a visible or palpable local twitch response (LTR) during snapping palpation. 
The rater quickly rolled the taut band under the fingertip, while examining the skin 
above the muscle fibers for this characteristic short and rapid movement. 
4 Presence of a general pain response during palpation, also known as a jump sign. 
While compressing the MTrP, the rater carefully examined the subjects reaction. A 
positive jump sign was defined as the subject withdrawing from palpation, wincing, or 
producing any pain-related vocalization. 
All four criteria were scored dichotomously: 
• Yes if the rater was certain of presence of a parameter 
• No if the rater was sure of the absence of a parameter or if the rater was unsure of 
presence or absence 
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Examination of the infraspinatus muscle was performed with the subjects seated with the 
arms hanging down by the side of the body. Examination of the anterior deltoid and biceps 
brachii muscles was performed with the forearms supported with slight elbow flexion 
(Figure 3). 
The raters were blinded to subject status; i.e., the subjects were not allowed to indicate 
whether they were symptomatic. They were instructed to mform the raters when they felt 
pain somewhere else than the palpation site or when they experienced a referred sensation. 
However, they were not allowed to tell the rater whether they felt a recognizable pain 
because that would negate attempts at rater blinding. 
In addition to scoring the separate criteria, the raters were asked to judge whether a 
trigger point was present or absent. Simons et al31 suggested that minimal diagnostic 
criteria for an MTrP consist of a palpable nodule present in a palpable taut band. Simons et 
al also required that this produce the patient's recognizable pain upon compression, but we 
should note that in this study, the subjects were not allowed to inform the examiners of 
their symptom status. Therefore, in this study the examiners decided that the MTrP was 
present when the palpable nodule in the taut band was present together with at least one 
or more of the other clinical characteristics. In all other combinations, it was said that the 
MTrP was absent. As a result of this study design, no distinction was made between active 
and latent MTrPs, as the examiners were not allowed to inquire whether subjects recognized 
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the pain from palpation. Therefore, examiners may have reported on both active and latent 
MTrPs in symptomatic and asymptomatic subjects. 
Methods 
During two morning sessions separated by a one-week interval, two different groups of 20 
subjects each were examined. The raters completed the assessment of each of the four 
characteristics for the three bilateral muscles within a 10 minute period. Subjects were 
examined in groups of three with each subject in a separate, private treatment room. 
Following the first assessment, the raters were randomly assigned to one of the two other 
rooms to assess another subject until all three raters had assessed all subjects. Upon 
completion of the assessment of the initial group of three subjects, three new subjects were 
assigned to the examination rooms and the procedures were repeated. An observer was 
present in each room during all examinations to verify correct implementation of the 
testing procedures, but the observer did not interfere with the examination. According to 
the observers, all examinations were performed in an appropriate manner. 
Table 2. The contingency matrix 
Rater 1 
Positive Negative 
Rater 2 Positive a b g. 
Negative c d g 2 
Total f, f2 η 
Siaiistical Analysis 
For the statistical analysis, we used the Statistical Package for the Social Sciences for Win­
dows version 12.0.1 (SPSS Inc., Chicago, IL). Frequencies were calculated for the subject 
demographic information. 
To express interrater reliability, we calculated both pairwise percentages of agreement 
(PA) and pair-wise Cohen Kappa-values (κ). The ΡΑ-value is defined as the ratio of the 
number of agreements to the total number of ratings made'6. 
Using the terminology from the contingency matrix provided in Table 2, PA = (a+d)/n. 
Cohen's κ is a coefficient of agreement beyond chance: κ = (PA - P
e
 )/(! - P
e
). The agree­
ment based on chance alone (P
e
) is calculated by the sum of the multiplied marginal 
totals corresponding to each cell divided by the square of the total number of cases (n): 
Pc = a1g1 + f2&)/n2. 
The K-value is widely used for dichotomous variables in interrater reliability studies, 
although there is no universally accepted value for good agreement37. Landis and Koch38 
proposed that a K-value < 0.00 be considered indicative of poor reliability and a value of 
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0.001-0.20 slight, 0.21-0.40 fair, 0.41-0.60 moderate, 0.61-0.80 substantial or good, 
and 0.81-1.00 almost perfect or very good reliability In this study, we considered a 
ΡΑ-value > 70% indicative of interrater reliability acceptable for clinical use, because under 
ideal circumstances, i.e., equal prevalence of negative and positive findings, when using a 
dichotomous test, a ΡΑ-value > 70% leads to a K" > 0.40. 
Table 3a. Example of the influence of a high value of the prevalence index on the κ value 
(Example used: Trigger point 3, right shoulder, couple A/C, palpation of a nodule) 
Observer 1 
Positive Negative 
Observer 2 Positive 35 2 37 
Negative 2 1 3 
Total 37 3 40 
in this cose, the percentage of agreement is high (0.90), hut because the prevalence index is 
also high (0.85), the K-vaiue indicates only fair agreement (0.28). 
Table 3b. Example of the influence of a low value of the prevalence index on the κ value 
(Example used: Trigger point 2, right shoulder, couple B/C, palpation of a nodule) 
Observer 1 
Positive Negative 
Observer 2 Positive 19 0 19 
Negative 5 16 21 
Total 24 16 40 
In this case the percentage of agreement is high (0.85), hut the prevalence index is low 
(0.08), so despite slightly lower percentage agreement than in Table 3a, the K-value (0.75) 
indicates good agreement. 
A major drawback to using K" as an index of agreement is that this statistic is very sensitive 
to the prevalence of positive and negative findings. To quantify this effect on the Κ values 
calculated, in this study we also determined the prevalence index (P,), which is the absolute 
value of the difference between the number of agreements on positive findings (a) and 
agreements on negative findings (d) divided by the total number of observations (n): P, = | 
a - d I / η 3g. If P, is high (closer to 1), chance agreement (P^ is also high and κ is reduced 
accordingly. If the P, is closer to 0, chance agreement (P,.) is low and κ will increase. This 
means that the K-statistic is more useful as an index of agreement in case of a low P, than it 
is with higher P
r
values. Table 3 provides examples of the influence of variations in P, on 
K-values. With K-values in this study strongly influenced by variations in prevalence as 
indicated by the wide range of P,, we were forced to focus on the ΡΑ-values for the 
interpretation of our findings. 
To compare the three pairs of raters, we used the Kruskal-Wallis test, which is a non-
parametric one-way analysis of variance. The test statistic Η will increase with increased 
variation. For graphical presentation, we used the box-and-whisker plot. To compare 
several data sets, this semi-graphical way of summarizing data, which provides median 
value, lower and upper quartiles, and the extreme values, is considered simple and useful'7. 
Results 
Patient Characteristics 
Thirty-two subjects with unilateral or bilateral shoulder pain and eight subjects without 
shoulder pain were included in this study. The mean age of subjects was 40 (SD = 11.5; 
range 18 to 70). Of these 40 subjects, 24 (60%) were female and 16 (40%) were male. The 
study population had a gender and age profile similar to the patient population of the 
physical therapy practice where the study was conducted. Most of the subjects (53%) were 
not diagnosed with a specific medical diagnosis for their shoulder complaints as suggested 
in the guidelines developed by the Dutch Society of General Practitioners3. Table 4 provides 
physician referral diagnoses for the 32 patients involved in this study. 
Table 4. Patient diagnosis and referral information 
Referral diagnosis Number of subjects Percentage 
No medical diagnosis. 17 53% 
The physician referred the patient to the practice without 
mentioning any medical diagnosis. This follows to the Dutch 
guidelines for general practioners. 
Calcifying tendonitis 
Tendonitis / bursitis / tendinosis 
Soft tissue disorder 
Degenerative changes in the acromioclavicular or glenohumeral joint 
Subacromial impingement syndrome 
Total 
2 
3 
7 
2 
1 
32 
6% 
9% 
22% 
6% 
3% 
1 0 0 % 
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Fig. 4. This box-and-
whisker plot shows the 
graphical expression [i.e., 
median, lower and upper 
quartile, minimum and the 
maximum value] of the 
dataset from the pairs of 
raters. This graphic shows 
only small differences (not 
statistically or ciinicairy 
relevant differences) 
between the three pairs of 
observers. 
Pair-Wise Interrater Agreement 
Tables 5 to 8 present the data of the various clinical characteristics of the MTrP in the 80 
shoulders of our 40 subjects, i.e., palpable nodule in a taut band, referred pam sensation, LTR, 
and the jump sign, respectively. The column PA provides the percentage agreement values for 
the three pairs of observers for both the left and right shoulder. The column Κ shows the 
corresponding K-value; the third column shows the corresponding prevalence index (P,). 
Although we have insufficient information to calculate mean agreement values for all rater 
pairs, we can cautiously conclude that the rater pairs seemed to be demonstrating similar 
reliability. When comparing the pair-wise ΡΑ-values for the presence or absence of MTrPs, 
we found no significant difference between the rater pairs (Kruskal-Wallis oneway ANOVA 
on ranks, H=0.841, Ρ > 0.05; Figure 4). 
Palpable Nodule in a Taut Band 
The ΡΑ-value for the palpable nodule in a taut band in the muscle varied from 45% in the 
medial head of the biceps brachii muscle to 90% in the infraspinatus muscle. The PA 
tended to be higher in trigger point 3 (83-90%) than in point 1 (63-73%). In the anterior 
deltoid muscle the PA varied from 63% to 75%. The PA for the biceps brachii varied from 
45% to 75%. Only the rater pair A/C agreed in both points more than 70%. The Κ varied 
from 0.11 to 0.75 The K-value varied from -0.13 to 0.64 (Table 5). 
Referred Pain Sensation 
The agreement on the referred pain sensation elicited by pressure on the nodule reached a 
ΡΑ-value > 70% in all but 3 cases (range 63-93%). The scores for referred pain sensation 
were the lowest in the infraspinatus (trigger point 1). The K-value varied from -0.13 to 
0.64 (Table 6). 
8 
ο 
_ _ 
ο ο 
Ι τ 
ι 
8 
ο 
60 
Table 5. Percentage of agreement (PA), kappa coefficient (κ), and the prevalence index 
(Pind) calculated for palpation of a nodule in a taut band in 6 localizations in 3 
muscles (left and right). 
Rater pairs 
TrP 
1 
2 
3 
4 
5 
6 
Side 
Left 
Right 
Left 
Right 
Left 
Right 
Left 
Right 
Left 
Right 
Left 
Right 
PA% 
65 
73 
70 
73 
83 
85 
63 
75 
45 
53 
53 
53 
A/B 
Κ 
0.22 
0.40 
0.35 
0.44 
0.26 
0.33 
0.34 
0.50 
0.16 
0.16 
0.22 
0.22 
Pind 
0.40 
0.32 
0.30 
0.18 
0.73 
0.75 
0.03 
0.15 
0.00 
0.13 
0.03 
0.03 
PA% 
68 
63 
80 
70 
90 
90 
70 
63 
68 
80 
73 
75 
A/C 
κ 
0.30 
0.24 
0.60 
0.43 
0.30 
0.28 
0.40 
0.26 
0.27 
0.58 
0.25 
0.44 
Pind 
0.38 
0.13 
0.10 
0.05 
0.85 
0.85 
0.20 
0.13 
0.38 
0.20 
0.53 
0.35 
PA% 
68 
70 
65 
88 
88 
85 
63 
68 
53 
53 
45 
58 
B/C 
κ 
0.34 
0.47 
0.30 
0.75 
0.25 
0.33 
0.25 
0.35 
0.14 
0.11 
0.15 
0.24 
Pind 
0.13 
0.30 
0.20 
0.08 
0.83 
0.75 
0.18 
0.03 
0.18 
0.18 
0.05 
0.13 
The numbers 1, 2, and 3 in the first column correspond with the localization in the infra­
spinatus muscle, 4 is localized in the anterior deltoid muscle, and 5 and 6 are localized in the 
biceps brachii muscle. In the second row, the three raters are mentioned as A, B, and C. 
The number of subjects is 40. 
Table 6. Percentage of agreement (PA), kappa coefficient (κ), and the prevalence index 
(Pind) calculated for palpation of referred pain in 6 localizations in 3 muscles (left 
and right). 
Rater pairs 
TrP 
1 
2 
3 
4 
5 
6 
Side 
Left 
Right 
Left 
Right 
Left 
Right 
Left 
Right 
Left 
Right 
Left 
Right 
PA% 
78 
78 
88 
80 
73 
83 
78 
88 
93 
85 
90 
88 
A/B 
κ 
0.48 
0.51 
0.38 
0.25 
0.46 
0.64 
0.13-
0.55 
0.36 
0.19 
0.45 
0.38 
Pind 
0.38 
0.33 
0.78 
0.70 
0.08 
0.18 
0.78 
0.68 
0.88 
0.80 
0.80 
0.78 
PA% 
63 
75 
88 
85 
63 
78 
85 
80 
83 
93 
75 
75 
A/C 
κ 
0.19 
0.41 
0.55 
0.33 
0.26 
0.54 
0.31 
0.25 
0.29 
0.63 
0.25 
0.15 
Pind 
0.28 
0.40 
0.68 
0.75 
0.13 
0.13 
0.75 
0.70 
0.73 
0.78 
0.60 
0.65 
PA% 
65 
73 
80 
85 
70 
80 
78 
88 
80 
88 
70 
78 
B/C 
κ 
0.21 
0.41 
0.23 
0.53 
0.36 
0.58 
0.13-
0.22 
0.13 
0.06-
0.03 
0.20 
Pind 
0.35 
0.28 
0.70 
0.6 
0.25 
0.2 
0.78 
0.83 
0.75 
0.88 
0.65 
0.68 
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Table 7. Percentage of agreement (PA), kappa coefficient (κ), and the prevalence index 
(P/IKO calculated for palpation of a local twitch response in 6 localizations in 
3 muscles (left and right). 
Rater pairs 
TrP 
1 
2 
3 
4 
5 
6 
n.c. = 
Side 
Left 
Right 
Left 
Right 
Left 
Right 
Left 
Right 
Left 
Right 
Left 
Right 
PA% 
80 
85 
100 
95 
53 
70 
73 
65 
43 
53 
53 
60 
= not calculated 
A/B 
κ 
0.09 
0.04-
n.c 
n.c. 
0.05 
0.15 
0.04 
0.21 
0.00 
0.01 
0.17 
0.23 
Find 
0.75 
0.85 
1.00 
0.95 
0.13 
0.55 
0.68 
0.35 
0.28 
0.43 
0.28 
0.35 
PA% 
73 
75 
73 
78 
58 
43 
63 
60 
50 
73 
68 
63 
A/C 
κ 
0.21 
0.05-
n.c. 
n.c. 
0.15 
0.13 
0.14 
0.20 
0.04 
0.45 
0.32 
0.25 
Pind 
0.58 
0.75 
0.73 
0.78 
0.38 
0.13 
0.38 
0.20 
0.00 
0.08 
0.28 
0.08 
PA% 
78 
75 
73 
78 
50 
33 
65 
60 
58 
60 
50 
58 
B/C 
κ 
0.36 
0.15 
n.c. 
0.11 
0.16 
0.07 
0.11 
0.20 
0.00 
0.13 
0.16 
0.21 
Pind 
0.58 
0.65 
0.73 
0.73 
0.25 
0.03 
0.55 
0.15 
0.48 
0.45 
0.25 
0.33 
The numbers 1, 2, and 3 in the first column correspond with the localization in the infra­
spinatus muscle, 4 is localized in the anterior deltoid muscle, and 5 and 6 are localized in the 
biceps brachii muscle. In the second row, the three raters are mentioned as A, B, and C. 
The number of subjects is 40. 
Local Twitch Response 
The LTR had only acceptable agreement for two locations in the infraspinatus. The lowest 
PA was 33% in trigger point 3, which is the most central point in the infraspinatus muscle. 
All three raters were unable to elicit an LTR in trigger point 2 (also in the infraspinatus 
muscle) in almost any of the subjects. This led to an agreement of 100% in one case; in 
most cases it was not possible to calculate a K-value because of the absence of the LTR in 
all cases of one rater (table 7). 
Table 8. Percentage of agreement (PA), kappa coefficient (κ), and the prevalence index 
(Pind) caiculated for palpation of the jump sign in 6 localizations in 3 muscles 
(left and right). 
Rater pairs 
TrP 
1 
2 
3 
4 
5 
6 
Side 
Left 
Right 
Left 
Right 
Left 
Right 
Left 
Right 
Left 
Right 
Left 
Right 
PA% 
75 
63 
70 
68 
70 
75 
78 
78 
68 
68 
68 
70 
A/B 
κ 
0.47 
0.27 
0.07 
0.02 
0.29 
0.47 
0.56 
0.54 
0.30 
0.31 
0.35 
0.37 
Pind 
0.25 
0.18 
0.60 
0.63 
0.40 
0.25 
0.18 
0.18 
0.33 
0.28 
0.28 
0.25 
PA% 
83 
73 
68 
75 
68 
75 
65 
78 
68 
68 
70 
83 
A/C 
κ 
0.60 
0.36 
0.12 
0.19 
0.22 
0.49 
0.31 
0.48 
0.33 
0.31 
0.40 
0.64 
Pind 
0.38 
0.38 
0.53 
0.65 
0.43 
0.15 
0.15 
0.43 
0.18 
0.28 
0.05 
0.18 
PA% 
78 
65 
88 
93 
78 
80 
73 
70 
65 
65 
63 
73 
B/C 
κ 
0.51 
0.31 
0.68 
0.58 
0.38 
0.58 
0.36 
0.34 
0.22 
0.16 
0.28 
0.41 
Pind 
0.33 
0.15 
0.53 
0.43 
0.53 
0.25 
0.38 
0.40 
0.35 
0.4 
0.18 
0.28 
The numbers J, 2, and 3 in the first column correspond with the localization in the infra­
spinatus muscle, 4 is localized in the anterior deltoid muscle, and 5 and 6 are localized in the 
biceps brachii muscle, in the second row, the three raters are mentioned as A, B, and C. 
The number of subjects is 40. 
Jump Sign 
The raters achieved the highest PA (93%) on the jump sign in the infraspinatus muscle and 
the lowest PA (63%) in the infraspinatus muscle and the biceps brachii muscle. The κ 
varied from 0.07 to 0.68 (Table 8). 
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Table 9. Percentage of agreement, kappa [κ] coefficient, and the prevalence Index for 
agreement on presence or absence of myofascial trigger points 
Raters PA% κ Pind 
1 Left 
1 Right 
2 Left 
2 Right 
3 Left 
3 Right 
4 Left 
4 Right 
5 Left 
5 Right 
6 Left 
6 Right 
A-B 
A-C 
B-C 
A-B 
A-C 
B-C 
A-B 
A-C 
B-C 
A-B 
A-C 
B-C 
A-B 
A-C 
B-C 
A-B 
A-C 
B-C 
A-B 
A-C 
B-C 
A-B 
A-C 
B-C 
A-B 
A-C 
B-C 
A-B 
A-C 
B-C 
A-B 
A-C 
B-C 
A-B 
A-C 
B-C 
75 
70 
70 
65 
65 
70 
78 
75 
73 
70 
73 
88 
73 
80 
83 
73 
78 
85 
63 
58 
65 
80 
68 
63 
53 
60 
58 
58 
73 
55 
58 
73 
50 
60 
80 
60 
0.50 
0.40 
0.40 
0.33 
0.29 
0.41 
0.38 
0.44 
0.38 
0.19 
0.29 
0.72 
0.18 
0.25 
0.29 
0.30 
0.40 
0.48 
0.31 
0.18 
0.25 
0.60 
0.35 
0.25 
0.22 
0.19 
0.18 
0.15 
0.45 
0.12 
0.28 
0.33 
0.20 
0.27 
0.58 
0.27 
0.05 
0.05 
0.05 
0.00 
0.15 
0.05 
0.53 
0.35 
0.38 
0.55 
0.53 
0.33 
0.58 
0.70 
0.73 
0.48 
0.53 
0.65 
0.13 
0.03 
0.30 
0.00 
0.03 
0.08 
0.13 
0.20 
0.28 
0.28 
0.03 
0.25 
0.08 
0.43 
0.00 
0.15 
0.20 
0.15 
The numbers 1, 2, and 3 correspond with the localization in the infraspinatus muscle, 4 is 
localized in the anterior deltoid muscie, and 5 and 6 are localized in the biceps brachii 
muscle. PA= Percentage of Agreement, κ = kappa coefficient, and Pind = prevalence index. 
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Overall agreement 
The percentage of agreement on MTrP presence or absence was acceptable for the infraspinatus 
muscle. In two out of three tngger point locations, ΡΑ-values exceeded 70%. In the anterior 
deltoid muscle and in the biceps brachii muscle, the ΡΑ-value was < 70% (Table 9). 
Discussion 
Palpation is the only method available for the clinical diagnosis of myofascial pain. 
Therefore, reliable MTrP palpation is the necessary prerequisite to considering myofascial 
pain as a valid diagnosis This study indicated that referred pain was the most reliable 
cntenon for palpatory diagnosis in all six MTrPs in all three muscles on both sides. Only in 
three of the 36 MTrP locations did the PA-value not reach the predetermined value of 70%. 
This finding is consistent with the results of other interrater reliability studies of MTrP 
examination2627. The nodule in the taut band, the LTR, and the jump sign were more 
reliable in the infraspinatus muscle than in the antenor deltoid and biceps brachii muscle. 
In general, the jump sign also proved a reliable palpatory characteristic in this study. This 
is in contrast to other studies, which may indicate that the raters in this study were more 
successful in standardizing the amount of pressure during the palpation In general, the 
LTR was not a reliable characteristic although it did prove reliable for MTrP 1 and 2 in the 
infraspinatus on either side. Palpation of the nodule in the taut band had sufficient 
reliability for the diagnosis of MTrPs in the infraspinatus muscle, but less for diagnosis of 
MTrPs m the anterior deltoid and biceps brachii muscles There was also a high level of 
agreement for the presence or absence of MTrPs in the infraspinatus muscle This agreement 
was lower for the antenor deltoid and biceps brachii muscles. 
Compared to various other commonly used physical examination tests such as the 
assessment of intervertebral motion or muscle strength, whose established interrater relia 
bihty ranges from 41% to 97%40''3, the interrater agreement with regard to MTrP palpation 
in these three shoulder muscles seemed acceptable However, the degree of agreement 
seemed to be strongly dependent on the muscle that was examined. Clinical experience 
suggests that some muscles are more accessible to palpation than others. There may even 
be differences within particular muscles. For trigger point 3 of the infraspinatus muscle, 
the raters achieved the highest agreement. Because MTrPs are often in close proximity to 
each other, raters did not always agree on which MTrP they were evaluating. For example, 
the raters may have had difficulty in distinguishing trigger points m the infraspinatus 
muscle, the teres minor muscle, and the posterior deltoid muscle. The area of referred pain 
may help in determining which muscle was palpated. However, recognition of pain elicited 
by palpation, as normally would occur in the clinical situation, was not determined in this 
study, as this could have endangered the blinding of the raters. Recognition of this 
characteristic pain by the patient may be an important aspect of reliable MTrP identification 
3 Interrater Re/iabi/ity of Palpation of Myofaicial Trigger Points in Three Shoulder Muscles 65 
For the biceps brachu muscle, the raters may have had difficulty distinguishing between 
the lateral and the medial head of the muscle It is conceivable that such difficulties could 
contribute to the lower level of agreement noted for this muscle 
We realize that by collapsing rating categones in this study to absent or present and by 
not including a third category of indeterminate findings, we may have artificially inflated 
reliability findings We decided to score dichotomously for the presence or absence of 
MTrPs and not include this indeterminate category because the treatment choice would 
have been similar independent of a negative or indeterminate finding When MTrPs are 
absent or when the physical therapist is unsure about the presence or absence of an MTrP, 
in the clinical situation no treatment will be directed to the MTrP 
We should again note that in this study no distinction was made between active and 
latent MTrPs, as the examiners were not allowed to inquire whether subjects recognized the 
pain from palpation Therefore, examiners may have reported on both active and latent 
MTrPs in symptomatic and asymptomatic subjects This may affect external validity in this 
study in that its findings cannot be directly extrapolated to the clinical situation where 
patient report of recognition of pain is available and the distinction between active and 
latent trigger points, therefore, can be made 
In the interpretation of the study findings, we chose to emphasize PA over K-values PA-
values do not take into account the agreement that would be expected purely by chance True 
agreement is the agreement beyond this expected agreement by chance, and κ is a measure 
of true, chance-corrected agreement However, as we earlier mentioned, the K-statistic is 
probably inappropnate for studies in which the positive and negative findings are not equally 
dismbuted"4 4 46 In this study, even asymptomatic subjects had some (obviously latent) 
trigger points in the shoulder muscles Subjects with unilateral shoulder pain often also may 
have latent or active tngger points in the contralateral shoulder47,48 Both may have 
contributed to the high prevalence of positive findings in this study The resultant Pi resulted 
in generally low K-values despite high ΡΑ-values, making the K-statistic less appropnate for 
the statistical representation and subsequent interpretation of study findings 
Training would seem important to achieve sufficient agreement, even when raters have 
considerable clinical expenence Prior to conducting this interrater reliability study, consensus 
about the standardization of manual palpation of MTrPs was achieved between raters In this 
study, there was no statistically significant difference between the rater pairs, even though one 
rater had only two years of clinical expenence with MTrP diagnosis and management We 
recognize that this consensus training may impact external validity in that the results of this 
study may not apply to situations and clinicians where such training has not occurred Future 
studies are needed to determine how many years of expenence and what extent of pre-study 
consensus training is needed to achieve sufficient interrater reliability 
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Conclusion 
In this study, three blinded raters were able to reach acceptable pair-wise interrater 
agreement on the presence or absence of TrPs as described by Simons et al31 Referred pain 
was the most reliable feature in all six MTrPs in all three shoulder muscles on both sides 
The nodule in the taut band, the LTR, and the jump sign were more reliable in the 
infraspinatus muscle than in the antenor deltoid and biceps muscle 
The results of this study support the idea that expenenced raters can obtain acceptable 
agreement when diagnosing MTrPs by palpation in the three shoulder muscles studied 
Allowing for patient report of pain recognition may provide for even better interrater 
reliability results Interrater agreement seems dependent on the muscle and even on the 
location of the trigger point within a muscle, and findings indicating acceptable interrater 
reliability cannot be generalized to all shoulder muscles The distinction between active 
and latent trigger points should be considered in future studies as should the effect of pre-
study consensus training and clinical expenence However, in summary we conclude that 
this study provides preliminary evidence that MTrP palpation is a reliable and, therefore, 
potentially useful diagnostic tool in the diagnosis of myofascial pain in patients with non­
traumatic shoulder pain 
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TREATMENT OF MYOFASCIAL TRIGGER 
POINTS IN COMMON SHOULDER 
DISORDERS BY PHYSICAL THERAPY: 
A RANDOMIZED CONTROLLED TRIAL 
Abstract Background Shoulder disorders are a common health problem in western 
societies Several treatment protocols have been developed for the clinical management of 
persons with shoulder pain However available evidence does not support any protocol as 
being superior over others Systematic reviews provide some evidence that certain physical 
therapy interventions (i e supervised exercises and mobilisation) are effective in particular 
shoulder disorders (i e rotator cuff disorders, mixed shoulder disorders and adhesive cap-
sulitis), but there is an ongoing need for high quality trials of physical therapy interventions 
Usually, physical therapy consists of active exercises intended to strengthen the shoulder 
muscles as stabilizers of the glenohumeral joint or perform mobilisations to improve 
restricted mobility of the glenohumeral or adjacent joints (shoulder girdle) It is generally 
accepted that a-traumatic shoulder problems are the result of impingement of the 
subacromial structures, such as the bursa or rotator cuff tendons Myofascial trigger points 
(MTrPs) in shoulder muscles may also lead to a complex of symptoms that are often seen 
in patients diagnosed with subacromial impingement or rotator cuff tendinopathy Little is 
known about the treatment of MTrPs in patients with shoulder disorders 
The primary aim of this study is to investigate whether physical therapy modalities to 
inactivate MTrPs can reduce symptoms and improve shoulder function in daily activities in 
a population of chronic a-traumatic shoulder patients when compared to a wait-and-see 
strategy In addition we investigate the recurrence rate during a one-year-follow-up penod 
Methods/Design: This paper presents the design for a randomized controlled tnal to be 
conducted between September 2007 - September 2008, evaluating the effectiveness of a 
physical therapy treatment for non-traumatic shoulder complaints One hundred subjects 
are included in this study All subjects have unilateral shoulder pain for at least six months 
and are referred to a physical therapy practice specialized in musculoskeletal disorders of 
the neck-, shoulder-, and arm 
After the initial assessment patients are randomly assigned to either an intervention 
group or a control-group (wait and see) The primary outcome measure is the overall score 
of the Dutch language version of the DASH (Disabilities of Arm, Shoulder and Hand) 
questionnaire 
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Discussion: Since there is only little evidence for the efficacy of physical therapy inter-
ventions in certain shoulder disorders, there is a need for further research. We found only 
a few studies examining the efficacy of MTrP therapy for shoulder disorders. Therefore we 
will perform a randomised clinical tnal of the effect of physical therapy interventions aimed 
to inactivate MTrPs, on pain and impairment in shoulder function in a population of 
chronic a-traumatic shoulder patients. We opted for an intervention strategy that best re-
flects daily practice. Manual high velocity thrust techniques and dry-needling are excluded. 
Because in most physical therapy interventions, blinding of the patient and the therapist is 
not possible, we will perform a randomised, controlled and observer-blinded study. 
Trial Registration: This randomized clinical trial is registered at current controlled trials 
1SRCTN75722066. 
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Background 
Shoulder pain is a common health problem in western societies There are substantial 
differences in reported prevalence in the general population The one-year prevalence of 
shoulder disorders has been reported to range from 20% to 50% This wide range is strongly 
influenced for example by the definition of shoulder disorders, including or excluding limited 
motion, age, gender and anatomic area ' 3 Of all shoulder patients who attend primary care 
physicians 50% recover within 6 months, meaning they do not seek any medical help after the 
first episode ' 4 6 Chromcity and recurrence of symptoms are common 7 θ According to the 
guidelines of the Dutch College of General Practioners 9, the recommended management of 
shoulder symptoms starts with educational information about the natural course of shoulder 
pain combined with the advise to avoid irritating and loading activities The use of analgesics 
or NSAIDs is recommended for the first two weeks When no recovery occurs within two 
weeks, subacromial or intra-articular injection therapy with corticosteroids are administered 
and eventually repeated Finally, physical therapy is only recommended after a 6-week period 
when there are functional limitations (specifically an activating and time-contingent approach) 
International guidelines for shoulder pain, including the Clinical Guideline of Shoulder pain 
of the American Academy of Orthopaedic Surgeons 1" and the Shoulder Guideline of the New 
Zealand Guidelines Group " differ more or less from the Dutch guidelines in classification, 
recommended interventions and timeline, and order of interventions Scientific evidence from 
randomized clinical tnals, meta-analyses or systematic reviews for either the efficacy of 
multimodal rehabilitation, injection therapy, medication, surgery or physical therapy or the 
order of application of commonly used therapies is lacking 1 2 1 6 
An alternative approach to the management of persons with shoulder problems consists of a 
treatment aimed at inactivating MTrPs and eliminating factors that perpetuate them MTrPs may 
be inactivated by manual techniques (such as compression on the trigger point or other massage 
techniques), cooling the skin with ethyl chloride spray or with ice-cubes followed by stretching 
of the involved muscle, trigger point needling using an acupuncture needle, or injection with 
local anaesthetics or Botulinum toxin, followed by ergonomie advises, active exercises, postural 
correction, and relaxation (with or without biofeedback) 1 7 1 e Over the years, MTrPs are 
increasingly accepted in the medical literature Clinical, histological, biochemical and 
electrophysiological research has provided biological plausibility for the existence of MTrPs " 2 4 
MTrPs are defined as exquisitely tender spots in discrete taut bands of hardened muscle 
that produce symptoms 25 26 A previous study showed that MTrPs can be detected reliably 
by trained physiotherapists 27 Palpation is still the only reliable method to diagnose 
myofascial pain clinically In reviews addressing the efficacy of interventions in shoulder 
patients, MTrP therapy and myofascial pain are rarely mentioned " However, some 
published case studies suggest that treatment of MTrPs in shoulder patients may be 
beneficial " ^ 
The primary aim of this study is to investigate the effectiveness of inactivation of MTrPs in 
shoulder muscles by physical therapy on symptoms and functioning of the shoulder in daily 
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activities in a population of chronic a-traumatic shoulder patients when compared to a waitand-
see strategy In addition, we investigate the recurrence rate during a one-year-follow-up period 
Methods/Design 
An examiner-blinded randomized controlled tnal will be conducted, which has been 
approved by the ethics committee of the Radboud University Nijmegen Medical Centre, 
the Netherlands [CMO 2007/022] 
Participants/Study sample 
Between September 2007 and September 2008, all consecutive patients referred to a phy-
sical therapy practice specialized in the treatment of individuals with musculoskeletal dis-
orders of the neck, shoulder and arm are potential study participants The referring 
physicians include general practitioners, orthopaedic surgeons, neurologists and physiatnsts 
Patients are eligible if they have unilateral shoulder complaints (described as pain felt in the 
shoulder or upper arm) for at least six months The patients present with persistent shoulder 
pain that has not spontaneously recovered The patients are between 18 and 65 years old 
Because the questionnaires are in the Dutch language, subjects must understand written 
and verbal Dutch Patients who have been diagnosed (pnor to the referral) with shoulder 
instability, shoulder fractures, systemic diseases (such as rheumatoid arthritis, Reiters syn-
drome, diabetes), or who's medical history or examination suggests neurological diseases, 
or other severe medical or psychiatric disorders will be excluded from the study The 
project leader will check all the available information from referral letters, additional 
information from the general practitioner and from the patients All eligible patients will be 
informed of the study and will be invited to participate Patients who are willing to par-
ticipate will be asked to review and sign the written informed consent 
Measurements 
Before randomization, all participants will be assessed dunng an individual baseline test 
session They will complete a battery of questionnaires and tests, determining data on social, 
demographic, and physical factors, and baseline values for the outcome measures In addition, 
subjects will complete the DASH, RAND-36-dutch language version, and passive range of 
motion tests of the shoulder (PROM) Dunng the initial assessment, MTrPs will be identified, 
based on compression-produced pain that is recognized by patients as their own shoulder 
pam If no MTrPs are detected, the subjects will be excluded from the study All measurements 
will be performed by the same independent observer, who is not employed by the physical 
therapy practice (This is to create optimal blinding of the observer, who is now not able to 
recognise the subjects) The observer is trained in identifying MTrPs and has several years of 
clinical expenence in MTrP therapy The observer participated in a former reliability study of 
MTrP palpation The baseline measurements will be at TO, the second measurement (Tl) will 
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be 6 weeks after the first assessment session, the third (T2) will be 12 weeks after the first 
assessment session All measurements (see table 1) will be performed outside the physical 
therapy practice to assure that the observer will not recognize any of the study participants 
when they come to the physical therapy practice for their treatment After this first assess-
ment, the patients will be randomly assigned to one of two groups' the intervention group or 
the control group. The patients in the control group will stay on the waiting list and will not 
receive any treatment. They are allowed to use over-the-counter painkillers during this 12-
week period After 6 weeks and 12 weeks, respectively, they will be examined by the same 
blinded observer After 12 weeks they will receive the same physical therapy program as the 
expenmental group (see Figure 1) The initial trial ends after 12 weeks, but 6 months and 12 
months after the start of the expenmental intervention shoulder function of the subjects will 
be re-evaluated with the DASH-Dutch language version 
Table 1 : Overview of variables 
Variable 
Age* 
Gender* 
Work 
Dominant side affected 
Duration of the complaints* 
DASH DLV 
Use of medication 
Use of other therapy 
Work% 
Improvement 
TO Baseline 
(percentage of perceived improvement) 
Number of involved muscles 
No. of treatment sessions 
Health status 
for baseline comparison 
Existence and severity 
of symptoms of depression 
Shoulder Passive ROM 
• flexion 
• abduction 
• external rotation 
• internal rotation 
• cross body adduction 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
T1After6wk T2 After 12 wk 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
Measured by 
Interview 
Interview 
Interview 
Interview 
Interview 
Questionnaire 
Interview 
Interview 
Interview 
Interview 
Assessment 
Assessment 
RAND-36 DLV 
Beck Depression Inventory 
X 
X 
X 
X 
X 
X 
Goniometry 
*Age, gender and duration of the complaints seem to be important prognostic variables [53]. 
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Figure 1 Recruitment and experimental plan 
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Intervention 
The patients in the intervention group will be treated by a physical therapist once a week 
for a maximum period of 12 weeks. All participating physiotherapists are experienced in 
treating patients with long-lasting shoulder symptoms and patients with MTrPs and 
myofascial pain, especially in the upper part of the body. They are trained and skilled in the 
identification of MTrPs and received a certification in manual trigger point therapy. The 
treatment starts with inactivation of the active (pain producing) MTrPs by using manual 
techniques (compression on the trigger point, manual stretching of the trigger point area 
and the taut band) combined with "intermittent cold application by using ice-cubes 
followed by stretching the muscle" according to Traveil32 to further inactivate the MTrPs. 
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Manual pressure will decrease the sensitivity of the painful nodule in the muscle while 
other massage techniques will mobilize and stretch the contracted muscle fibres The appli-
cation of the ice-cubes has a desensitizing effect, and makes it easier to stretch shoulder 
muscles Each treatment session will end with a heat application to increase the circulation 
of the involved muscles 
Patients will be advised to do stretching exercises and will be taught to perform these 
correctly by means of surfaceelectromyography-assisted stretching3334 Furthermore they 
will be advised to perform relaxation exercises, and to apply heat (like a hot shower, hot 
packs) several times (at least twice) a day If there is abnormal measurable higher electro-
myographic activity in the upper trapezius muscle (measured by surface Electromyography 
(sEMG) using a Myomed 932 (Enraf Nonius, Delft, the Netherlands) during standing and/ 
or sitting " , relaxation exercises will be performed using a portable myofeedback device 
(Myotrac I, Thought Technology, Quebec, Canada) Abnormal sEMG activity is defined as 
a constantly measured value above 1-5% of the maximally voluntary contraction 36 ^ , 
which is in general above 10 microvolt, during several minutes and the patient is not able 
to relax the muscle spontaneously or on request Finally, all patients will receive ergonomie 
recommendations, and instructions to assume and maintain "good" posture 40'" Manual 
high velocity thrust techniques of the cervical spine and the shoulder and dry needling are 
excluded from the treatment protocol, because not all participating physical therapists are 
skilled to perform these techniques The content of each session may vary as it depends on 
the findings dunng the first treatment session and the results of the previous treatment 
sessions Thus, there are differences in the content of the individual treatments, but within 
the limits of the treatment protocol 
Stopmle 
The treatment ceases when the patient is completely symptom-free or the patient and the 
therapist agree that treatment will not further benefit the patient, although their participation 
in the study will prolong If patients decide that they no longer wish to participate in the 
study they are free to withdraw from the study at any moment 
Control of intervention integrity 
To enhance the integnty of this complex intervention, every week all participating physical 
therapists will discuss the content of each therapy session with the researcher (CB) without 
mentioning names or other information which will assure the blinding of the independent 
researcher (CB) After 6 and 12 weeks, the patients of the intervention group will be inter-
viewed about the content of the received treatment sessions to assure that all patients will 
be treated according to the protocol If patients are not treated according to the protocol, 
they will be identified and participation may be discontinued 
Expectations regarding treatment outcome 
At the start of the mal (TO) both the patients and physical therapists will complete a 
questionnaire regarding the anticipated treatment outcome 
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Setting 
The study will be conducted in a physical therapy practice specialized in management of 
persons with musculoskeletal disorders of the neck, shoulder and arm. After randomisation 
every patient assigned to the experimental group will be treated by the same physical 
therapist. 
Objectives 
In the current study we will test the following hypothesis (HO) 
A physical therapy treatment to inactivate MTrPs within a three months' period is as 
effective as a "wait and see" approach of patients with chronic shoulder complaints in a 
three month penod 
Population characteristics 
• To identify potential confounding factors, demographic information for all subjects will 
be collected including age, gender, education, occupation, sports and leisure activities, 
duration of the complaints, and type of onset, among others. 
• The Dutch language version of the RAND-36 item Health Survey will be used for base 
line characteristics of the study population The RAND-36, which is almost identical to 
the MOS SF-36 42, scores the functional status and quality of life and is widely used for 
screening health status in medical, social and epidemiological research. The RAND-36 
consists of 36 items divided into 8 subscales concerning physical functioning, role 
limitations due to physical health, role limitations due to emotional problems, energy 
and fatigue, emotional wellbeing, social functioning, pain, general health perception 
and health change This questionnaire is considered to be a reliable instrument for 
comparing groups (internal consistency Cronbach's alpha > 0.70). The test-retest 
stability is sufficient (0 58 - 0.82) and the questionnaire is responsive when scoring 
after at least 4 weeks. The construct validity was estimated by comparing the RAND-36 
with other Health questionnaires (like the Nottingham Health Profile (NHP) and the 
Groninger Activities Restriction Scale (GARS). There are significant correlations 
between the subscales of the RAND-36 and the subscales of the NHP (correlation 
coefficient 0.42 - 0.69). The correlation coefficient between the subscale physical 
functioning and the GARS is 0.65. A higher score (maximum is 100 points) defines a 
more favourable health status. 
• The Beck Depression Inventory (BDI) is used to discriminate between patients with major 
depression and those without or with minor depressive feelings. The BDI is included 
because depression may be a confounding factor. The BDI is widely accepted and used in 
clinical and experimental research and us predictive value is rated as good. A BDI-score 
equally or higher than 21 indicates a major depression (specificity 78.4%)43 
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Outcomes 
The following outcome parameters will be used. 
Primary 
The overall score of the DASH (Disability of Arm Shoulder and Hand) questionnaire -
Dutch language version will be used as the primary outcome measure. The DASH is a 
multidimensional (physical, emotional and social) 30-item self-report measure focussing 
on physical function pain and other symptoms. At least 27 of the 30 items must be 
completed for a score to be calculated. The assigned values for all completed responses are 
simply summed and averaged. This value is then transformed to a score out of 100 by 
subtracting one and multiplying by 25. The transformation is done to make the score easier 
to compare to other measures using a 0-100 scale A higher score indicates greater disability. 
[(sum of η responses )-1] 
DASH disability/sympton score = χ 25 
where η is equal to the number of completed responses. 
Scoring is on a 5-point Likert scale from no difficulty (0 points) to very difficult (5 points). The 
range of the total score is from 0 to 100, where 0 means no symptoms (pain, tingling, weakness 
or stiffness) and no difficulty in performing daily activities, while 100 means extreme, severe 
symptoms and unable to perform any daily activity Content and face validity of the DASH were 
confirmed by a variety of experts of the American Academy of Orthopaedic Surgeons (AAOS), 
the council of Musculoskeletal Speciality Societies (COMSS) and the institute for Work and 
Health (Toronto, Ontario, Canada) throughout the development process ^ 
Its internal consistency was excellent (Cronbach's alpha = 0.96) during field-testing. The test-
retest reliability was excellent (ICC2.1 = 0.92 and 0.96) in two studies 4 5 4 6 and satisfactory 
in one study (Pearson 0.98 and kappa 0.67). The minimal detectable Change (MDC) was 
calculated in a population of 172 patients with several upper limb disorders (Osteoarthritis, 
Carpal Tunnel syndrome, Rotator Cuff syndrome, Rheumatoid Arthntis and Tennis Elbow)47. 
The Minimal Detectable Change (MDC) vaned between 10.70 (at 90% confidence level) and 
12.75 (at 95% confidence level). The DASH demonstrated to be a responsive questionnaire. 
The inter- and intra-observer reliability is good to excellent (intra-observer reliability Pearson 
r = 0.96 to 0.98; ICC = 0.91 to 0.96; Inter-observer agreement Cohens kappa = 0.79). 
The construct validity was estimated by comparing the DASH to several other questionnaires. 
The correlation with other instruments like the SPADI (Shoulder Pain and Disability Index) 
is good (Pearson's r = 0.82 to 0.88) The DASH questionnaire is one of the best among 
16 other questionnaires for shoulder symptoms 4 β. 
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Secondary 
An independent examiner will perform the following tests. 
• The total number of shoulder muscles with MTrPs will be counted and compared to the 
baseline measurement findings. 
• Passive range of motion of the shoulder will be measured by a handheld digital 
inclinometer (The Saunders group Ine, Chaska, MN). The range of motion of the non-
painful shoulder will be used as reference 494930 Because the normal range of motion 
differs from one individual to another, we focus on improvement of limited range of 
motion during the experiment (both experimental group and control group). 
- For the measurement of passive external rotation, the patient is in a supine position, 
with the shoulder in 0° of abduction and rotation, the elbow flexed at 90° and the 
forearm in a neutral position This position is defined as the position of 0° The 
observer then performs external rotation until pain limits the range of motion or the 
extreme of the range is reached. The inclinometer is placed against the volar side of 
the forearm. This range of motion is recorded in degrees. The normal range of motion 
for external rotation is between 70° and 90°. 
- For the measurement of passive glenohumeral abduction, the patient is seated upright, 
and the position of 0° is defined as the upper arm is in a neutral position. While 
palpating the lower angle of the scapula with the thumb, the examiner elevates the 
upper arm of the patient until the scapula begins to rotate or pain limits further 
motion The inclinometer is placed against the lateral side of the upper arm near the 
elbow. The range of motion is recorded in degrees. The normal range of motion is 90°. 
- For the measurement of passive elevation (through flexion), the patient is in the 
supine position with the arm along the side This position is defined as the position 
of 0°. The observer than performs elevation until pain limits the range of motion or 
the extreme of the range is reached Then the inclinometer is placed against the 
medial side of the upper arm near the elbow. The range of motion is recorded in 
degrees. The normal range of motion is between 165° and 180° 
- For the measurement of internal rotation the patient is in a prone position. The 
shoulder is 90° abduction, and the forearm is in neutral position. This position is 
defined as the position of 0°. The observer than performs internal rotation until pain 
limits the range of motion or the extreme of the range is reached. The sensor is placed 
against the volar side of the forearm The normal range of motion is 70° 
- For the measurement of horizontal adduction the patient is in a supine position The 
arm is in 90° abduction This position is defined as the position of 0°. The observer 
performs adduction, while the arm stays in the vertical plane, until pain limits the 
range of motion or the extreme of the range is reached. The normal range of motion 
is 135° 
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• Finally the total number of treatment sessions will be counted This is done by an 
assistant, who is not involved in the study by using the administration-software of the 
practice (see Table 1) 
Sample size 
The initial sample size is based on the assumption that the overall score of the pnmary 
outcome measure DASH shows a mean improvement of 15 points (SD = 22) 5 1 
To test the null hypothesis of equality of treatment at α = 05 with 90% power and assuming a 
uniform dropout rate of 5%, it was calculated that 52 patients in each group would be sufficient 
Randomization 
After inclusion the patients will be randomly assigned to either the intervention group or 
the "wait and see" group The randomisation will be performed by an assistant not otherwise 
involved in the study by generating random numbers using computer software Stratification 
or blocking strategies will not be used 
Informed consent 
The patients will be informed about the study prior to the first assessment and will be 
asked to give written informed consent 
Blinding 
Blinding of the patients or the physical therapists, who are involved in the treatment, is 
impossible due to the treatment charactenstics 
An independent observer will collect baseline data and outcome data The independent 
observer is blinded The successfulness of the blinding procedure will be evaluated by 
asking the observer to which group she believes the subjects belong 
Statistical analysis 
For compansons of prognostic variables on baseline we will use the Student's t test for 
continuous variables with normal distribution and the chi-square test for categoncal vanables 
or continuous vanables with non-normal distnbution32 For the overall score of the DASH 
(pnmary outcome measure) we will use the unpaired t-test for normally distnbuted data or 
Mann-Whitney Rank Sum-test for non-normally distnbuted data to assess the difference 
between the two groups after the treatments Regression analyses will be used to include 
prognostic factors, such as the baseline scores like age, gender and duration of the com­
plaints, in the analyses All significance levels will be set at ρ < 0 05 All data will be analysed 
pnmanly according to intention-to-treat pnnciple We will use Sigmastat 3 11 and Systat 12 
for Windows (Systat Ine Richmond, California, USA) for the statistical analyses 
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Discussion 
Since there is little evidence for the efficacy of physical therapy interventions in some 
shoulder disorders, there is a need for further research Therefore we will perform a 
randomised clinical tnal dealing with the effect of physical therapy interventions aimed to 
inactivate MTrPs on pain and impairment in shoulder function in a population of chronic 
a-traumatic shoulder patients To the best of our knowledge, few studies of the efficacy of 
MTrP therapy are published We choose for an intervention strategy that best reflects daily 
practice We excluded manual high velocity thrust techniques and intramuscular MTrP 
release by dry needling, because these interventions are not commonly used by Dutch 
physical therapists and not all participating therapists were skilled to perform these 
techniques at the beginning of the study In most physical therapy interventions, blinding 
of the patient and the therapist is not possible The observers will be blinded for the 
allocation procedure The results of this trial will be presented as soon as they are available 
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Abstract 
Background: Shoulder pain is reported to be highly prevalent and tends to be recurrent or 
persistent despite medical treatment The pathophysiological mechanisms of shoulder pain 
are poorly understood Furthermore, there is little evidence supporting the effectiveness of 
current treatment protocols Although myofascial trigger points (MTrPs) are rarely 
mentioned in relation to shoulder pain, they may present an alternative underlying 
mechanism, which would provide new treatment targets through MTrP inactivation While 
previous research has demonstrated that trained physiotherapists can reliably identify 
MTrPs in patients with shoulder pain, the percentage of patients who actually have MTrPs 
remains unclear The aim of this observational study was to assess the prevalence of muscles 
with MTrPs and the association between MTrPs and the seventy of pain and functioning in 
patients with chronic non-traumatic unilateral shoulder pain 
Methods: An observational study was conducted Subjects were recruited from patients 
participating in a controlled trial studying the effectiveness of physical therapy on patients 
with unilateral non-traumatic shoulder pain Sociodemographic and patient-reported 
symptom scores, including the Disabilities of the Arm, Shoulder, and Hand (DASH) 
Questionnaire, and Visual Analogue Scales for Pain were compared with other studies To 
test for differences in age, gender distribution, and education level between the current 
study population and the populations from Dutch shoulder studies, the one sample T-test 
was used One observer examined all subjects (n=72) for the presence of MTrPs Frequency 
distributions, means, medians, standard deviations, and 95% confidence intervals were 
calculated for descriptive purposes The Spearman's rank-order correlation (p) was used to 
test for association between variables 
Results: MTrPs were identified in all subjects The median number of muscles with MTrPs 
per subject was 6 (active MTrPs) and 4 (latent MTrPs) Active MTrPs were most prevalent in 
the infraspinatus (77%) and the upper trapezius muscles (58%), whereas latent MTrPs were 
most prevalent in the teres major (49%) and antenor deltoid muscles (38%) The number of 
muscles with active MTrPs was only moderately correlated with the DASH score 
Conclusion: The prevalence of muscles containing active and latent MTrPs in a sample of 
patients with chronic non-traumatic shoulder pain was high 
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INTRODUCTION 
Shoulder pain, which is often persistent or recurrent, is one of the major reasons patients 
consult with pnmary healthcare providers ' " However, the pathophysiological mechanisms 
underlying shoulder pain are poorly understood Although subacromial impingement is 
often suggested to be a potential source of shoulder pain 7 8, solid evidence is lacking In 
fact, calcifications, acromion spurs, subacromial fluid, or signs of tendon degeneration are 
equally prevalent in healthy subjects and in patients with shoulder pain g l 2 Furthermore, 
physical examination tests of subacromial impingement are not reliable " ", and the results 
of imaging diagnostics do not correlate well with pain ' 10 16 17 In addition, interventions 
targeting subacromial problems are, at most, only moderately effective at treating shoulder 
complaints 'β 24 
Myofascial trigger points (MTrPs) may offer an alternative explanation for the patho­
physiological mechanisms underlying shoulder pain In recent years, our understanding of 
the etiology, pathophysiology, and management of MTrPs has increased 25 3(' MTrPs are 
local points, that are highly sensitive to pressure, the application of which causes 
characteristic referred sensations, including pain, muscle dysfunction26, and sympathetic 
hyperactivity " " 
MTrPs are classified into active and latent myofascial trigger points Active MTrPs are 
charactenzed by the presence of clinical pain and constant tenderness Specifically, active 
MTrPs prevent full lengthening and weakening of the muscle Diagnostically, active MTrPs 
refer patient-recognized pain upon compression and mediate a local twitch response in 
muscle fibers when stimulated When compressed within the patients' level of pain tolerance, 
active MTrPs produce referred motor phenomena and often sympathetic hyperactivity, 
(generally in the pain reference zone), and cause tenderness in the pain reference zone In 
contrast, latent MTrPs are clinically quiescent, and are only painful when palpated With the 
exception of spontaneous pain, a latent MTrP can present with all the clinical characteristics 
of active MTrPs In addition, latent MTrPs are within a taut band that increases muscle tension 
and restricts patients' range of motion26 Although the exact pathophysiology of MTrPs is not 
yet fully understood, abnormal electrical activity, called endplate noise, has been associated 
with both latent and active MTrPs, and several pain-inducing and pro-inflammatory sub­
stances have been found at active MTrP in humans 27 M 
In clinical practice, identification of MTrPs is usually performed by palpation In a recent 
study33, we confirmed that this technique is a reliable method for detecting MTrPs in shoulder 
muscles Although prevalence studies are sparse :,6''2, based on clinical expenence, MTrPs 
seem to be associated with shoulder pain, disability, and dysfunction43 " Still, little is known 
about the impact of MTrPs on pain and functioning in patients with shoulder disorders ^ 
Because MTrPs refer pain to the shoulder, they may contnbute substantially to the clinical 
picture of shoulder pain (Figure J) Expenmental muscle pain, clinical muscle pain, and 
MTrPs have all been shown to alter motor activation patterns in a similar manner as the 
kinematic disturbances seen in shoulder pain patients often referred to as SIS 47 ^ 
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The aim of this study was to determine the prevalence of MTrPs and the correlation between 
MTrPs and pain and functioning, in a sample of patients presenting with chronic, non-
traumatic unilateral shoulder complaints. 
Figure I: Referred pain patterns (gray) from the lower trapezius (a), upper trapezius (b), 
anterior deltoid (c), and infraspinatus (d) muscle MTrPs (Xs), according to Simons et al. 
illustrations courtesy of LifeART/MEDlCLIP, Manual Medicine 1, Version 1.0a, 
Lippincoti,Williams & Wilfeins, 1997 
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Material and methods 
Stuify design 
This observational study was embedded in a clinical trial (registered at current controlled 
tnals ISRCTN75722066) addressing a specific treatment of patients with shoulder pain 50 
The Committee of Human Research of the region Nijmegen-Arnhem, the Netherlands, has 
approved the study protocol [CMO 2007/22] 
Study Participants 
Study participants were recruited from patients participating in a controlled trial inves-
tigating the effectiveness of physical therapy on patients with unilateral, non-traumatic 
shoulder pain This study was conducted at a primary care practice for physical therapy, 
which specializes in the treatment of patients with disorders of the shoulder, the neck, and 
upper extremities A power analysis was performed prior to beginning this study, and it 
was calculated that 104 subjects were needed for the clinical trial 
All patients who contacted the practice for non-specific shoulder complaints from 
September 2007 until September 2009, were requested to participate in the study The 
inclusion cntena were 1) age between 18 and 66 years, 2) unilateral non-traumatic shoulder 
pain, and 3) duration of symptoms of more than six months Patients were excluded from 
the study if they presented with a prior diagnosis of shoulder instability, shoulder fractures, 
any systemic diseases, or a medical history or examination suggestive for the presence of 
neurological disease, internal diseases, or psychiatric disorders All patients signed a 
wntten informed consent before participating in the study 
General Applicability 
To determine the potential general applicability of this study to primary care shoulder pain 
patients, we searched for Dutch studies conducted on primary care patients from 1995 
until 2009 Eight studies were found and sociodemographic data (age, gender, education 
level, and duration of shoulder pain) were analyzed and compared to the current study 
population 2 5 5155 
Measures 
At baseline, age, gender, hand dominance, and education level were recorded For compa-
nson reasons we classified the education level as high education (university and higher 
vocational school), medium education (middle vocational school and higher or middle 
general secondary school), and low education (lower vocational school, lower general 
secondary school, primary school, or no education),4 Shoulder-pain related data (duration 
of shoulder-pain, recurrence rate and location of the complaints) were collected and the 
study subjects were asked to complete a set of standardized self-report measures, including 
the Disabilities of the Arm, Shoulder, and Hand outcome measure - Dutch Language 
Version (DASH-DLV), Visual Analogue Scale for Pain (VAS-P) and the Beck Depression 
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Inventory- Second Version- Dutch Language Version (BDI-II-DLV) 50. The BDI-II-DLV is 
used to discriminate between patients with major depression and those with only minor 
depressive feelings or no depression, which may be a confounding factor. The BDI-II has 
good predictive value, is widely accepted, and is commonly used in both clinical and 
experimental research. A BDI-II-DLV score equally or > 21 indicates major depression 
(specificity 78.4%)56. 
For every study participant, one of the two available observers measured the passive range of 
motion (PROM) of the shoulder in flexion, internal and external rotation, abduction, and 
(horizontal or cross-body) adduction with a handheld digital inclinometer (The Saunders 
Group Ine, Chaska, MN). Range of motion was expressed in degrees and presented as the 
sum of the value measured for the non-affected shoulder minus the value measured for the 
affected shoulder. A positive value means that the affected shoulder had impaired range of 
motion as compared to the non-affected shoulder. Next, the observer examined each subject 
for the presence of MTrPs in the shoulder muscles of their affected shoulder according to the 
guidelines outlined in Simons et al26; the non-affected shoulder was examined as a control. 
Following these guidelines, an MTrP is defined as: a nodule in a taut band that is extremely 
painful upon compression, and may produce referred pain or sensations. MTrPs were 
classified as either 'active' when the pain was recognized by the patient as a familiar pain, and 
'latent' when the observer found a firm nodule in a taut band, which was painful on 
compression, but did not produce a recognizable pain. The inter-examiner reliability of 
trigger point palpation has been established in several studies 3 5 ' 5 7 · 5 8 . All 17 muscles that are 
known to produce pain in the shoulder or may result in dysfunction of shoulder muscles 
were systematically examined and the number of muscles with MTrPs in the affected shoulder 
was counted, regardless of the number of MTrPs per muscle (Table 1). The two observers were 
physical therapists, each with 30 years of clinical experience in primary care practice. Both 
observers had attended an extensive, postgraduate course on MTrP diagnosis and therapy 
and had more than 5 years experience in identifying MTrPs and treating patients with MTrPs 
prior to the start of the study. 
Table 1. List of muscles examined for presence of MTrPs 
upper trapezius muscle 
infraspinatus muscle 
teres minor muscle 
middle deltoid muscle 
pectoralis minor muscle 
scalene muscles 
middle trapezius muscle 
supraspinatus muscle 
teres major muscle 
posterior deltoid muscle 
biceps brachi! muscle 
subclavius muscle 
lower trapezius muscle 
subscapularis muscle 
anterior deltoid muscle 
pectoralis major muscle 
triceps brachii muscle 
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The DASH-DLV is a widely used multidimensional (physical, emotional and social) 30-
item self-reporting questionnaire that focuses on physical function, pain and other symp-
toms DASH-DLV scores ranges from 0 to 100, with higher scores indicating greater 
disability DASH is a reliable and valid questionnaire, with good to excellent intra- and 
inter-rater reliability, and good correlation with the Shoulder Pain and Disability Index 
Because of these advantages, DASH is considered to be one of the best questionnaires 
available for shoulder symptoms (http //www dash iwh on ca/) ,g 60 
The VAS-P is a self-report scale consisting of a 100 mm horizontal line anchored by word 
descriptions on each side 6| VAS-P can be used to measure pain current pain levels 
(VAS-P1), the average pain over the last 7 days (VAS-P2), and the most severe pain over the 
last 7 (VAS-P3) VAS-P scores ranges from 0 (no pain) to 100 (the worst pain imaginable) 
The Visual Analogue Scale has properties consistent with a linear scale for patients with 
mild to moderate pain 
Data was collected and transferred to a worksheet by a research assistant (who was not 
involved in the physical examination or palpation of MTrP) 
Data analysis 
Frequency distributions, means, medians, standard deviations, and 95% confidence 
intervals were calculated for descriptive purposes The Shapiro-Wilk W test was used to 
test for normality of the data Because the number of muscles with MTrPs (active, latent 
and total) was not normally distributed we used the Spearman's rank-order correlation (p) 
test for all variables For interpretation of the p-values, we used the classification proposed 
by Feinstein " A correlation coefficient < 0 30 was considered to be indicative of a poor 
correlation A correlation coefficient a 0 30 and s 0 70 was considered to be indicative of 
moderate correlation, and a correlation coefficient Ä 0 70 was defined as substantial or a 
good correlation To test for differences in age, gender distribution, and education level 
between the current study population and study populations from Dutch shoulder studies 
(from 1995 until 2009), we used a one sample T-test The α level for statistical significance 
was set at 0 05 All analyses were performed using Systat 12 or Sigmastat 3 1 for Windows 
(Systat Software, Ine Chicago, IL, USA) 
Results 
A flowchart describing patient participation is depicted in Figure 2 Out of 211 patients 
who were treated for shoulder disorders, between September 2007 and September 2009, 
72 patients (50 females and 22 males, mean age 43 9 years, SD 12 3, 95% CI 41 0 to 46 0) 
presented with unilateral, non-traumatic shoulder complaints, met the study inclusion 
catena, and agreed to participate in this study Twenty-six subjects were suffering from 
their first episode of shoulder pain, while for 19 subjects, this was their second episode 
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The remaining 27 subjects had suffered from a 3 episodes of shoulder pain. Study parti­
cipants' characteristics are summarized in Table 2. A comparison of data obtained from the 
present study with data from previous Dutch studies is presented in Table 3. The mean age 
of the present study population was lower (p < 0.05) and the proportion of female subjects 
was higher (p < 0.05) compared to these other studies. In addition, the current study 
population was more highly educated (p < 0.05) than the previous study populations for 
which educational data was reported3 ' '2. Comparison of the duration of shoulder pain 
was not possible because different classifications were used. 
Figure 2: Flow chart showing α schematic summary of patient participation in this study 
Consecutive subitet i wiih shoulder 
pam w i c t i i n ] lo i cl iüibil i ls 
(η 211) 
' r 
Eligible 
( n H 8 l 
1 r 
Subjects 
« u h umlaieral shoulder pam 
In 7S1 
' 
««etodadte 1361 
pnman fro/en shoulder (η 20) 
bilaieral shoulder pain (n-26) 
posl-traumatic(n^8) 
posl-surijicaKn 5) 
vOMMiluiion (n JO) 
t 
subjects with umlateial nontraumalic 
shoulder pam were 
applicable lor a iubsis 
Declined to participate 
(η Π Ι 
I subiects were excluded after physical 
evanunalion. becauseof signs and symptoms 
of primary fro/en shoulder (n 21 or sesere 
language problems ( n = M 
94 
Table 2 Characteristics of patients participating in this study (n=72). 
Characteristics n(%) mean (SD; 95% CI); median 
Age (years) 
Gender, female 
Duration of shoulder pain 
6-9 months 
9-12 months 
1 -2 years 
2-5 years 
>5 years 
Recurrence rate 
1st episode 
2nd episode 
3rd > episode 
Hand dominance, left-handed 
Side of complaints right 
DASH-DLV (0-100)a 
VAS-P1 (0-100)b 
VAS-P2(0-100)b 
VAS-P3(0-100)b 
BDI-II-DLV (0 - 63)c 
0-13 
14-19 
20-28 
28-63 
50(69.4) 
17(23.6) 
14(19.4) 
13(18.0) 
14(19.4) 
14(19.4) 
26(36.1) 
19(26.4) 
27(37.5) 
4(5.6) 
48 (66.7) 
68 (94.4) 
3 (4.3) 
0 (0.0) 
1 (1.4)d 
43.9(12.3; 41.0-46.8); 45.0 
30.8 (14.1; 27.5-34.1); 28.3 
30.0 (23.9; 27.0 - 39.9); 30.0 
42,1 (17.7; 37.4-50.0); 40.0 
56.6 (19.8; 51.2-61.9); 57.0 
6.1 (6.0; 4.7-7.6); 5.00 
Higher Dosh-DLV (Disabilities of the Arm, Shoulder and Hand outcome measure- Dutch 
Language Version) scores mean more disability with a maximum oj 100 (range from 0 to 100)59. 
Higher VAS-P scores (Visual Analogue Scales jor Pain) mean more pain, with a maximum of 
100 (range from 0 to 100). VAS-PJ represents the current pain score, VAS-P2 represents the 
average pain score over the past seven days, and VAS-P3 represents the most severe pain score 
over the past seven days. 
Higher scores on the BD1-U-DLV (Peck Depression Inventory-second edition- Dutch Language 
Version) mean more symptoms of depression. Clinical interpretation of scores is accomplished 
through criterion-referenced procedures utilizing the/oilowing interpretive ranges: 0-13 minimal 
depression; 14-19 mild depression; 20-28 moderate depression; and 29-63 severe depression77. 
One patient scored 45 points, which is indicative of major depression. This high score was due 
to a major event that happened on the day of inclusion in the study. 
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Table 3 Socio-demographic characteristics of the current study population and eight other 
Dutch shoulder research study populations. 
Current 
study 
N=72 
Van der 
Windt 
1996 
N=335 
De 
Winter 
1999 
N=201 
Winters 
1999 
N=101 
Bot 
2005 
N=281 
Bergman 
2005 
N=71 
Kuijpers 
2006 
N=492 
Feleus 
2008 
N=682 
Reilingh 
2008 
N=587 
Age (years,± S 
43 
(12.3) 
3) 
49.6 
(14.4) 
48 
(12) 
47.3 
(15.4) 
49.2 
(13.8) 
47.8 
(11.8) 
52 
(14) 
45* 49.5(14.7)t 
51.9(13.9)1: 
52.9(13.3)11 
Gender(%) 
female 69 
Education leve 
Low 
Medium 
high 
6 
47 
47 
56 
NA 
NA 
NA 
66 
NA 
NA 
NA 
58 
NA 
NA 
NA 
63 
44 
42 
14 
52 
NA 
NA 
NA 
1 
50 
NA 
NA 
NA 
52 
36 
36 
28 
50 
36 
41 
23 
Duration of shoulder pain (month) 
< 3 m 
3-6 m 
>6m 
0 
100 
85 
15 
26 
16 
55 
75 
25 
66 
34 
70 
30 
60 
40 
26 
74 59 
41 
* Feîeus reported the median instead of the mean age 
f Mean age (±SD) of the acute pain group (< 6 weeks) 
t Mean age (±SD) of the subacute pain group (6-12 weefes) 
Î Mean age (±SD) of the chronic pain group (> 3 months) 
NA (not available). It was not possible to derive these data from the papers. 
Prevalence of myofascial trigger points per subject 
Muscles containing active MTrPs were found in all 72 subjects. The median number of 
muscles with active MTrPs per subject was 6 (range 2 to 16). Muscles containing latent 
MTrPs were found in 67 subjects. The median number of muscles with latent MTrPs per 
subject was 4 (range 0 to 11). Figure 3 shows the frequency distribution of active and 
latent MTrPs per subject. Neither active MTrPs nor latent MTrPs were normally distributed 
(Shapiro W= 0.95; ρ < 0.05; W=0.96; ρ < 0.05 respectively). 
96 
Figure 3: The number of active (black bar) and latent (grey bar) ojMTrPs per subject. The 
X-axis shows the number ojMTrPs per subject, and the Y-axis shows the number of subjects. 
The exact number ofMTrPs is shown above every bar(n=72) 
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Prevalence of myofascial trigger points per muscle 
Active MTrPs were found in the infraspinatus muscle in 56 subjects and in the upper 
trapezius muscle in 42 subjects. In addition, active MTrPs were highly prevalent in the 
middle trapezius (n=31), anterior deltoid (n=34), middle deltoid (n=36), posterior deltoid 
(32), and teres minor (n=34) muscles. 
Latent MTrPs were found in the infraspinatus muscle in 11 subjects and in the upper 
trapezius in 27 subjects. Latent MTrPs were found in the teres major muscle in 35 subjects 
and in the anterior deltoid muscle in 27 subjects. Figure 4 presents the distribution of 
active and latent MTrPs per muscle. 
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Figure 4: The number of subjects with active (black bar) or latent MTrPs (gray bar) per 
muscle. The X-axis shows the muscles ihat were examined for identification ofMTrPs, and 
the Y-axis shows the number of subjects with MTrPs. The exact number ofMTrPs is shown 
above every bar (n=72). 
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DASH-DLV, VAS-P, BDI-II-DLV, and PROM 
The mean score on the DASH was 30.8 (SD 14.1; 95% CI 27.5 to 34.1). Mean VAS-P scores 
were follows: the VAS-P score for 'current pain' (VAS-Pl) was 30 (SD 23.9; 95% CI 27.0 to 
39.9), for 'average pain in the last seven days' (VAS-P2) was 42.1 (SD 17.7; 95% CI 37.4 to 
50.0) and for 'for the most severe pain in the last seven days' (VAS-P3) was 56.6 (SD 19.8; 
95% CI 51.2 to 61.9). The mean PROM score, calculated as the sum the PROM value 
measured for the non-affected shoulder minus the PROM value measured for the affected 
shoulder, was 32.4 degrees (SD 34.8; 95% CI 24.2 to 40.6), where a positive value indicates 
that the affected shoulder has a impaired range of motion. Both DASH and PROM scores 
were normally distributed (W = 0.97; ρ < 0.05 and W = 0.91; ρ < 0.05 respectively). 
VAS-Pl, VAS-P2, and VAS-P3 scores were also considered to be normally distributed, 
although the Shapiro-Wilk test did present borderline results for VAS-P2 and VAS-P3. 
^ e 
1 
active 
latent 
Table 4: Correlation matrix of the current study population (n=72). 
0.30* 
-0.12 
-
0.16 
0.02 
0.35* 
-
0.33* 
-0.02 
0.66* 
0.33* 
-
0.28* 
-0.06 
0.58* 
0.18 
0.68* 
-
0.01 
0.04 
0.27* 
0.07 
0.35* 
0.57* 
0.12 
0.04 
0.05 
0.13 
0.18 
0.18 
-0.10 
MTrPs Active Latent DASHDLV BDI-II VAS VAS P2 VAS Duration 
MTrPs MTrPs DLV P1 P3 
MTrPs - 0.65* 0.11 0.29* 0.22 0.44* 0.31* 0.06 0.26* 
AMTrPs - -0.64* 
LMTrPs 
DASH-DLV 
BDI-II-DLV 
VAS-P1 
VAS-P2 
VAS-P3 
Duration 
The data represent Spearman's rank correlation coefficient. Correlation coefficients between 
the number of muscles with myofascial trigger points (MTrPs), the number of muscles with 
active MTrPs (AMTrPs) and the number of muscles with latent MTrPs (LMTrPs), the DASH 
(Disability of the Arm, Shoulder and Hand) outcome measure- Dutch Language Version 
(DASH-DLV), the Beck Depression Inventory-second version- Dutch language Version (BDI-
II-DLV), the Visual Analogue Scales/or current pain (VAS-PI), the average pain over the 
last seven days (VAS-P2), the most severe pain over the last seven days (VAS-P3) and the 
duration of shoulder pain (Duration), are given (* p< 0.05). 
Correlation between the number muscles of MTrPs and pain and disability scores (DASH-
DLV, VAS-P) 
The number of muscles with active MTrPs only moderately correlated with the DASH-DLV 
(p= 0.30; ρ < 0.05) and VAS-PI scores (p =0.33; ρ < 0.05), and poorly correlated with 
VAS-P2 (p= 0.28; p< 0.05) and the duration of the shoulder pain (p=0.26, ρ < 0.05). We 
were unable to detect statistically significant correlations between the number of muscles 
with MTrPs (either active or latent) and VAS-P3 (p= 0.09; ρ > 0.05) or the PROM (p =0.13; 
ρ > 0.05) scores. Table 4 provides an overview of the correlations and Figure 5 shows a 
scatterplot of DASH scores versus the number of active MTrPs. 
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Figure 5; Scatterplot of DASH scores versus the number of muscles with active MTrPs. The 
regression line shows a weak positive correlation (r = 0.3), indicaiing that increasing 
numbers of active MTrPs have only a moderate effect on DASH scores. 
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Discussion 
Prevalence of MTrPs 
All subjects with unilateral, chronic, non-traumatic shoulder pain presented with multiple 
shoulder muscle MTrPs. In addition, MTrPs were found in all 17 muscles examined. 
However, the number of shoulder muscles with MTrPs appeared to vary greatly among 
subjects. In particular, MTrPs were most frequently located in the infraspinatus and upper 
trapezius muscles, in agreement with results from Skootsky 37 and Simons 26, who found 
that infraspinatus muscles were frequently associated with myofascial shoulder pain. There 
are very few other prevalence studies in the literature, and to the best of our knowledge, 
this is the first extensive report on the prevalence of MTrPs in patients with chronic, non­
traumatic unilateral shoulder pain. 
Mean and median scores on DASH-DLV and VAS-P scores 
The mean DASH-DLV score measured for the current study population is comparable with 
the mean baseline scores measured for other study populations for subjects with shoulder 
and arm pain "6 5 . According to Beaton t" subjects (n=200) with DASH scores < 23 6 are 
still able to perform all desired daily activities, although they may experience some 
discomfort. For comparison, in a study population from the US (n= 1706), the mean DASH 
score was 10.10 (SD 14 68) and in young active and healthy adults the mean DASH score 
was 1.85 (SD 5.99) 66. Importantly, the DASH-DLV score primarily reflects the level of 
dysfunction with less emphasis on pain and other symptoms. While 23 items refer to the 
ability of the subject to perform activities, only 7 items assesses the seventy of symptoms 
Subjects with long-standing shoulder complaints may alter the way in which they perform 
activities by using compensatory movements In addition, DASH-DLV does not discriminate 
between activities performed using the affected or non-affected arm, which may influence 
the magnitude of the disability and therefore the final DASH-DLV score. In support of this, 
several subjects in our study commented that their DASH score would have been different 
if the activities in question were related to the affected arm. 
Correlation between number of muscles with MTrPs, DASH-DLV scores, and VAS-P scores 
The number of muscles containing active MTrPs moderately and positively correlated with 
DASH-DLV, VAS-P1, VAS-P2 scores, and the duration of the shoulder pain, suggesting that 
the number of muscles with active MTrPs explained only 10% of the vanation of the outcome 
measures. In addition, other clinically relevant factors may have contributed to the primary 
and secondary outcome scores. First, although we did not measure the pain intensity at the 
MTrP, this may have a significant impact on pain and functioning. Hidalgo et al found that 
patients with shoulder pain had a larger number of both active and latent MTrPs than healthy 
subjects. They also found that active MTrPs were associated with greater pain intensity, and 
that lower Pain Pressure Thresholds (PPT) were reported for active MTrPs compared to latent 
and patients with shoulder pain displayed lower PPT than healthy subjects4g. Second, in this 
study we did not take into consideration the number of MTrPs per muscle, which may have 
contnbuted to the moderate correlation observed between the number of muscles with 
MTrPs and the DASH-DLV and VAS-P scores. The total number of muscles with MTrPs was 
poorly but positively correlated with the duration of the complaints, indicating that the 
number of shoulder muscles with MTrPs may increase over time regardless of whether the 
MTrPs were active or latent. Finally, because one of the characteristics of the DASH-DLV score 
is, that it does not discriminate between the affected and the non-affected shoulder, one 
could speculate that patients with chronic shoulder pain may develop strategies to overcome 
pain and disability caused by their shoulder disorder, for instance by using the non-affected 
arm, resulting in decreased DASH-DLV and VAS-P scores All these factors may have a 
substantial influence on the correlation coefficient Although the number of shoulder muscles 
with active MTrPs correlates moderately with the vanous outcome measures, this does not 
imply that MTrPs are clinically unimportant 
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Clinical implications 
To date, unilateral shoulder pain has mainly been proposed to be due to either the presence 
of inflammation in the subacromial tendons and bursae, or degenerative rotator cuff 
ruptures (diagnosed using modem imaging techniques, such as MRI or sonography) 
Although these pathological structures may cause pain, it is also known that similar 
abnormalities have been found in asymptomatic shoulders 
Active MTrPs, which are painful spots that produce familiar shoulder pain dunng 
contraction, stretching or compressing, these MTrPs may provide an alternative explanation 
for shoulder pain, which is independent of the presence of subacromial abnormalities 
According to Simons, Traveil and Simons 26, MTrPs within the infraspinatus muscle (which 
were most prevalent) cause pain in the anterior and middle deltoid regions which expands 
into the frontal upper arm, as well as referred pain and referred sensations felt in the wnst 
and the hand In addition, internal rotation and cross-body adduction may be impaired, 
which is often the case in patients with shoulder pain Both experimentally induced and 
spontaneous muscle pain lead to an aberrant motor activation pattern that is also present 
in patients with shoulder pain 67 m Although latent MTrPs are not usually an immediate 
source of pain, they can elicit referred pain when mechanically stimulated, or during 
sustained or repeated muscle contraction In addition, latent MTrPs may disturb normal 
motor recruitment patterns and movement efficiency Lucas et al showed that subjects 
who received myofascial dry needling, followed by passive muscle stretching to remove 
latent MTrPs, showed normalized motor activation patterns within 20 to 30 minutes 
following the treatment4Θ Therefore, it is reasonable to expect that treatment of MTrPs may 
lead to normalization of motor activation patterns and may facilitate spontaneous recovery 
of shoulder pain, either without exercising or by making exercise more effective 
Based on the results of this study, we propose that an alternative approach may be 
indicated for the assessment and management of patients with chrome, non-traumatic 
shoulder pain Current treatment regimens consist primarily of pharmacological 
interventions, including anti-inflammatory medications, or muscle strengthening exercises 
If MTrPs are one of the main reasons for shoulder pain (active MTrPs) and altered motor 
activation patterns (active and latent MTrPs), as several authors have proposed, then anti­
inflammatory treatment 26 4tì M and muscle strengthening exercises should not be the 
treatment of first choice Instead, the treatment should begin with MTrP inactivation 
Manual techniques, including manual compression of the MTrP, known as ischemic 
compression or trigger point release, trigger point dry needling or injection therapy are 
used to inactivate MTrPs After MTrP inactivation, muscle stretching and relaxation 
exercises, heat applications, dynamic exercises to improve range of motion and muscle 
reconditioning are instructed as appropriate This therapy is accompanied with a gradual 
increase in daily activities 
If the above hypothesis is true, treatment of MTrPs could provide an innovative, promising 
therapy for shoulder pain This study shows the results of patients' characteristics for a 
102 
sample of patients with chronic, unilateral non-traumatic shoulder pain, who were 
recruited for a randomized clinical trial to study the results of MTrPs directed interventions 
by physical therapists in this group The results of this study are accepted for publication 
(Bron et al BMC medicine) 
General Applicability 
We compared sociodemographic data from the current study population with similar data 
from several other Dutch shoulder pain research studies Because none of these studies 
investigated MTrPs, we made this comparison to see whether there was reason to expect 
that the high prevalence of MTrPs we observed was unique to our population In our study 
population more females were included, and the subjects were significantly younger and 
more highly educated than subjects from the other Dutch populations, although a specific 
explanation for these differences is lacking There is no reason to suspect that educational 
levels correlate with the number of MTrPs and awareness of educational levels is mainly 
important for effectiveness studies, because they may impact the patients' motivation and 
compliance 70 71 However, increased age may also be associated with increased number of 
MTrPs n Because the subjects of the present study were younger, and musculoskeletal 
complaints tend to increase with age 72, there is no reason to suspect that we overestimated 
the prevalence of MTrPs in our population On the other hand, there were more females in 
our study population, and females may be more prone to musculoskeletal disorders in 
general " Thus, for this reason there may be a chance that MTrPs were slightly more 
prevalent in our study population 74 76 Despite the above-mentioned differences, we 
conclude that our subjects are comparable with other patients with chronic shoulder pain 
and the findings of this study can be generalized to other patients 
Strengf h and limitations of the present study 
One of the limitations of our study is that we only examined patients with unilateral 
chronic shoulder pain and dysfunction, whereas MTrPs are thought to be responsible for 
both acute and chronic pain It is conceivable that patients who developed chronic shoulder 
pain may have more MTrPs, and persistent MTrPs in the acute phase than patients who 
recover easily In future research projects assessment of MTrPs in patients with acute 
shoulder problems should also be included The small sample size is another limitation of 
this study Before starting this study a power analysis was performed and it was calculated 
that 104 subjects would be needed for the clinical trial After two years (one year more than 
originally planned, 72 subjects were enrolled in the study For practical reasons, the study 
was completed with this smaller sample size, which may have influenced some of the 
results of this study We used two observers in this study, with identical clinical experience 
and post-graduate training on myofascial trigger point therapy In addition, both observers 
found a comparable mean number of active MTrPs Because there was no statistically 
significant difference in mean DASH scores obtained by the two observers, we consider 
both groups to be comparable and the findings obtained by both observers to be similar 
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Conclusion 
This study demonstrates that MTrPs are very prevalent in patients with chronic unilateral, 
non-traumatic shoulder pain In addition, the number of MTrPs is moderately correlated 
with DASH-DLV outcome measures and VAS-P pain measures, indicating that MTrPs 
contnbute to the clinical picture of common shoulder pain problems We recommend that 
the MTrP examination and treatment should be considered for patients with shoulder pain 
in both future clinical studies and clinical practice 
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Abstract 
Background Shoulder pain is a common musculoskeletal problem that is often chronic or 
recurrent Myofascial tngger points (MTrPs) cause shoulder pain and are prevalent in 
patients with shoulder pain However, few studies have focused on MTRP therapy The aim 
of this study was to assess the effectiveness of multimodal treatment of MTrPs in patients 
with chronic shoulder pain 
Methods A single assessor blinded randomized controlled trial was conducted The inter-
vention group received a comprehensive treatment once a week, consisting of manual com-
pression on the MTrPs, manual stretching of the muscles, and intermittent cold application 
with stretching. Patients were instructed to perform muscle stretching and relaxation exercises 
at home, received ergonomie recommendations and advises to assume and maintain "good" 
posture The control group remained on the waiting list for three months The Disability of 
Arm, Shoulder, and Hand outcome measure score (DASH [primary outcome]), Visual Analogue 
Scale for pain (VAS-P), Global Perceived Effect (GPE), and the number of muscles with MTrPs 
were assessed at 6 and 12 weeks in the intervention group and compared with a control group 
Results Compared to the control group the intervention group showed significant 
improvement (p< 0 05) after 12 weeks on the DASH (mean difference 7 7; 95% confidence 
interval [CI] 1 2 to 14.2), VAS-P for current pain (13.8,95% CI 2.6 to 25 0), VAS-P for pain 
in the last week (10.2, 95% CI. 0.7 to 19.7), and VAS-P most severe pain in the last week 
(13.8; 95% CI. 0.8 to 28.4). After 12 weeks 55% of the subjects in the intervention group 
reported to be improved (from slightly improved to completely recovered) versus 14% in the 
control group. The mean number of muscles with active MTrPs decreased in the intervention 
group compared to the control group (mean difference 2.7; 95% Cl· 1.2 to 4.2) 
Conclusions The results of this study show that a 12-week comprehensive treatment of MTrPs 
in shoulder muscles reduces the number of muscles with active MTrPs and is effective in 
reducing symptoms and improving shoulder function in patients with chronic shoulder pain 
Trial Registration Current Controlled Tnals [ISRCTN75722066] 
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Background 
Shoulder pain is a common musculoskeletal problem In several countries the one-year 
prevalence is estimated to be 20% to 50% ' 2 The annual incidence of shoulder pain and 
symptoms in Dutch primary care practice ranges from 19 to 29 5 per 1000 3 4 Shoulder 
pain is the main contributor to non-traumatic upper limb pain, in which chromcity and 
recurrence of symptoms are common 5 6 The most common cause of shoulder pain is 
considered to be subacromial impingement syndrome (SIS), causing inflammation and 
degeneration of subacromial bursae and tendons 7 9 SIS was first described in 1867 by 
French anatomist and surgeon Jaηavay and in 1972 re-introduced by Neer 9 10 Although 
the interpretation of the physical signs during shoulder examination is far from reliable, 
the diagnosis of SIS is based mainly on the clinical picture of pain in the shoulder as 
descnbed by Neer " 13 The clinical picture consists of an arc of pain, crepitus and muscle 
weakness, and a positive impingement test, which means complete relief of pain with 
forced forward elevation of the upper arm after injection of a local anesthetic into the 
subacromial space 13 Scientific evidence from randomized controlled trials (RCTs), meta­
analyses, or systematic reviews of RCTs on the effectiveness of multimodal rehabilitation, 
injection therapy, medication, surgery, physical therapy, or the application of other therapies 
in patients with shoulder pain is conflicting or lacking 14 24, which justifies a search for an 
alternative explanation of shoulder pain, whether or not diagnosed as SIS 
A common cause of muscle pain is myofascial pain caused by myofascial trigger points 
(MTrPs)25 26 MTrPs in the shoulder muscles produce symptoms similar to other shoulder 
pain syndromes, including pain at rest and with movement, sleep disturbances, and pain-
provocation during impingement tests 27 Clinical, histological, biochemical, and electro­
physiological research have provided biological plausibility for the existence of MTrPs28 37 
As a result, the role of MTrPs in musculoskeletal pain is increasingly accepted in the medical 
literature MTrPs are defined as exquisitely tender spots in discrete taut bands of hardened 
muscle that produce symptoms, known as myofascial pain 
MTrPs are classified into active and latent trigger points According to Simons et al "an 
active MTrP causes a clinical pain complaint It is always tender, prevents full lengthening 
of the muscle, weakens the muscle, refers a patient-recognized pain on compression, 
mediates a local twitch response of muscle fibers when adequately stimulated, and, when 
compressed within the patient's pain tolerance, produces referred motor phenomena and 
often autonomic phenomena, generally in its pain reference zone, and causes tenderness in 
the pain reference zone" A latent MTrP is defined as " clinically quiescent with respect to 
spontaneous pain, it is painful only when palpated A latent MTrP may have all the other 
clinical characteristics of an active MTrP and always has a taut band that increases muscle 
tension and restricts range of motion" 27 Palpation is still considered the only reliable 
clinical method to diagnose MTrPs Previous studies have shown that trained physical 
therapists can reliably detect MTrPs by palpation 38 w Although magnetic resonance 
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Figure 1 : Referred pain patterns (red) from supraspinatus (a), infraspinatus (b), teres minor 
(c), and subscapulars (d) muscle MTrPs (Xs), according to Simons et al. Illustrations 
courtesy of LifeART/MEDlCLIP, Manual Medicine 1, Version 1.0a, Lippincott,Williams dy 
Wilfeins, 1997 
elastography and ultrasound imaging studies have shown potential to visualize MTrPs, 
their clinical usefulness has yet to be established 32 ". 
Manual techniques, spray-and-stretch, and trigger point needling can inactivate MTrPs. 
MTrP inactivation may be combined with ergonomie advice, active exercises, postural 
correction, and relaxation if and when appropriate 27 40"46. Treatment of MTrPs is rarely 
included in systematic reviews of the effectiveness of conservative interventions in patients 
with shoulder pain. However, several case studies suggest that the treatment of MTrPs in 
patients with shoulder pain may be beneficial, although well-designed controlled studies 
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are still lacking47 32 Recently, Hams et al compared ischemic compression of relevant MTrPs 
(intervention) with ischemic compression of irrelevant MTrPs (sham treatment) The 
results of this study suggest that ischemic compression on MTrPs in shoulder muscles may 
reduce the symptoms of patients experiencing chronic shoulder pain " 
The aim of the current study was to assess the effectiveness of a comprehensive treat-
ment program of MTrPs in shoulder muscles on symptoms and functioning of the shoulder 
in patients with chrome non-traumatic shoulder pain compared to a wait-and-see approach 
Methods and Subjects 
A single-blinded randomized controlled trial (RCT) was conducted, which was approved 
by the Medical Ethics Committee of the Radboud University Nijmegen Medical Centre, the 
Netherlands [CMO 2007/022] This RCT is registered at Current Controlled Trials 
[ISRCTN75722066] and the study protocol was published 54 
Participants/Study sample 
Between September 2007 and December 2009, all consecutive patients with shoulder pain 
referred to a primary care practice for physical therapy, were potential study participants The 
patients were self-referred or referred by general practitioners, orthopedic surgeons, 
neurologists, or physiatnsts Patients were eligible if they had unilateral non-traumatic 
shoulder pain for at least six months and were aged between 18 and 65 years old, and whose 
clinical presentation did not warrant referral for further diagnostic screening Patients who 
previously had been diagnosed with shoulder instability, shoulder fractures, systemic diseases, 
such as rheumatoid arthntis, Reiter's syndrome, or diabetes, or whose medical history or 
physical examination suggested neurological diseases, or other severe medical or psychiatric 
disorders were excluded from the study Patients with signs and symptoms of a primary 
frozen shoulder were also excluded Because the questionnaires were in the Dutch language, 
subjects had to understand wntten and verbal Dutch The lead investigator (CB) checked all 
available information from referral letters and additional information from the patients All 
eligible patients were invited to participate in the study The patients were informed of the 
study before the first assessment and signed a wntten informed consent 
Data assessment 
Two research assistants (MO and MB, see acknowledgements), each with 30 years of clinical 
experience in primary care practice and more than 5 years experience in identifying and 
treating MTrPs, performed the physical examination, including the assessment of passive 
range of motion (PROM) of the shoulder and the MTrPs palpation of the shoulder muscles 
The total number of shoulder muscles with active and latent MTrPs was counted The 
research assistants were blinded to the treatment allocation during the entire study period 
The assessments were at intake, prior to the randomization, and at 6 and 12 weeks For 
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every single patient only one observer was active A detailed medical history was completed, 
which included demographic vanables and potential prognostic factors 55 56, and a set of 
self-administered questionnaires for outcome measurements, including the Disabilities of 
Arm, Shoulder and Hand questionnaire (DASH), Visual Analogue scales for Pain (VAS-P), 
RAND-36, and the Beck depression Inventory-II (BD1-I1) A third research assistant (IS, see 
acknowledgements) transferred the collected data to a worksheet After transferring the 
data from the worksheet into a statistical software package the lead investigator (CB), who 
was blinded to the treatment allocation until all statistical tests were performed, analyzed 
the data Blinding of the patients or the treating physical therapists was impossible due to 
the treatment characteristics 
Sample size 
The planned sample size was based on an assumed mean improvement of the primary 
outcome, DASH questionnaire score of 15 points (SD 22), which implies an effect size of 
0 68 57 To test the null hypothesis at α = 05 with 90% power and assuming a uniform 
dropout rate of 5%, it was calculated that 52 patients in each group would be required 
Randomization 
After collection of patient's data at baseline, the included patients were randomly assigned 
to either the intervention group or the "wait and see" group A research assistant (IS) 
performed the randomization by generating random numbers using computer software 
(Research Randomizer on wwwsocialpsychologyorg) These numbers were stored on a 
computer and were only accessible to the assistant No stratification or blocking strategies 
were used 
interventions 
The patients in the intervention group were treated by a physical therapist once a week for 
a maximum period of 12 weeks Five physical therapists were involved in the treatment of 
the patients All participating physical therapists were expenenced in treating patients with 
persistent shoulder pain and MTrPs They were trained and skilled in the identification and 
treatment of MTrPs and had successfully completed a certification-training program in 
trigger point therapy 
The treatment started with inactivation of active, pain-producing MTrPs by manual 
compression The physical therapist applied gentle, gradually increasing pressure on the 
MTrP until the finger encountered a definite increase in tissue resistance At that point the 
patient commonly would feel a certain degree of discomfort or pain The pressure was 
maintained until the therapist sensed relief of tension under the palpating finger or the 
patient experienced a considerable decline of pain At that point the therapist could repeat 
this procedure several times until pressure on the MTrP would only provoke little discomfort 
without pain This technique was combined with other manual techniques, such as deep 
stroking (pressure directed along the length of the taut band) or strumming (pressure 
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perpendicularly across the muscle fibers). Both techniques can manually stretch the trigger 
point area and the taut band. These manual techniques could be preceded or followed by 
"intermittent cold application by using ice-cubes followed by stretching the muscle" 
according to Simons et al27. The effectiveness of muscle stretching exercises was enhanced 
by including short isometric contractions and relaxation (hold-relax). Patients were 
instructed to perform at home simple gentle static stretching and relaxation exercises 
several times during the day. When appropriate, the relaxation exercises were augmented 
by using a portable myofeedback device (Myotrac I, Thought Technology, Quebec, Canada). 
Furthermore patients were instructed to apply heat, such as a hot shower or hot packs, for 
muscle relaxation and pain relieve at least twice every day. All patients received ergonomie 
advice and instructions to assume and maintain "good" posture 58'39. The content and aim 
of each session varied based on the specific findings from the initial evaluations and 
patients' responses to previous treatment sessions. All individual treatments however, were 
consistent with the limits of the treatment protocol54. 
Figure 2; Manual compression on the MTrP in the infraspinatus muscle of the left shoulder 
(a), stroking with ice (in a polystyrene cup) in unidirectional parallel strokes combined with 
gentle muscle stretching applied for the infraspinatus muscle of the left shoulder in side lying 
(b), and cross-body muscie stretching exercise for posterior shoulder muscles, including the 
infraspinatus muscle (c). 
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Stop rule 
Treatments were discontinued when patients were completely free of symptoms or when a 
patient and physical therapist agreed that treatment would not further benefit the patient 
Participation in the study continued, unless patients decided to stop participation in the 
study Subjects were free to withdraw from the study at any time without consequences for 
their treatment 
Treatment integrity 
To enhance the integrity of the interventions, all participating physical therapists were 
allowed to discuss the content of each therapy session with the lead investigator (CB) 
without releasing names or any other information that could jeopardize the blinding of the 
lead investigator After 6 and 12 weeks, the lead investigator interviewed the patients of the 
intervention group to assure that the received treatments had been consistent with the 
study protocol 
Wait and See 
Patients in the control group remained on a waiting list and were informed that they would 
receive the same physical therapy treatment after 3 months had passed They were 
instructed not to change their self-management of their shoulder pain If they were using 
either prescribed or over-the-counter medication they were encouraged to continue the 
medication at the patients discretion, because of their participation in the study In 
addition, they were requested to report any other intervention or other relevant change 
dunng the study penod Every six weeks they visited the physical therapy practice and 
provided research data similar to the patients from the intervention group After 12 weeks 
they started the physical therapy treatment 
Outcome measures 
Primary Outcome Measure 
The DASH is an internationally widely used multidimensional 30-item self-report measure 
focusing on physical function, pain, emotional, and social parameters 6C The score ranges 
from 0 to 100 whereby a higher score indicates greater disability The Minimal Clinically 
Important Difference (MC1D) is approximately a 10-point difference between pre- and post 
treatment " 61 62 The DASH is a reliable and valid questionnaire and considered to be one 
of the best questionnaires for patients with shoulder symptoms 61 63 
Secondary Outcome Measures 
The Visual Analogue Scale for Pain (VAS-P) is a self-report scale consisting of a horizontal 
line, 100 mm in length, anchored by the words "no pain" at left side (score 0) and "worst 
pain imaginable" at the right side (score 100)64 66 The VAS-P was used to measure pain at 
116 
the current moment (VAS-P1), the average pain during the last seven days (VAS-P2), and 
the most severe pain during the last seven days (VAS-P3). A 14 mm change is considered 
to be a MC1D in patients with rotator cuff disease 67 7ί,. 
To assess Global Perceived Effect (GPE) the subjects rated the effect of treatment on an 
ordinal 8-point scale with categories ranging from "1 = much worse" to "8 = completely 
recovered". GPE was then dichotomized into the number of improved (from slightly improved 
to completely recovered) versus not improved (from unchanged to much worse) patients. 
GPE has good test-retest reliability and correlated well with changes in pain and disability 71. 
Passive range of motion (PROM) of the shoulder was measured by a handheld digital 
inclinometer (The Saunders group Ine, Chaska, MN) and recorded in degrees. Forward 
elevation of the shoulder, external rotation, and cross-body adduction were measured in 
the supine position, internal rotation in prone position, and glenohumeral abduction in the 
upright position. The range of motion of the non-painful shoulder was used as a reference. 
A detailed description of the goniometrie measurement of the PROM is published in the 
design of the study 54. 
Table 1. List of muscles examined for MTrPs 
upper trapezius muscle 
infraspinatus muscle 
teres minor muscle 
middle deltoid muscle 
pectoralis minor muscle 
scalene muscles 
middle trapezius muscle 
supraspinatus muscle 
teres major muscle 
posterior deltoid muscle 
biceps brachi! muscle 
subclavius muscle 
lower trapezius muscle 
subscapularis muscle 
anterior deltoid muscle 
pectoralis major muscle 
triceps brachii muscle 
The total number of shoulder muscles with MTrPs was counted using the same methods as 
at baseline and then compared to the baseline measurements. While the patient was in 
supine or in prone position, depending on the muscle that was examined, seventeen 
muscles were palpated bilaterally for the presence of a taut band, spot tenderness, the 
presence of a nodule, local twitch response, and local and referred pain (table 1). When the 
patient recognized the pain from compression on the tender spot, the MTrPs were 
considered to be active. When the pain was only local and not familiar, MTrPs were 
considered to be latent27 3 8 1 4 . 
At 6 and 12 weeks, participants were asked to complete a self-assessment form, which 
included questions regarding whether they had changed their self-management, or had 
received any medical treatment that could have influenced their shoulder pain. 
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Table 2. Characteristics of participants at baseline. 
Age (years; mean; SD; 95% CI) 
Female (n; %) 
Level of education* (n; %) 
Low 
Intermediate 
High 
Right-handed (n; %) 
Pain dominant side (n; %) 
Duration of complaints (n; %) 
6-9 months 
9-12 months 
1 -2 years 
2-5 years 
>5 years 
Episode (n; %) 
first 
second 
third or more 
DASH-DLV (mean; SD; 95% Cl)t 
VAS-P1 (mean; SD; 95% Cl)§ 
VAS-P2 (mean; SD; 95% Cl)§ 
VAS-P3 (mean; SD; 95% Cl)§ 
BDI-II-DLV (mean; SD: 95% CI)H 
RAND-36-DLV (mean; SD; 95% CI)" 
social functioning 
limitations due to physical problems 
vitality 
bodily pain 
general health perception 
PROM (mean; SD;95% Cl)i 
Muscles with MTrPs (mean; 95% C\)tt 
active MTrPs 
latent MTrPs 
Intervention (n=34) 
42.8 (11.7; 38.7-46.9) 
21 (62) 
2(6) 
13(38) 
19(56) 
33 (97) 
24 (70) 
10(29) 
4(12) 
8(23) 
6(18) 
6(18) 
13(38) 
8(24) 
13(38) 
30.3(16.6;24.5-36.1) 
31.9 (24.3; 21.9-41.9) 
41.3(19.7;33.2-49.4) 
54.9(21.9:45.8-63.9) 
6.3 (4.0; 4.9-7.8) 
78.7(20.3:71.6-85.8) 
47.7(43.0:32.5-63.0) " 
59.3(17.0:53.3-65.1) 
51.6(16.0:45.7-57.6) 
52.9(8.5:50.0-55.9) 
28.4(34.8:16.1-40.7) 
7.4(3.6:6.1 - 8.7) 
4.2(2.7;3.2-5.1) 
Control (n=31) 
45.0(13.2:40.2-49.9) 
23 (74) 
2(7) 
17(55) 
12(38) 
29 (94) 
19(61) 
5(16) 
8(26) 
6(19) 
5(16) 
7(23) 
11 (35) 
8(26) 
12(39) 
30.8(11.9:26.5-35.2) 
35.2 (25.7; 25.7-43.0) 
43.4(17.0:37.2-50.0) 
59.5(18.2:52.8-66.2) 
5.8 (8.2; 2.8-8.8) 
81.1(18.5 
49.5 (37.2 
62.6(17.9 
52.7(12.3 
74.3 - 87.8) 
35.8-63.1) 
56.0-69.1) 
48.2 - 57.2) 
56.6(7.0:54.1-59.2) 
39.0(34.9:26.2-51.8) 
6.1 (3.5:4.8-7.4) 
5.9 (3.0; 4 8-7.0) 
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* High education (universiiy and higher vocational school), medium education (middle 
vocational school and higher or middle general secondary school), and low education (lower 
vocational school, lower general secondary school, primary school, or no education). 
t Higher Dash-DLV (Disabilities of the Arm, Shoulder and Hand outcome measure- Dutch 
Language Version) scores indicate more disability with a maximum of 100 (range O to 100). 
§ Higher scores on the VAS-P (Visual Analogue Scales for Pain) indicate more pain with a 
maximum of 100 (range 0 to 100). VAS-P1: current pain score, VAS-P2; average pain score 
of the past seven days, and VAS-P3: most severe pain score of the past seven days. 
1 Higher scores on the BDl-ll-DLV (Beck Depression Inventory-second edition- Dutch Language 
Version) indicate more symptoms of depression (range 0-63). 
** Only the subscales of the nine suhscales of the RAND-36 thai differ significantly from a 
normal Dutch population are presented here m. Higher scores indicate a better quality of life 
(range 0-100). 
f A positive number (degrees) of the mean score of PROM (Passive Range Of Motion) indicates 
impairment of the PROM of the affected shoulder. 
ft Number of Muscles with active, resp. latent MTrPs (range 0-17 muscles) 
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Statistical Analysis 
Analyses were performed according to the intention-to-treat principle Both groups were 
compared for baseline characteristics using t-test and Chi-square for binominal variables 
For the DASH, VAS-P, and the number of muscles with MTrPs the t-test for normally 
distributed data was used to assess the difference between the two groups at week 6 and 
week 12 We considered a mean difference of more than 10 points on the DASH as clinically 
important (MCID) Effect sizes Cohen's d were calculated to examine the average impact of 
the intervention 72 According to Cohen, d - 0 2 indicates small effect, negligible clinical 
importance, d - 0 5 indicates medium effect, moderate clinical importance, and d - 0 8 
indicates a large effect, crucial clinical importance 7 3 To compare patients who improved 
more than 10 points on the DASH with patients who improved less than 10 points we 
calculated relative risk (RR) and their 95% confidence intervals (95% CI) To examine the 
impact on individual patients in more detail, we dichotomized participants' measures of 
GPE into improved versus not improved The proportions of patients who had clinically 
improved between groups were compared by calculating RR and the 95% CI at 6 weeks 
and 12 weeks Pearson correlation coefficients were used to relate the variables of the 
number of muscles with active MTrPs and the DASH score 
In addition, the effect of the intervention was evaluated in a regression analysis The 
DASH score at 12 weeks was the dependent variable, the group variable, the DASH score 
at baseline, the number of muscles with active MTrPs at intake, the number of muscles with 
latent MTrPs at intake, and PROM included as covanates in this multiple linear regression 
model 
To evaluate the successfulness of the blinding procedure, both observers were asked to 
identify the treatment allocation A goodness-of-fit χ2 test was used to determine that the 
number of correctly and incorrectly identified cases fitted a probability of 50% For all 
comparisons, ρ < 0 05 was considered statistically significant (two-tailed) If the 95% 
confidence interval (95% CI) of the difference does not include the value 0, the difference 
is statistically significant (at α = 0 05) Systat 12, Sigmapiot 11, and Sigmastat 3 11 (Systat 
Ine Richmond, California, USA) for Windows were used for the statistical analysis 
Results 
Between September 2007 and September 2009, 72 patients were randomly assigned to 
either the intervention group or the control group See figure 3 for the schematic summary 
of the patient participation and table 2 for the patients' characteristics at baseline At 
baseline, both groups were comparable for all variables with no statistical or clinical 
relevant differences, except for the number of muscles with latent MTrPs and the level of 
education 
Figure 3: Flow diagram showing the schematic summary of the patient participation. 
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' 
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w 
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because of signs and symptoms of primary 
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treatment (n= 37 ) 
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withdrawals (n= 0) 
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shoulder (n=2) or cervical 
radiculopathy (n=l) 
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primary and secondary 
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Primary outcome 
DASH 
The difference between the intervention group and the control group was not significant 
after 6 weeks (4.1; 95% CI -2.8 to 11 1), and significant after 12 weeks (7 7; 95% Cl· 1.2 
to 14.2). The graphical presentation of the mean DASH scores at intake, after 6 and 
12 weeks is shown in figure 4. 
Seventeen subjects (50%) in the intervention group and seven (22%) in the control group 
improved more than 10 points (MCID) on the DASH outcome measurement (relative nsk 
2.3; 95% Cl 1.1 to 4.7) (jfigure 4). The effect size (Cohen's d) was 0.60 (table 3). 
The multiple linear regression analysis with the baseline score as a covariate demonstrated 
a significantly higher DASH score at 12 weeks of 7 447 (95% Cl: 2 14 to 12.75) in the 
intervention group compared with the control group Adjustment for the covanates had no 
influence on this result. 
Secondary outcomes 
VAS-P1, VA5-P2, and VAS-P3 
The intervention group showed on average significantly lower scores on all VAS-P scales 
compared to the control group after 12 weeks (VAS-P1,13 8; 95% CI: 2.6 to 25.0), VAS-P2; 
10.2; 95% Cl: 0.7 to 19.7), and VAS-P3; 13 8; 95% CI 0.8 to 28 4). The differences after 
6 weeks were not significant, except for VAS-P3 (15.6; 95% Cl· 2.3 to 28.8) The difference 
between baseline and after 12 weeks in the intervention group reached the MCID for all 
three VAS-P scales, while changes in the control group did not reach the MCID The effect 
sizes on the three VAS-P scales varied from 0.5 to 0.7 (table 3). 
GPE 
After 6 weeks, improvement was reported by 49% (16/33) of the patients in the intervention 
group versus 17% (5/30) patients in the control group (relative risk 2.9, 95% CI. 1.2 to 
7.0). After 12 weeks, 55% (18/33) of the patients in the intervention group reported to be 
improved versus 14% (4/28) of the patients in the control group (relative nsk 3 8; 
95% Cl: 1.46 to 10 0) (table 3). 
Number of muscles with trigger points 
The number of muscles with active MTrPs was significantly lower in the intervention group 
compared to the control group after 12 weeks (mean difference 2.7, 95% CI. 1.2 to 4 2). 
The change in the number of muscles with latent MTrPs was non-significant versus control 
group (mean difference 0.4, 95% Cl· -0.7 to 1 5) (table 3). Effect size (Cohen's d) for active 
MTrPs after 12 weeks was 0.89, a large effect and for latent MTrPs 0.13 
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Figure 4: The mean DASH scores (error bars present 95% confidence interval) at intake, 
after 6, and after 12 weeks for the intervention group (n=34) and control group (n=31). 
The mean Dash scores of patients with shoulder pain (95% confidence interval) 
at intake, after 6, and after 12 weeks for the intervention group (n=34) 
and control group (n=31) 
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Correlation between the number of muscles with active MTrPs and the DASH outcome at 12 weeks 
The number of shoulder muscles with active MTrPs was positively correlated with the DASH 
outcome at 12 weeks (r = 0 49; regression coefficient = 2.13, ρ = 0.000; ANOVA F = 9 6, ρ = 
0.000), when corrected for muscles with active MTrPs at intake). This implies that the 
number of muscles with active MTrPs was associated with 24% of the vanation in DASH 
outcome. Two cases were identified as significant outliers dunng the multiple linear regression 
analysis (both in the intervention group) and were removed before further analysis. 
PROM 
The PROM difference between the groups did not change significantly during the 
measurements at 6 weeks (mean difference 8 8, t= 1 14, ρ > .05) and 12 weeks (mean 
difference 8.2; t= 1.19; ρ >.05). 
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Table 3. Primary and secondary outcomes in intervention group and control group after 6 
and 12 weeks 
outcome intervention control mean difference p-value Effect Size 
(n=34) (n=31) (95% CI) (Cohen's d) 
DASH (mean; SD)t 
baseline 
after 6 weeks 
after 12 weeks 
VAS-P1 (mean; SD)§ 
baseline 
after 6 weeks 
after 12 weeks 
VAS-P2 (mean; SD)§ 
baseline 
after 6 weeks 
after 12 weeks 
VAS-P3 (mean; SD)§ 
baseline 
after 6 weeks 
after 12 weeks 
GRE (proportion; %)* 
Improved 
after 6 weeks 
after 12 weeks 
30.3(16,6) 
23,4(12,6) 
18.4(12,3) 
31,9 (24,3) 
29,0(18,4) 
17.2(19,5) 
41,3(19,7) 
32,9(19,3) 
22,5(16,4) 
54,9(21,9) 
41,0(25.1) 
34.0(21,9) 
16/33(49%) 
18/33(55%) 
30.8(11.9) 
27.5(15.5) 
26.1 (13.8) 
35.2 (25.7) 
37.8(17.9) 
31.0 (21.0) 
43.4(17,0) 
40,0 (20,7) 
33.2 (23,3) 
59,5(18,2) 
56,6 (28,3) 
47,8 (27.3) 
5/30(17%) 
4/28(14%) 
0.5 (-6.7 to 7.7) 
4.1 (-2.8 to 11.1) 
7.7 (1.2 to 14.2) 
3.3 (-9.1 to 15.7) 
8.8 (-0.2 to 17.8) 
13.8 (2.6 to 25.0) 
2.0 (-7.1 to 11.1) 
6,7 (-3,6 to 17,0) 
10,2 (0,7 to 19.7) 
4.6 (-14.6 to 5.4) 
15.6 (2.3 to 28.8) 
13.8 (0.8 to 28.4) 
Number of muscles with active trigger points (mean; SD) 
baseline 
after 6 weeks 
after 12 weeks 
7,4 (3.7)) 
6,2 (3.5) 
4.8 (3.0)) 
6.1 (3.5) 
6.8 (3.6) 
7.5 (3.2) 
1.3 (-0.5-3.1) 
0.6 (-1.2-2.4) 
2.7(1.2-4.2) 
Number of muscles with latent trigger points (mean; SD) 
baseline 
after 6 weeks 
after 12 weeks 
ES = effect size. NS 
4.2 (2.7) 
3.8(2.1) 
4.7 (2.3) 
5.9 (3.0) 
4.8 (2.8) 
4.4 (2.3) 
= noi signi/ìcani. 
t Higher Dash-DLV (Disabilities of the Arm, 
1.7 (-0.3-3.1) 
1.0 (-2.3-0.2) 
0,4 (-0.7-1.5) 
Shoulder and Hand 
Language Version) scores, more disability with a maximum of 100 
§ Higher scores < 
NS 
NS 
<.05 
NS 
NS 
<.05 
NS 
NS 
<.05 
NS 
<.05 
<.05 
0.60 
0.69 
0.54 
0.57 
RR (95% Cl) 
<.05 
<.05 
NS 
NS 
<.05 
<.05 
NS 
NS 
outcome 
2.9(1.2-7.0) 
3.8(1.5-10.0) 
0.89 
0.13 
measure- Dutch 
(range from 0 to 100). 
on the VAS-P (Visual Analogue Scales for Pain) indicate more pain with a 
maximum of 100 (range from 
represents the average pain si 
score of the past seven days. 
* GPE; Global Perceived Effect 
0 to 100). VAS-P1 represents the c 
.ore oj the past : seven days, and VA. 
urrent pain score, VAS-P2 
S-P3 the most severe pain 
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Figure 5: Number of subjects that improved more than 10 points (minimal clinically 
important difference) on the DASH outcome measure after 12 weeks for the intervention 
(n=34) and control group (n=31). 
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Evaluation of Blinding 
After 6 weeks, the observers identified the treatment allocation correctly in 62% (χ2 =4.70, 
ρ = 0.03) and after 12 weeks in 71% (χ2 =13.86, ρ = 0.00) of the patients after completing 
the physical examination and MTrP count. 
Co-interventions 
We checked whether the participants in either group had received other interventions 
other than those described in the treatment protocol. During the first 6 weeks of the study, 
one subject in each group received an injection administered by a general practitioner. 
After 6 weeks no co-interventions were reported in either group. 
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Discussion 
Summary of main findings 
This single blinded randomized controlled trial evaluated the effectiveness of a 12-week 
comprehensive MTrP physical therapy treatment program in patients with chronic non-
traumatic unilateral shoulder pain when compared to a wait-and-see strategy After 12 
weeks the intervention group showed statistically as well as clinically significant differences 
compared to the control group on the primary and secondary outcome measures The 
effect sizes were considered to be medium and consistent with the hypothesized effect size 
The number of shoulder muscles with active MTrPs was significantly lower in the inter-
vention group than in the control group), supporting the assumed biomedical mechanism 
underlying MTrP therapy 
Explaining the results/ comparing with other studies 
To our knowledge, this is the first study of the effectiveness of a comprehensive MTrP 
therapy program in patients with shoulder pain The difference of the DASH scores between 
groups was smaller than the MCID However, the mean of the baseline DASH score was 
smaller than was expected based on results from other studies " 74 " With a smaller mean 
value, it is less likely to get great differences between baseline and follow up at 12 weeks 
However, the effect size was 0 6, which is considered to be a medium effect that is clinically 
relevant When considering the number of subjects improving more than 10 points, there 
is a clinically relevant result Furthermore, many more subjects in the intervention group 
reported improvement (GPE) than in the control group 
Previous trials have investigated vanous types of physical, manual or exercise therapy 
The treatments in these studies included interventions showing similarities to components 
of the treatment program of this study, but were not specifically aimed at treating MTrPs 
For example, exercise therapy or manual therapy interventions included soft tissue massage 
and muscle stretching exercises, which generally are performed for anterior and posterior 
muscle tightness 76 ^ These interventions may have an unintentional effect on MTrPs in 
shoulder muscles, as MTrPs seem to be prevalent in patients with shoulder pain, which 
may have contnbuted to the results of other studies 25 26 However, as these studies did not 
focus on MTrPs, there is no direct evidence that these interventions did have or did not 
have effect on MTrPs 
Recently, Hams published the first report on the effectiveness of ischemic compression 
therapy of MTrPs in shoulder muscles in chronic shoulder conditions compared to sham 
compression The intervention group received 15 sessions (compnsing of 15 second 
compression of MTrPs in up to four muscles, including the supraspinatus, infraspinatus, 
deltoid, and biceps muscles) three times a week without taking any other therapeutic 
measures The control group received sham therapy (15 seconds compression of MTrPs in 
shoulder muscles, considered irrelevant for the shoulder pain) The intervention group 
showed a significant improvement on the Shoulder Pain and Dysfunction Index (SPADI) 
when compared to the sham group " . The authors did not report any change in the number 
of MTrPs in the shoulder muscles or in the number of shoulder muscle with MTrPs The 
current study showed that a decrease of the numbers of shoulder muscles with active MTrPs 
is correlated with better outcome. While the number of muscles with active MTrPs decreased 
in the intervention group, the number of muscles with latent MTrPs tended to increase 
slightly. One explanation can be that the state of MTrPs is more or less dynamic and changes 
from active to latent and vice versa occur, depending on the degree of irritabilityeo. 
One of the clinical features of active MTrPs is spontaneous pain, in rest or during 
activity, which is felt at a distant from the MTrP side and, by definition, has to be recognized 
by the patients as their familiar pain. According to Mense, "the current concept of the 
referral of muscle pain is based on the observation that the efficacy of synaptic connections 
of central dorsal hom neurons can change, particularly under the influence of a nociceptive 
input. The important point is that ineffective synaptic connections can become effective 
under pathological circumstances. This means that a neuron can acquire new receptive 
fields in the presence of nociceptive input"β 1. This process is called central sensitization 
By expanding receptive fields, non-nociceptive input, originating from a location other 
than the originally painful location, may be perceived as painful. In patients with shoulder 
pain, MTrPs in, for example, the infraspinatus, supraspinatus, teres minor, or subscapulans 
muscle may cause local and referred pain, which can be felt deep in the shoulder In other 
words, MTrPs may mimic pain interpreted as pain arising from subacromial bursitis, 
tendonitis or tendonopathy, which may explain why often treatment of inflammation is so 
ineffective. 
Furthermore, MTrPs can cause particular motor effects as well. MTrPs can lead to muscle 
weakness of the involved painful muscle and reorganization of motor activation patterns. 
Restncted range of motion may be observed secondary to a contracted taut band β0 θ2 β3. 
A changed motor activation pattern is often reported in the shoulder pain literature 84. Since 
MTrPs can alter such patterns, MTrP inactivation should be considered prior to any form 
of muscle strengthening exercises When muscle weakness persists, it may alter a patient's 
shoulder kinematics and eventually causes humeral head migration, rotator cuff degene­
ration and formation of bony spurs in the subacromial space. Early recognition and 
treatment of MTrPs may prevent patients from developing chronic shoulder pain and early 
degeneration. 
As we did not examine the effects of single components of the intervention we cannot 
conclude whether a single component or a combination of components attributed more to the 
treatment effect than others. Others have examined the effect of single ischemic compression 
or a combination of ischemic compression and stretching and concluded that both interventions 
had positive effects on the recovery 45. The management of MTrPs is not restncted to MTrP 
inactivation, but needs correction of perpetuating factors, that are clinically apparent, but not 
yet necessanly scientifically established 27 42 θ3 Further research is needed to clanfy the 
importance of perpetuating factors in shoulder patients, such as mechanical factors86. 
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Limitations of the study 
The power analysis indicated that 104 subjects were needed for this clinical trial Partly 
because of an overestimation of the number of eligible subjects and partly because of the 
unwillingness of patients to enter the trial, the study was completed with a smaller sample 
size This study took two years to complete, which is one more year than originally was 
planned However, the results were significant and clinically relevant, although the study 
population was smaller than the initially calculated sample size A greater sample size is 
unlikely to have altered the direction of the results 
In the intervention group the participants had a higher level of education than in the 
control group Awareness of educational levels is important, as it may impact the patients' 
motivation and compliance87 θ8, but adding the level of education as covanate in a multiple 
linear regression analysis did not alter the results 
Evaluation of the blinding of the independent observers, who performed the physical 
examination and counting of MTrPs, revealed that after 12 weeks the observers were able to 
identify to which group a patient belonged It is likely that the changes in physical findings 
and decrease in the number of MTrPs improved the observers' accuracy of group identi­
fication Since the blinding only influenced the observer, who performed the MTrP 
identification, this finding had no effect on the reliability of the other outcomes scores 
The subjects in the control group were instructed to maintain their self-management of 
their shoulder pain and to report any management deviation While this may pose a 
potential threat for the comparability of the groups, no significant changes were reported 
As all patients were suffering from chronic shoulder pain and likely had explored vanous 
self-management strategies before entering into the study, we did not anticipate that they 
would change their self-management strategy during the study penod 
Although the observers did not intend to give some "good" advise during the physical 
examination, they may have unintentionally instructed the subjects to avoid provocative 
activities When the subjects in the control group followed the instructions and acted more 
carefully dunng daily live, their symptoms may have reduced, while they were still suffering 
from MTrPs This may explain the improvement in the control group 
Implications f or research and clinical practice 
This study showed that patients with chronic unilateral non-traumatic shoulder pam had 
better outcome after a treatment for MTrPs than those without treatment and this outcome 
was correlated with a decrease of the number of muscles with active MTrPs 
Treatment of MTrPs can be considered as a promising approach for the treatment of 
patients with shoulder pain Future clinical tnals should be directed to establishing the 
effectiveness of MTrP treatment in patients with varying underlying pathology of the 
shoulder and in a wider context than a specialized physical therapy practice It would be 
worthwhile to identify predictors for successful MTrP treatment, and to investigate whether 
MTrPs treatment is more successful when combined with supportive interventions, such as 
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exercises and manual therapy Observational follow-up studies are needed to investigate 
the long-term effects of treatment of MTrPs in patients with chronic shoulder pain 
Given the high number of patients with shoulder pain, this will require a substantial 
effort and financial investment Studies on the cost-effectiveness of treatment of patients 
with MTrPs in the shoulder muscles are therefore needed 
Conclusions 
Participants in the intervention group had better outcome on all outcome measures after 
12 weeks of comprehensive MTrP treatment program than those on the waiting list 
Clinically relevant improvements were achieved in 55% of the patients with shoulder pain 
and the number of muscles with active MTrPs was significantly decreased 
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GENERAL DISCUSSION 
The central aim of this thesis was to descnbe the impact of myofascial trigger points (MTrPs) 
on pain and functioning in patients with chronic unilateral non-traumatic shoulder pain 
Background 
Non-traumatic shoulder pain is often called non-specific shoulder pain, which means that a 
specific medical diagnosis is not provided Specific shoulder pain diagnoses include, among 
others, glenohumeral labral lesions, fractures, tendon tears, dislocations, glenohumeral insta-
bility, osteoarthritis, infections and rheumatoid arthritis 
Shoulder pain is highly prevalent in the population Together with low back pain and 
neck pain, it is the most common among musculoskeletal disorders Furthermore, shoulder 
pain is persistent and recurrent, even with medical treatment Most non-traumatic shoulder 
pain is explained as being the result of inflammation, degeneration or impingement of the 
soft tissues in the subacromial space, usually referred to as subacromial impingement 
syndrome (SIS) Medical treatment usually consists of anti-inflammatory drugs, muscle 
strengthening exercises for the rotator cuff muscles or surgery for decompression of the 
impinged tendons and bursa 
However, there is no evidence that any of these therapeutic interventions are effective 
in patients with non-traumatic shoulder pain, with a few exceptions ' 4 These exceptions 
are subacromial corticosteroid injections for rotator cuff disease and intra-articular injection 
for adhesive capsulitis They may be beneficial although the effect may be small and not 
well-maintained 2 Exercises combined with mobilization, including soft tissue massage, 
shoulder muscle strengthening and stretching exercises, are beneficial for patients with 
rotator cuff disorders (SIS)3 5 7 
Shoulder diagnostics are hampered by the fact that physical examination tests have only 
limited diagnostic validity due to low specificity, and abnormalities revealed by medical 
imaging are not necessarily pathognomonic810 
Research studies on shoulder pain have rarely mentioned MTrPs, and the effect of MTrP 
therapy in patients with shoulder pain remains unclear In this thesis, a comprehensive 
MTrP therapy program administered by specifically-trained physical therapists over three 
months was compared to a wait-and-see strategy in patients with chronic (duration more 
than six months) unilateral non-traumatic shoulder pain 
In Chapter 2 we presented an evidence-informed review on MTrPs with the current 
knowledge of aetiology, pathophysiology and clinical implications This chapter offers a 
conceptual framework which helps to explain why MTrPs develop, why they are sustained, 
and what mechanism explains the therapeutic effects MTrPs are determined by manual 
palpation and together with information from the patients' medical history and findings from 
the physical examination, the assessment of myofascial shoulder pain caused by MTrPs can 
be made Gerwin and Sciolti have confirmed the reliability of manual MTrP palpation " 12 
Simons et al have recommended 'clearly, a clinical or experimental research study of human 
MTrPs, to obtain the most meaningful results, should employ both expenenced and trained 
examiners who have been tested for interrater reliability before the study is conducted' " 
In Chapter 3, we presented the results of an interrater reliability study This study compared 
the palpation findings of three different observers, examining bilaterally six MTrP locations in 
three shoulder muscles (infraspinatus, anterior deltoid and biceps brachii muscles) in 40 
subjects Thirty subjects had unilateral shoulder pain, and 10 subjects had no current shoulder 
pain The raters were blinded to the pain status of the subjects All subjects were examined for 
the charactenstic features of MTrPs, including a hard nodule in a taut band, referred pain, the 
local twitch response and the jump sign In this study, we found a high prevalence of latent 
MTrPs in the unaffected shoulder of the patients with unilateral shoulder pain as well as in the 
shoulders of pain-free shoulder subjects Latent MTrPs are described as "clinically quiescent 
with respect to spontaneous pain, it is painful only when palpated A latent MTrP may have all 
other clinical characteristics of an active MTrP and always has a taut band that increases 
muscle tension and restncts range of motion" Since all raters were blinded for the status of 
the subjects (shoulder pain or non-shoulder pain) they were not able to distinguish active 
from latent MTrPs In reliability studies, the Cohen's kappa is most often used as a statistical 
measure for agreement The unexpected high number of MTrPs had an unintentional influence 
on the Cohen's kappa Therefore, we also provided the prevalence index (P,), which expresses 
the ratio between the presence and absence of certain features In other words, when the P, is 
high, the Cohen's kappa will be low, although the percentage of agreement is high It has been 
reported that latent MTrPs are highly prevalent in the shoulder muscles of asymptomatic 
healthy subjects H, and in future studies, it is recommended to check control subjects for 
latent MTrPs before entering the study In clinical practice, the patient provides the clinician 
with information about the sensitivity of the MTrP and the recognizable sensations, including 
pain and paresthesia, caused by compression on the MTrP This extra information is likely to 
increase the reliability of MTrP palpation Objective criteria, confirming the assessment of 
MTrPs by palpation, are provided by needle EMG, microdialysis, magnetic resonance elasto-
graphy and ultrasonography, but these facilities are not available in primary care 15 " 
In Chapter 4, the study protocol of the clinical randomized trial was presented This study 
was conducted in one physical therapy practice All participating physical therapists were 
specialized in the treatment of patients with musculoskeletal disorders of the neck, shoulder 
and arm They were experienced in diagnosing and treating of patients with MTrPs Thus, the 
results of this trial may apply only to expenenced physiotherapists In this tnal, we compared 
a comprehensive MTrP therapy protocol with a waiting list The vanous elements of this MTrP 
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approach were according to the guidelines of Simons et al n Due to the design of the study, 
we were only able to make conclusions on this MTrP therapy and not on its single elements 
In general, treatment followed the principles of inactivation of MTrPs, restoration of muscle 
function and correction of the factors that precipitated and perpetuated the MTrPs 24 
A combination of treatment elements may be more effective than a single element13 " 2 7 
For example, myofeedback or MTrP compression alone is probably not effective, but an 
effective combination employs MTrP compression, which decreases the sensitivity of the 
muscle and therefore makes it easier to relax, and myofeedback, which helps to relax and 
thereby decreases sustained muscle overloading Applying heat as a single modality seems 
to be ineffective, but applying it after MTrP compression followed by muscle stretching 
exercises may improve blood circulation within the muscle Normalizing blood circulation 
seems to be a key factor in the physiological response after MTrP therapy " " 28 
Since the prevalence of MTrPs in patients with shoulder pain was unclear, we collected data 
on the presence of MTrPs in our study sample at baseline The results of this observational 
study are presented in Chapter 5 We found active MTrPs in all patients, indicating that 
MTrPs are responsible for at least a part of the shoulder pain in all patients The median 
number of active MTrPs was six, but vaned greatly per subject If multiple MTrPs contribute 
to shoulder pain, then elimination of only one MTrP will probably not improve the patients' 
pain and functioning Conversely, some or probably all active MTrPs have to be treated 
adequately before the patient improves Most active MTrPs were found in the infraspinatus 
and the upper trapezius muscle According to Simons et al, the infraspinatus muscle refers 
pain to the frontal and lateral side of the shoulder and the pain is felt as 'deep shoulder 
pain' The upper trapezius muscle refers to the top of the shoulder and eventually to the 
neck, and even to the temporal region of the head 13 When (ipsilateral) headache accom-
panies shoulder pain, this may also have a myofascial ongin " 3 3 We looked at the 
association between the number of active and latent MTrPs, the DASH and the VAS-P 
There was a significant positive, but only moderate, correlation between active MTrPs and 
the DASH or VAS-P 1 scores This may have several reasons 
1 We counted the number of muscles with active MTrPs and not the total number of 
active MTrPs It is likely that the number of active MTrPs is more correlated to the 
outcome scores than the number of muscles with active MTrPs 
2 We did not determine the sensitivity of the MTrPs, which can be measured by the Pain 
Pressure Threshold (PPT) According to Hidalgo, 'active MTrPs in some muscles are 
associated to greater pain intensity and lower PPTs when compared to those with latent 
TrPs in the same muscles', and 'significant negative correlations between pain intensity 
and PPT levels are found' Therefore, we assume that a higher sensitivity of MTrPs 
could result in higher outcome scores 
3 The mean DASH score was 30 8 (95% CI 27 5 to 34 1, minimum 0 and maximum 
100) This relatively low score happens to be common in other shoulder research 
investigating chronic shoulder pain In studies examining the effects of conventional 
therapy in patients with chronic shoulder pain, the DASH at baseline ranged from 313 
to 35 0 34 36. In studies examining the effects of surgical interventions, the DASH score 
was slightly higher, ranging from 42 0 to 43.0 34 37 3e There may be several reasons for 
generally low outcome scores at baseline in patients with chronic musculoskeletal pain, 
including shoulder pain. First, this may be explained by the fact that chronic shoulder 
patients may have learned to cope with their shoulder pain and the limitations in 
functioning and therefore, have a lower score on the DASH. Second, as patients with 
higher DASH scores have more pain and more disability, they are less willing to 
participate in a study because of the chance of being allocated in the control group, 
which means that they have to wait another three months before therapy starts 
Therefore, it is conceivable that selection bias has led to a relatively low DASH score. 
For the same reasons, this also holds true for VAS-P1 (mean 30.0; 95% CI 27 0 to 
39.9), VAS-P2 (mean 42 1; 95% CI 37.4 to 50.0) and VAS-P3 (mean 56.6; 95% CI 51 2 
to 61.9). 
In Chapter 6, we presented the results of the RCT. We had calculated that we needed 104 
patients (52 in each arm) to detect a clinically relevant improvement. Partly because of an 
overestimation of the number of eligible subjects and partly because of the unwillingness 
of patients to enter the tnal, the study was completed with a smaller sample size The study 
took two years to complete, which is one more year than was originally planned. The 
reason for the declined patient flow remained unclear. Despite the smaller sample size, we 
found significant and clinically relevant differences between the intervention group and the 
control group. While the study stopped after three months, it is unclear whether the 
improvement will continue or stop after this time. A follow up study is needed to assess 
this, but this was not part of this thesis. As previously mentioned, the functional status of 
included patients at baseline was relatively good This implies that it is difficult to achieve 
significant improvement, even a 50% improvement is still only 15 points on the DASH. 
Nevertheless, small improvements may have important clinical implications, although they 
are close to or even smaller than the Minimal Clinical Important Difference (MCID). In this 
study, all patients were treated once a week for 12 weeks The duration of each session was 
30 minutes. It is unclear whether this is the most optimal frequency and the most optimal 
duration of the session. In this study, we used manual techniques for inactivation of MTrPs 
There were two major reasons for this choice First, not all participating physical therapists 
had attended courses in addition to manual MTrP therapy. Second, manual techniques can 
easily be administered by general physical therapists without any additional extensive 
educational course. In recent years, new techniques have become available for physical 
therapists in several countnes, including the Netherlands. Especially, trigger point dry 
needling (TPDN) is one of the innovations in MTrP therapy 39. TPDN might be more 
effective than manual techniques, but requires additional training, since physical therapists 
are not allowed to treat invasively without additional training 40 42. 
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Recommendations 
Clinical practice 
We recommend to use the clinical diagnostic term 'shoulder pain caused by MTrPs', when 
the presence of MTrPs is confirmed by physical examination, including palpation and 
provocation by firm digital pressure, instead of using the generally accepted term 'non-
specific shoulder pain' We further recommend examining patients who have already been 
diagnosed with subdeltoid or subacromial bursitis, rotator cuff disorder, tendonitis, 
tendinopathy or subacromial impingement for the presence of MTrPs, since MTrPs may 
accompany other diseases or disorders of the shoulder 
While a substantial number of patients benefitted from the MTRP therapy, it is important 
to note that some patients did not benefit It remains unclear whether continued treatment 
or innovative types of MTrP treatment would be beneficial in this group Future observational 
studies can help to elucidate these ambiguities 
For the moment, we recommend evaluating patient progress carefully and stopping 
MTrP treatment when no improvement occurs Based on the results of the RCT, we are not 
able to define a clear stop rule, but based on clinical experience, it is conceivable that 
patients with chronic shoulder pain need more treatment sessions over a longer period of 
time than the three months period of the RCT 
Other authors have suggested that it may take more than 11 weeks for patients with 
chronic shoulder pain to fully enjoy the benefits of an active exercise program " 
Implementation 
Nationwide implementation of MTrP treatment is a new challenge, which was not consi-
dered in our clinical studies Nevertheless, these studies give some clues about possible 
barners for implementation Most implementation experts recommend identifying the 
most relevant barriers for change and tailoring implementation interventions to those 
barners However, even carefully developed and well-applied implementation programs 
have mixed and moderate effects The uptake of biomedical knowledge in clinical practice 
is a slow and haphazard process 'H 45 Regarding MTrP therapy, we suggest that the following 
factors may be associated with its implementation 
1 Knowledge and skills of physiotherapists regarding MTrP assessment and management 
2 Motivation to apply this assessment and management among physiotherapists 
3 Knowledge and motivation among physicians to refer patients for MTrP treatment 
4 Preferences, concerns and expectations of patients with shoulder pain 
5 Strength of evidence related to MTrP treatment 
6 Availability of alternative, effective treatments for shoulder pain 
7 Reimbursement for the treatment (insurance and/or co-payment) 
8 Annual number of patients needed for optimally effective and efficient delivery 
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Organizational, legal or economic factors may be underlying barners for change in clinical 
practice The knowledge and skills of physical therapists regarding MTrP treatment are 
obviously important, as in almost all situations of implementation Physicians and therapists 
can reliably identify MTrPs in shoulder muscles, provided that they are trained well and 
have enough clinical expenence Dutch physical therapists should be able to provide 
manual therapy interventions, including vanous massage techniques and muscle stretching 
exercises, as it is part of their undergraduate education In addition, continued education 
has to be provided and followed to keep up with new developments In many countnes, 
post-graduate manual trigger point therapy and trigger point dry needling courses are 
offered Trigger point dry needling (TPDN) is an invasive procedure in which a solid 
filament needle (acupuncture needle) is inserted into the skin (superficial dry needling) 
and muscle (deep dry needling) As the name implies, TPDN is directed at MTrPs and its 
aim is to inactivate them TPDN falls within the scope of physical therapy practice in many 
countnes including Canada, Spain, Ireland, South Africa, Australia, the Netherlands, 
Switzerland, and in a growing number of states in the United States 39 
Generally, physical therapists have to get motivated to apply the clinical aspects of 
MTrPs, among clinical signs and symptoms by means of research evidence on the effect-
iveness of their intervention, the satisfaction of their patients and financial viability of 
providing the treatment Because MTrPs are highly prevalent in patients with shoulder 
pain, health insurance companies may also be interested when MTrP therapy is shown to 
be capable of decreasing the overall costs for shoulder pain interventions, for example by 
preventing unnecessary shoulder surgery Cost-effectiveness studies can help to convince 
decision makers to reimburse MTrP treatment 
Physicians should consider MTrP therapy for patients with shoulder pain and refer to 
physical therapists with or without in combination with other interventions, such as steroid 
injections or NSAIDs With persistent shoulder pain, MTrP therapy can be considered prior 
to resorting to surgical interventions 
Since direct access to physical therapy was introduced in 2006, the number of patients 
who contacted physical therapists without consulting a general practitioner gradually 
increased from 21% (2006) to 38% (2009) (from wwwmvel nl/lipz) Since 7% of these 
patients receiving physical therapy in 2009 had shoulder pain, there is a need for 
undergraduate and post-graduate physical therapy and medical education to include 
training in MTrP assessment and management to assure that patients may be treated 
accordingly 
Clinical guidelines 
The authors of clinical guidelines should include the assessment and management options 
of MTrPs when revising the guidelines, since MTrPs are highly prevalent, easily diagnosed 
and effectively treated by relatively simple interventions, including physical therapy We 
also recommend the introduction of the concept of MTrP, and teaching the diagnostic and 
therapeutic tools at schools for physical therapy and medical schools, and further 
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implementation of assessment and treatment of MTrPs in the daily practice of physicians 
and physical therapists MTrP therapy may be helpful in recovering from shoulder pain, 
especially in those cases which seem resistant to other interventions such as steroid 
injections or exercise therapy 
Future research 
We recommend that in future clinical studies on the assessment and management of MTrPs 
should be considered in patients with shoulder pain The effectiveness of MTrP therapy 
should be compared with other interventions, and combinations of MTrP therapy with 
other interventions should also be explored For example, the combination of a single 
steroid injection for short-term relief (up to six weeks) combined with MTrP therapy for 
long-term relief may be beneficial for the patient and may help to decrease the recurrence 
rate Such combination therapies may be more effective than single intervention approaches, 
and may eventually help to lower the costs for society Other MTrP interventions, such as 
TPDN may be even more effective than manual soft tissue massage or mobilization 
techniques Therefore, these interventions should be investigated as well as other 
interventions The optimal dose, duration and intensity of interventions in physical therapy 
practice are still unknown and this has to be established as well In future studies, PPT and 
counting the number of active MTrPs should be included, instead of the number of muscles 
with active MTrPs, and in addition to subjective patient self-reported outcomes, more 
objective tests to measure function, for instance lifting a heavy weight or carrying a 
shopping bag, can be used as well 
In recent decades, several articles have contnbuted to explain the aetiology and 
pathophysiology of myofascial pain and myofascial trigger points 20 46 49 However, there is 
still a need for more fundamental research in this field For example, there is evidence for 
a central role for acetylcholine in the integrated tngger point hypothesis, although evidence 
collected by analyzing its concentrations in the vicinity of the neuromuscular junction by 
microdialysis is still lacking 
Furthermore, some studies have shown that experimental and clinical shoulder muscle 
pain can induce abnormal motor activation patterns, but only one study has shown an 
association between latent MTrPs and abnormal motor activation patterns 50 Studies using 
objective parameters, including electromyography, can help to explain the association 
between MTrPs and muscle function In clinical studies, using physical therapy modalities, 
it is not possible to blind the therapist and the patient, which means that it is impossible 
to exclude the placebo effect Therefore, the magnitude of the placebo effect remains 
unclear in physical therapy However, pragmatic controlled studies companng several 
interventions can help us to find the most effective intervention 
Conclusions 
From the studies in this thesis, we may conclude that MTrPs in patients with shoulder pain 
are highly prevalent and are at least partly responsible for shoulder pain Physical exami-
nation, including palpation according to the guidelines of Simons et al , is a reliable method 
to diagnose MTrPs, which may increase when patients guide the physician or therapist 
dunng physical examination, in terms of recognizable pain " Our study shows that 
comprehensive treatment of MTrPs was effective in patients with chronic shoulder pain 
within 12 weeks 
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Shoulder pain is, after low back pain and neck pain, the most common complaint of the 
musculoskeletal system In The Netherlands and other countries, the percentage of 
individuals with shoulder pain in the population is estimated to be around 20% to 50% per 
year Shoulder pain has an important influence on the daily functioning of the individual 
patient About half of all patients with shoulder pain seek medical help Patients with 
shoulder pain have difficulties in recovering from shoulder pain so that it is often recurrent, 
despite medical treatment Shoulder pain affects not only the patient but also the whole of 
society through direct and indirect costs and sick leave 
The terms "shoulder pain", "shoulder complaint", and "shoulder disorder" are often 
used interchangeably In this thesis, we use the term "shoulder pain", as pain was the main 
complaint of the patients when consulting a physician or therapist Shoulder pain caused 
by trauma is beyond the scope of this thesis 
The clinical picture, which the patient presents with, consists of pain at the frontal or 
lateral side of the shoulder, often radiating to the upper arm and sometimes even into the 
forearm and hand The pain is often present at rest and almost always provoked or 
aggravated by posture or (repeated) movements of the arm The patient sleeps poorly 
because of the inability to he on either shoulder The pain often leads to limitations in daily 
life and problems with participation in work, sporting and leisure activities 
Non-traumatic shoulder pain is mostly explained by local pathological changes in the 
subacromial space ', including inflammation of the rotator cuff tendons or the subacromial 
bursa, or degenerative changes in the subacromial space, such as tendon degeneration 
However, there is growing scientific evidence to indicate that local inflammation is not the 
(only) causal explanation for shoulder pain, and degenerative changes in rotator cuff 
tendons are seen as often in people without shoulder pain as patients with shoulder 
complaints Therefore, it remains unclear as to whether or not the abnormal findings of 
additional imaging techniques, including ultrasound and magnetic resonance imaging 
(MRI), can explain the existence or occurrence of shoulder pain 
The main etiological explanation for shoulder pain was described by Dr Charles Neer, 
who in 1972 argued that the so-called subacromial space in these patients was too small 
Because of this insufficient space, impingement of the subacromial bursa and the rotator cuff 
tendons may occur The constant and repetitive encroachment of these structures could lead 
to acute bursitis, or, when persistent, to chronic bursitis, and finally, to degenerative rotator 
tendon tears This is called subacromial impingement syndrome (SIS) and up until today it 
has been the main explanation for non-traumatic shoulder pain Because the physical 
examination of patients with shoulder pain and additional imaging are of limited diagnostic 
value, and since there is only a small amount of scientific evidence for the effectiveness of 
vanous interventions aimed at the treatment of SIS, the question of whether or not there 
might be another possible explanation for non-traumatic shoulder pain is justified 
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To date, there has been little or no attention paid to the role of myofascial trigger points 
(MTrPs) in shoulder muscles in the scientific literature on the emergence or persistence of 
shoulder pain MTrPs are local changes in skeletal muscles that may result in sensory, 
motor and autonomic symptoms An MTrP is defined as a hypenrntable spot in skeletal 
muscle that is associated with a hypersensitive palpable nodule (muscle hardening) in a 
taut band MTrPs are divided into active and latent trigger points Active MTrPs cause 
spontaneous pain and latent MTrPs only cause pain and other sensations when directly 
stimulated by mechanical compression, muscle contraction, or muscle stretching Both 
active and latent MTrPs can decrease the mobility of the shoulder and may cause muscle 
weakness 
The aim of the research described in this thesis was to gain more insight into the role 
of MTrPs in patients with shoulder pain 
Before examining the influence of MTrPs on the pain in patients with shoulder pain, 
Chapter 2 descnbes what is known about the etiology, pathophysiology and clinical 
implications of MTrPs for physiotherapy treatment 
In particular, Dr Janet Traveil (1901-1997) and Dr David Simons (1922-2010) are 
generally credited with bringing MTrPs to the attention of medical and other healthcare 
providers 
The comprehensive "expanded integrated hypothesis" descnbes the complex 
interactions that can help explain the emergence and persistence of MTrPs It is assumed 
that various mechanisms can cause MTrPs, such as sustained or frequently repeated muscle 
contractions and unusual eccentnc or concentnc muscle contractions, leading to higher 
intramuscular pressure, and direct (muscle bruising) or indirect (sprain or strain) muscle 
trauma In all of these cases, the repeated or sustained loading of the muscle goes beyond 
the properties of the tissue, which may lead to muscle overload in the end Dunng muscle 
overload, biochemical changes in and around the muscle fibers occur, leading to an 
increased and sustained contracture (contraction due to high concentrations of Ca2* in the 
muscle fiber, without depolanzation) and to the release of various sensitizing and other 
pain-related substances Under this condition, there is no motor neuron activity that leads 
to sustained contraction As a result, this muscle overload creates a lack of adenosine 
triphosphate (ATP), which is an energy-rich substance needed for the release of large 
amounts of Ca2+ from the myosin-actin-complex and for us re-uptake into the sarcoplasmic 
reticulum, where it is stored 
The lack of ATP results in prolonged linking of the proteins actin and myosin, causing 
a shortened and thickened muscle fiber It is assumed that the thickening of multiple 
muscles fibers obstructs blood flow through the smallest capillanes, resulting in ischemia 
and hypoxia of the muscle tissue For the synthesis of ATP, large amounts of oxygen are 
needed, which can only be obtained through the capillary blood flow 
As the thickened muscle fiber cells prevent a sufficient blood flow, a self-perpetuating 
situation develops 
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Chapter 3 desenbes an inter-rater reliability study of the palpation of MTrPs in three 
shoulder muscles, ι e the infraspinatus, antenor deltoid, and biceps brachn muscles A 
total of 6 MTrP locations on both shoulders in 40 subjects were studied 
Thirty subjects had unilateral shoulder pain and ten subjects were symptom-free at the 
time of investigation The observers did not know whether one of the shoulders was painful 
or not, and if so, which one it was The muscles were palpated to determine the presence 
or absence of a noticeable hardening in a taut band, to determine whether or not firm 
compression during palpation could generate referred pain 2 (RP), and to determine 
whether snapping palpation could elicit a local twitch response 3 (LTR) or cause a "jump 
sign"4 (JS) The palpation findings were subjected to a pairwise comparison Finally, based 
on the combination of these findings, the presence or absence of an MTrP was scored 
The most reliable characteristics of the MTrPs were RP and JS, followed by the 
localization of a local hardening (nodule) in a taut band and the LTR The highest degree 
of reliability for the presence or absence of an MTrP was found in the infraspinatus muscle 
One of the three observers had 2 years of experience in MTrP therapy and the other two 
investigators had 16 and 21 years of experience in MTrP therapy, respectively 
No difference was found in the degree of agreement between the different pairs of 
observers 
Based on this study, it was concluded that palpation of MTrPs in shoulder muscles is 
reliable and, therefore, a potentially useful diagnostic tool in the diagnosis of myofascial 
pain in patients with non-traumatic shoulder pain It also appears that 2 years of experience 
is sufficient 
Chapter 4 describes the research protocol for a randomized controlled trial (RCT) of 
the effectiveness of MTrP therapy in patients with chronic, unilateral, and non-traumatic 
shoulder pain This study took place between September 2007 and December 2009 
The treatment consisted of physical therapy (aimed at eliminating MTrPs in shoulder 
muscles) for three months, compared with expectant management 
The primary outcome measure used was the Disabilities of Arm, Neck and Hand 
questionnaire (DASH) The secondary outcome measures used were the Visual Analogue 
Scale for pain for current pain (VAS-P1), the average pain in the last week (VAS-P2), the 
worst pain in the last week (VAS -P3), the global perceived effect (GPE), and the number 
of muscles with active or latent MTrPs Pnor to the study, it was calculated that in order to 
show a clinically relevant difference on the DASH, 104 patients would be needed (52 
patients per group) 
Chapter 5 describes the prevalence of MTrPs in 17 shoulder muscles in patients with 
unilateral shoulder pain Mainly because of logistical reasons, this study was completed 
with a smaller sample size than was originally calculated All patients (n = 72), who were 
included in the RCT, were examined pnor to randomization for the presence of active or 
latent MTrPs 5 The number of muscle MTrPs was counted 
Muscles containing active or latent MTrPs were found in all 72 subjects The median 
number of muscles with active MTrPs was 6 (ranging from 2 to 16) The median number 
of muscles with latent MTrPs was 4 (ranging from 0 to 11) Active MTrPs were most 
prevalent in the infraspinatus, upper trapezius, and middle deltoid muscles Latent MTrPs 
were most prevalent in the teres major, antenor deltoid, and upper trapezius muscles The 
number of muscles with active MTrPs only moderately correlated with the DASH score 
(Spearman's ρ = 0 3) The number of muscles with active MTrPs only explained 10% of the 
variation of the DASH outcome measure Other factors were the degree of sensitivity of the 
individual MTrPs, alone or in combination with the number MTrPs per muscle In addition, 
there may have been other relevant factors that were not included in this study 
Based on these prevalence data, examination for the presence of MTrPs in patients with 
shoulder pain is recommended 
Chapter 6 describes the results of physical therapy in patients with chronic, unilateral 
non-traumatic shoulder pain In the period from September 2007 to December 2009, 65 
patients were included in this study Patients in the intervention group were treated by one 
of five expenenced physical therapists from the same physical therapy practice, specialized 
in the management of patients with musculoskeletal disorders of the neck, shoulder and 
arm, once a week for a 3-month penod Patients in the control group remained on the 
waiting list They were instructed not to change their self-management regarding their 
shoulder pain or to report any changes At intake, relevant patient charactenstics were 
recorded and several questionnaires were completed The passive range of shoulder motion 
was measured and the number of muscles with MTrPs was counted The treatment consisted 
of inactivating the MTrPs by sustained compression of the MTrP, followed by stretching the 
muscle, including the "taut band", and a combination of muscle stretching exercises and a 
cold application (which was a vanant of the spray-and-stretch method originally descnbed 
by Dr Janet Traveil) 
Subsequently, the patients were instructed to perform muscle stretching and relaxation 
exercises several times a day When appropriate, these relaxation exercises were augmented 
by the use of a (portable) myofeedback device Finally, all patients received ergonomie 
advice and instructions to assume and maintain "good posture" 
In this study, we chose an intervention strategy aimed at treating MTrPs that best 
reflects daily physical therapy practice The idea behind this was that the different parts 
might have no (permanent) or little effect separately, whereas their combination may have 
an effect as the various components reinforce each other The disadvantage of this approach 
is that the influence of the various components of the final outcome remains unknown 
Compared to the control group, after 12 weeks the intervention group scored 
significantly better on the pnmary and secondary outcome measures (DASH, VAS PI, P2 
and VAS VAS-P3) The differences were all clinically relevant 
After 12 weeks, 55% of the patients in the intervention group were reported to have 
improved versus 14% in the control group Also, the extent to which the patients improved 
was significantly greater in the intervention group than in the control group The average 
number of muscles with active MTrPs decreased significantly in the intervention group, 
whereas this number increased in the control group The number of muscles with latent 
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MTrPs did not change significantly in the intervention group and was significantly decreased 
in the control group The number of muscles with active MTrPs moderately correlated with 
the improvement in the DASH score (Pearson's r = 0.49) All of the abovementioned effects 
were achieved after 12 weeks. 
Although after 6 weeks a slight trend was seen in the improvement of the outcomes in 
favor of the intervention group, the difference between the two groups after 6 weeks was 
not significant. Because the study ended after 3 months, no conclusions can be drawn 
concerning the effects of the treatment beyond this period, but it is conceivable that a 
longer-term treatment may lead to a better result. 
Chapter 7 presents the general discussion and the main conclusions of this thesis. 
The main conclusions of this thesis were: 
• MTrPs provide a promising new explanation and treatment target for shoulder pain, 
which is well grounded in pathophysiological knowledge. 
• MTrPs in the shoulder muscles can be reliably determined by palpation and are an 
important addition to the physical examination. 
• MTrPs are highly prevalent in shoulder muscles in patients with chronic, unilateral, 
non-traumatic shoulder pain. 
• Most active MTrPs were found in the infraspinatus, the upper trapezius, and the middle 
deltoid muscles Most latent MTrPs were found in the teres major, anterior deltoid, and 
the upper trapezius muscles 
• The multimodal treatment of MTrPs in shoulder muscles in patients with chronic, 
unilateral, non-traumatic shoulder pain is effective. 
• The multimodal treatment of MTrPs in shoulder muscles in patients with chronic, 
unilateral, non-traumatic shoulder pain takes 12 weeks to complete at a frequency of 
one treatment per week. 
References 
1 The subacromial space lies underneath ihe acromion, the coraco-acromial ligament, and the coracoid process 
and above the humeral head, the upper margin of the glenoid fossa and the supenor labrum 
2 Referred pain (RP) is not felt at the site of a tissue lesion but is fell at some distance from it, often entirely 
remote from us source It is often described as radiating pain 
3 A local twitch response (LTR) is a transient contraction of a group of tense muscle fibers (taut band) that 
traverse an MTrP The LTR can be elicited by snapping palpation of the taut band or by needling the MTrP 
4 The jump sign is a general pain response of the patient, who winces, may cry out, and may withdraw in 
response to pressure applied to an MTrP 
5 Active MTrPs cause spontaneous pain in rest or during (repeated) movement The pain that anses from firm 
digital palpation is recognized as the patients' familiar pain Latent MTrPs have the same characteristics as 
active MTrPs, but they are clinically silent 
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Schouderpijn is na lage-rugpijn en nekpijn, de meest voorkomende klacht van het 
musculoskeletale systeem Zowel in Nederland, als in diverse andere landen, wordt het 
percentage personen met schouderpijn in de bevolking geschat op zo'n 20 tot 50% per jaar 
Schouderpijn heeft een belangrijke invloed op het dagelijks functioneren van de individuele 
patient Ongeveer de helft van alle patiënten met schouderpijn zoekt medische hulp 
Verder blijkt dat patiënten moeilijk herstellen van schouderpijn en dat deze klacht, ondanks 
medische behandeling, gemakkelijk recidiveert Schouderpijn heeft met alleen invloed op 
de individuele patient, maar ook op de totale samenleving door ziekteverzuim en directe 
en indirecte kosten 
De begnppen 'schouderpijn' (shoulder pain), 'schouderklachten' (shoulder complaints) 
en schouderaandoening' (shoulder disorder) worden vaak door elkaar gebruikt In dit 
proefschrift gebruiken we zoveel mogelijk de term schouderpijn (shoulder pain), omdat 
pijn een van de belangrijkste klachten is waarmee de patiënt bij de dokter of fysiotherapeut 
komt Schouderpijn door traumata valt buiten het bestek van dit proefschrift Het klinische 
beeld, waarmee de patiënt zich presenteert, bestaat uit pijn aan de voor- of zijkant van de 
schouder, vaak uitstralend naar halverwege de bovenarm en soms zelfs tot in de onderarm 
en hand De pijn is vaak m rust aanwezig en wordt vnjwel altijd uitgelokt of verergerd door 
(herhaalde) bewegingen of houdingen van de arm De patient slaapt vaak slecht, omdat hij/ 
zij noch op de aangedane schouder, noch op de met-aangedane schouder kan liggen De 
pijn leidt regelmatig tot beperkingen in het dagelijks leven en participatieproblemen in 
werk, sport en hobby's 
De verklaring voor met-traumatische schouderpijn wordt gezocht in veronderstelde locale 
pathologische veranderingen in de subacromiale ruimte', bestaande uit een ontsteking van 
de pezen van de rotator cuff of de subacromiale bursa of degeneratieve verandenngen in de 
subacromiale ruimte, zoals degeneratieve scheuren van de rotator cuff Er zijn in 
toenemende mate wetenschappelijke aanwijzingen dat deze lokale ontstekingen met de 
causale verklaring bieden voor schouderpijn Degeneratieve veranderingen van de rotator 
cuff worden net zo vaak gezien bij personen zonder schouderklachten als bij patiënten mét 
schouderklachten Het is dan ook onduidelijk of afwijkende bevindingen van aanvullend 
beeldvormend onderzoek, waaronder echografie en magnetic resonance imaging (MRI), 
verklarend zijn voor het bestaan of ontstaan van schouderpijn 
De belangrijkste etiologische verklaring voor deze schouderpijn is beschreven door dr 
Charles Neer, die in 1972 stelde, dat de zogenaamde subacromiale ruimte bij deze patiënten 
te genng was Door deze te gennge ruimte ontstaat er inklemming van de bursa en de 
pezen van de rotator cuff Het voortdurend repeterend inklemmen van deze structuren zou 
kunnen leiden tot acute of, bij voortduring, tot chronische bursitis en degeneratieve 
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scheuren in de pezen van de rotator cuff Du wordt het subacromiale impingement 
syndroom (SIS) genoemd en wordt tot op heden als belangrijkste verklaring voor met-
traumatische schouderpijn gehanteerd Hoewel het lichamelijk onderzoek bij patiënten 
met schouderpijn en het aanvullend beeldvormend onderzoek weinig diagnostisch valide 
zijn en er weinig overtuigend bewijs voor de effectiviteit van de verschillende interventies, 
gencht op de behandeling van de gevolgen van het SIS, bestaat, is de vraag gerechtvaardigd 
of er niet een andere mogelijke verklaring is voor de schouderpijn 
Tot op heden is er in de wetenschappelijke literatuur over het ontstaan of voortbestaan van 
schouderpijn niet of nauwelijks aandacht voor de rol van myofasciale tnggerpomts (MTrPs) 
in schouderspieren MTrPs zijn lokale veranderingen in skeletspieren, die sensorische, 
motorische en autonome verschijnselen kunnen geven Een MTrP is gedefinieerd als een 
sterk prikkelbare plaats in de skeletspier, die samenvalt met een overgevoelige palpabele 
spierverharding ('nodule') in een strakke band MTrPs worden ingedeeld in actieve en 
latente trigger points Actieve MTrPs geven spontane pijnklachten en latente MTrPs geven 
alleen pijn en andere sensaties bij directe stimulatie door mechanische druk of door 
aanspanning of rek van de spier Zowel actieve als latente MTrPs kunnen verminderde 
beweeglijkheid van de schouder en krachtsverhes van de schouderspieren tot gevolg 
hebben Het doel van het onderzoek, dat beschreven is in dit proefschrift, is om meer 
inzicht te verkrijgen in de rol van de MTrPs bij patiënten met schouderpijn 
Alvorens in te gaan op de invloed van MTrPs op de klacht bij patiënten met schouderpijn, 
wordt in hoofdstuk 2 beschreven wat er bekend is over de enologie, de pathofysiologie 
van MTrPs en de klinische implicaties voor de fysiotherapeutische behandeling Het zijn 
met name dr Janet Traveil (1901-1997) en dr David Simons (1922-2010) geweest, die 
MTrPs onder de aandacht hebben gebracht van (para-)medici 
De uitgebreide, geïntegreerde hypothese beschrijft de complexe interactie, die het 
ontstaan en het persisteren van MTrPs kan helpen verklaren Er wordt daarin aangenomen, 
dat er diverse mechanismen zijn die MTrPs kunnen veroorzaken, zoals langdurig 
aangehouden of veelvuldig herhaalde contracties, ongewone excentrische of concentrische 
contracties, waarbij hoge intramusculaire druk ontstaat, en direct (spierkneuzing) of 
indirect (overrekkingsletsel) spiertrauma In alle gevallen gaat het om situaties, waarbij de 
belasting van de spier als anatomische structuur de belastbaarheid kortdurend, herhaaldelijk 
of langdurig overstijgt Gedurende deze situaties ontstaan biochemische veranderingen in 
en om de spiervezels, die enerzijds leiden tot een toegenomen en aanhoudende contractuur 
(contractie, als gevolg van hoge concentraties Ca2+ in de spiervezel, zonder depolansaties) 
en anderzijds tot het vrijkomen van talrijke aan nocisensonek en pijn gerelateerde stoffen 
Er is in deze conditie geen sprake van een activiteit vanuit de motorische zenuwvezel die 
tot deze aanhoudende contractie leidt Als gevolg van deze spieroverbelasting ontstaat een 
tekort aan adenosinetnfosfaat (ATP) Deze energierijke stof is nodig om de grote hoeveelheid 
aan myosine en actine gebonden Ca2+ vnj te maken en terug op te nemen in het 
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sarcoplasmatisch reticulum. Door dit tekort blijven de myosine en actine eiwitten 
gekoppeld, waardoor de spiercel verkort en verdikt. Deze verdikking, zo wordt aangenomen, 
zorgt voor obstructie van de bloedtoevoer via de allerkleinste weefselcapillairen, waardoor 
ischemie en hypoxie van de spier ontstaat. Voor de vorming van ATP zijn grote hoeveelheden 
zuurstof nodig, die via de capillaire aanvoer moet worden verkregen. De verdikte spiercellen 
verhinderen deze aanvoer en een zich zelf in standhoudende situatie is ontstaan. 
Hoofdstuk 3 beschnjft het onderzoek naar de interbeoordelaarsbetrouwbaarheid van 
palpane naar het voorkomen van MTrPs in drie schouderspieren, namelijk de M. 
infraspinatus, de M deltoideus pars anterior en de M. biceps brachii. Bij 40 proefpersonen 
werden aan beide schouders in totaal 6 MTrP locaties onderzocht. Van deze proefpersonen 
hadden 30 enkelzijdige schouderklachten en 10 hadden op het moment van onderzoek 
geen schouderklachten. Elke proefpersoon werd door drie verschillende onderzoekers 
onderzocht. De onderzoekers wisten niet of de schouder pijnlijk was en zo ja, welke 
schouder pijnlijk was. Er werd gescoord op de aan- of afwezigheid van een voelbare 
verharding in een strakke streng, het opwekken van 'referred pain2' (RP), en de mogelijkheid 
tot het opwekken van een 'local twitch response3' (LTR) of het veroorzaken van een 'jump 
sign4'. De zo verkregen gegevens werden tussen de dne beoordelaars paarsgewijs vergeleken 
Op basis van de combinatie van bevindingen werd gescoord op de aan- of afwezigheid van 
een MTrP De meest betrouwbare kenmerken van MTrPs waren het opwekken van RP en 
een 'jump sign' , gevolgd door de lokalisatie van een lokale verharding (nodule) in een 
strakke streng (taut band) en de LTR. De hoogste mate van betrouwbaarheid voor de aan-
of afwezigheid van een MTrP werd gevonden in de M. infraspinatus. Een van de drie 
onderzoekers had twee jaar ervaring in MTrP-therapie en de andere twee onderzoekers 
hadden respectievelijk 21 en 16 jaar ervaring met MTrP-therapie Er werd daarbij geen 
verschil gevonden in de mate van overeenkomst tussen de verschillende combinaties van 
onderzoekers Op basis van dn onderzoek werd geconcludeerd dat de palpane van MTrPs 
in deze schouderspieren betrouwbaar was en een goede aanvulling was op het lichamelijk 
onderzoek bij patiënten met met-traumatische schouderpijn Verder blijkt dat twee jaar 
ervaring voldoende was om du even betrouwbaar te doen als iemand met langere ervaring. 
Hoofdstuk 4 beschnjft het onderzoeksprotocol voor een gerandomiseerd, gecontroleerd 
onderzoek (Randomized Controlled Tnal [RCT]) naar de effectiviteit van MTrP therapie bij 
patiënten met chronische, enkelzijdige, niet-traumatische schouderpijn. Du onderzoek heeft 
plaatsgevonden tussen september 2007 en december 2009 De behandeling bestond uit 
fysiotherapeutische behandeling (gencht op het opheffen van MTrPs in schouderspieren) 
gedurende dne maanden, vergeleken met een afwachtend beleid De pnmaire uitkomstmaat 
was de score op Disabilities of Arm, Hand and Neck questionnaire (DASH). De secundaire 
uitkomstmaten waren de scores op Visual Analogue Scale voor pijn (VAS-P) voor de huidige 
pijn (VAS-P1), voor de gemiddelde pijn in de laatste week (VAS-P2), de hevigste pijn van de 
afgelopen week (VAS-P3), op het globaal ervaren effect (GPE), het aantal spieren met actieve 
of latente MTrPs. Voorafgaande aan het onderzoek werd berekend, dat voor een relevant 
klinisch verschil op de DASH, 104 patiënten nodig waren (52 patiënten per groep). 
Hoofdstuk 5 beschrijft de prevalentie van MTrPs in 17 schouderspieren bij patiënten 
met unilaterale schouderpijn. Door vooral logistieke problemen is het niet gelukt om het 
gewenste aantal patiënten te includeren. 
Alle patiënten (n=72), die werden geincludeerd voor de RCT, werden voorafgaande aan 
de randomisatie, onderzocht op de aanwezigheid van actieve en/of latente MTrPs5. Daarbij 
werd het aantal spieren geteld met MTrPs. 
Alle onderzochte patiënten hadden meerdere actieve en latente MTrPs. De mediaan van 
het aantal spieren met actieve MTrPs bedroeg 6 (vanërend van 2 tot 16) en met latente 
MTrPs 4 (vanerend van 0 tot 11). De spieren met de meeste actieve MTrPs waren de M. 
infraspinatus, de M. trapezius (pars descendens) en de M. deltoideus (pars médius). De 
spieren met de meeste latente MTrPs waren de M. teres major, de M deltoideus (pars 
antenor) en de M. trapezius (pars descendens). Er was een gennge correlatie tussen het 
aantal spieren met actieve MTrPs en de DASH score (spearman's ρ = 0 3). De hoogte van de 
DASH score wordt voor ongeveer 10% verklaard door het aantal spieren met actieve MTrPs. 
Andere factoren zijn de mate van gevoeligheid van de afzonderlijke MTrPs, al of niet in 
combinatie met het aantal MTrPs per spier Daarnaast zijn er wellicht ook andere relevante 
factoren, die in dit onderzoek met zijn meegenomen. Op basis van deze prevalentiegegevens 
wordt het onderzoeken van de patiënt met schouderpijn op de aanwezigheid van MTrPs 
aanbevolen. 
Hoofdstuk 6 beschnjft de resultaten van de fysiotherapeutische behandeling van 
patiënten met langdurige, enkelzijdige met-traumatische schouderpijn. In de penode van 
september 2007 tot december 2009 werden 65 patiënten geincludeerd. De patiënten in de 
interventiegroep werden door 5 ervaren fysiotherapeuten uit dezelfde gespecialiseerde 
fysiotherapie praktijk behandeld gedurende maximaal 3 maanden één keer per week. De 
patiënten in de controlegroep bleven op de wachtlijst staan en werden gevraagd hun zelf-
management/attitude ten aanzien van hun schouderpijn niet te veranderen of veranderingen 
tijdens de meetsessies te rapporteren Bij de intake werden de relevant geachte patient-
kenmerken vastgelegd, diverse vragenlijsten ingevuld, passieve bewegingsuitslagen van de 
schouder gemeten en het aantal spieren met MTrPs geteld. De behandeling bestond uit het 
inactiveren van MTrPs door aanhoudende druk op het MTrP, gevolgd door het rekken van de 
spier inclusief de 'taut band', en een combinatie van spierrekkingsoefemngen met ijsapplicatie 
(een vanant van de door Janet Traveil omschreven "spray and stretch'- methode). Vervolgens 
werden de patiënten geïnstrueerd meerdere keren per dag spierrekkings- en ontspannings-
oefeningen te doen. Indien gewenst, kon het leren ontspannen worden ondersteund met een 
(portable) myofeedbackapparaat Tenslotte kregen alle patiënten adviezen over hun houding, 
en ergonomische adviezen. In dit onderzoek is er voor gekozen om een behandeling gencht 
op MTrPs te geven, die overeenkomt met een fysiotherapeutische behandeling uu de 
dagelijkse praktijk. De gedachte hierachter is dat de verschillende onderdelen afzonderlijk 
geen of weinig (blijvend) effect hebben, maar dat de verschillende componenten elkaar 
versterken. Het nadeel van een dergelijke aanpak is, dat de invloed van de verschillende 
onderdelen op het eindresultaat onbekend blijft. 
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Vergeleken met de controlegroep scoorde de interventie groep na 12 weken op de primaire 
en secundaire uitkomstmaten (DASH, VAS-P1, VAS-P2 en VAS-P3) significant beter. De 
verschillen werden allen klinisch relevant beschouwd. Na 12 weken gaf 55% van de 
patiënten uit de interventiegroep aan te zijn verbeterd tegen 14% uit de controlegroep. 
Ook de mate waarin de patiënten verbeterden was groter in de interventiegroep dan in de 
controlegroep. Het gemiddelde aantal spieren met actieve MTrPs nam af in de interventie-
groep, terwijl dit aantal toenam in de controlegroep. Het aantal spieren met latente MTrPs 
veranderde in de interventiegroep met-significant en nam significant af in de controlegroep. 
Er werd een positieve correlatie gevonden tussen de afname van het aantal spieren met 
actieve MTrPs en de verbetering van de DASH-score (r = 0.49) Alle bovengenoemde 
effecten werden bereikt na 12 weken. Hoewel er na 6 weken een lichte trend was te zien in 
de verbetering op de uitkomstmaten in het voordeel van de interventiegroep, was het 
verschil tussen beide groepen na 6 weken niet significant. Omdat het onderzoek na 3 
maanden eindigde kunnen geen uitspraken worden gedaan over het effect van een behan-
deling die langer duurt dan dne maanden, maar het is niet ondenkbaar dat een langer 
durende behandeling wellicht tot een beter resultaat leidt. 
In hoofdstuk 7 worden de discussie en belangrijkste conclusies van dit proefschrift 
gepresenteerd. 
De belangrijkste conclusies van dit proefschrift zijn: 
• MTrPs leveren een veelbelovende verklaring en nieuwe behandelmogelijkheden voor 
schouderpijn, gebaseerd op pathofysiologische inzichten 
• MTrPs in schouderspieren kunnen voldoende betrouwbaar worden vastgesteld door 
palpane en zijn een belangrijke aanvulling op het lichamelijk onderzoek. 
• MTrPs komen veelvuldig voor in schouderspieren bij patiënten met chronische, 
enkelzijdige, niet-traumatische schouderpijn. 
• De meeste actieve MTrPs werden gevonden in de M infraspinatus, de M. trapezius 
(pars descendens) en de M deltoideus (pars médius) De meeste latente MTrPs werden 
gevonden in de M. teres major, M. deltoideus (pars antenor) en de M. trapezius (pars 
ascendens). 
• De behandeling van MTrPs in schouderspieren bij patiënten met chronische, enkel-
zijdige, met-traumatische schouderpijn is effectief 
• De effectieve behandeling van MTrPs in schouderspieren bij patiënten met chronische, 
enkelzijdige, niet-traumatische schouderpijn neemt 12 weken in beslag bij een frequentie 
van één behandeling per week 
Voetnoten 
1 De subacromiale ruimte is aan de bovenzijde begrensd door het acromion, het ligamentum coraco-acromiale 
en het processus coracoideus en aan de onderzijde door de bovenrand van de cavitas glenoidale, hel labrum 
glenoidale en het caput humen 
2 Referred pain is pijn die niet gevoeld wordt op de plek van de weefselbeschadiging, maar die gevoeld wordt 
op enige afstand van die plek Du wordt vaak omschreven als uitstralende pijn of irradiatie 
3 Local twitch response (LTR) is een korte contractie van een groep spiervezels in de strakke streng (taut band) 
Deze LTR ontstaat als gevolg van een kone dwarse manipulatie van de strakke streng of door het aanpnkken 
van het MTrP met een (injectie, emg of acupunctuur) naald 
4 Jump sign is een algemene respons van de patiënt in de vorm van grimassen, kreunen, terugtrekreactie als 
reactie op de palpane van een MTrP 
5 Actieve MTrPs veroorzaken spontane pijn in rust of bij (herhaald) bewegen De pijn die ontstaat als gevolg 
van palpane wordt door de patient herkend als de 'bekende' pijn Latente MTrPs hebben alle karakteristieken 
van een MTrP, zijn ook drukpijnlijk, maar geven bij palpane geen herkenbare pijn 
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STELLINGEN 
behorend bij het proefschrift 
MYOFASCIAL TRIGGER POINTS IN SHOULDER PAIN. 
Prevalence, diagnosis and therapy 
Card Bron, 19apnl2011 
1 Myofasciale tnggerpoints in schouderspieren zijn betrouwbaar vast te stellen 
door palpane (dit proefschnft) 
2 Myofasciale tnggerpoints in schouderspieren komen zeer frequent voor bij 
patiënten met chronische met-traumatische schouderklachten (du proefschnft) 
3 Het aantal spieren met myofasciale tnggerpoints voorspelt met de ernst 
van de klacht (du proefschnft) 
4 Fysiotherapeutische behandeling van myofasciale tnggerpoints bij 
schouderklachten is effectief (du proefschnft) 
5 Er bestaat een positieve correlatie tussen de afname van pijnklachten 
en het verbeteren van het functioneren enerzijds en de afname van het aantal 
spieren met myofasciale tnggerpoints anderzijds (du proefschnft) 
6 Lijkbleek is dichter bij de waarheid dan spierwit 
7 Spierpijn (muscle pain) is meer dan alleen maar spierpijn (muscle soreness) 
8 De term "subacromiale pijn" suggereert ten onrechte dat de diepgevoelde 
schouderpijn zijn oorsprong vindt in de subacromiaal gelegen anatomische 
structuren 
9 Het gemotiveerd afwijken van de richtlijnen op basis van resultaten van 
"nieuw" wetenschappelijk onderzoek moet met alleen worden getolereerd, 
maar zelfs worden aangemoedigd om de voortgang in de ontwikkeling van 
de geneeskunde in het algemeen en de fysiotherapie in het bijzonder niet te 
belemmeren 
10 Een promovendus heeft vaker behoefte aan een hfehne dan aan een deadline 
11 There is nothing so practical as a good theory (Kurt Lewin (1890- 1947) 
12 Although skeletal muscle occupies nearly half of our body, no medical 
specialty claims it as its focus organ (David G Simons 1922-2010) 
13 Het is buiten kijf dat een buitenpromovendus buitengewoon weinig in 
de buitenlucht komt 

